Strategies for prevention of ultrasound-guided prostate biopsy infections

Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/ oncology patients after anticancer chemotherapy naima a al-Mulla

[1]  Mimi,et al.  Taylor, , 2020, Catalysis from A to Z.

[2]  S. Pool,et al.  Principles of Clinical Medicine for Space Flight , 2020 .

[3]  W. Shimp.  How Long Is This Going to Take? , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Dayan Wang,et al.  Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017 , 2018, Antiviral research.

[5]  S. Michie,et al.  Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.

[6]  Alan H. Feiveson,et al.  Study of the Impact of Long-Term Space Travel on the Astronauts' Microbiome. (Microbiome) , 2017 .

[7]  O. Manuel,et al.  Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  D. Kowalski,et al.  Pharmacokinetic and Pharmacodynamic Evaluation of the Drug‐Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects , 2016, Clinical pharmacology in drug development.

[9]  T. Chao,et al.  Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[10]  D. Kowalski,et al.  Pharmacokinetic Assessment of Drug‐Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults , 2016, Clinical pharmacology in drug development.

[11]  D. Kowalski,et al.  Pharmacokinetic Evaluation of CYP3A4‐Mediated Drug‐Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults , 2016, Clinical pharmacology in drug development.

[12]  D. Kowalski,et al.  Pharmacokinetic Interaction Between Isavuconazole and a Fixed‐Dose Combination of Lopinavir 400 mg/Ritonavir 100 mg in Healthy Subjects , 2016, Clinical pharmacology in drug development.

[13]  D. Kowalski,et al.  Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects , 2016, Clinical pharmacology in drug development.

[14]  D. Kowalski,et al.  Pharmacokinetic Effects of Isavuconazole Coadministration With the Cytochrome P450 Enzyme Substrates Bupropion, Repaglinide, Caffeine, Dextromethorphan, and Methadone in Healthy Subjects , 2016, Clinical pharmacology in drug development.

[15]  B. Wynne,et al.  The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects , 2016, Journal of acquired immune deficiency syndromes.

[16]  Christine S. M. Lau,et al.  Sequential (as Opposed to Simultaneous) Antibiotic Therapy Improves Helicobacter pylori Eradication in the Pediatric Population , 2016, Clinical pediatrics.

[17]  W. Hope,et al.  Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis , 2016, Expert review of clinical pharmacology.

[18]  P. Bonate,et al.  Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study) , 2016, Antimicrobial Agents and Chemotherapy.

[19]  J. Perfect,et al.  Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Ruobing Wang,et al.  Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance. , 2016, International journal of antimicrobial agents.

[21]  Y. Chen,et al.  Rapid onset of rhabdomyolysis after switching to a raltegravir-based antiretroviral regimen. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[22]  M. Lappalainen,et al.  Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012 , 2016, Infectious diseases.

[23]  A. Shorr,et al.  Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial , 2016, Journal of medical economics.

[24]  S. Mujais,et al.  Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment , 2016, Antimicrobial Agents and Chemotherapy.

[25]  Christine S. M. Lau,et al.  Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis , 2016, International journal of general medicine.

[26]  J. Baddley,et al.  Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial , 2016, The Lancet.

[27]  T. Walsh,et al.  Pharmacokinetics and Concentration-Dependent Efficacy of Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis , 2016, Antimicrobial Agents and Chemotherapy.

[28]  J. You,et al.  Cost-effectiveness of culture-guided antimicrobial prophylaxis for the prevention of infections after prostate biopsy. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[29]  T. Wichelhaus,et al.  The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections. , 2016, Deutsches Arzteblatt international.

[30]  J. Cohen,et al.  A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs. , 2016, Vaccine.

[31]  U. Bødtger,et al.  Bad news itself or just the messenger? The high mortality of Fusobacterium spp. infections is related to disseminated malignancy and other comorbidities , 2016, European Clinical Respiratory Journal.

[32]  A. Wald,et al.  Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial. , 2015, The Journal of infectious diseases.

[33]  W. Halford,et al.  Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2 , 2015, PloS one.

[34]  R. Agarwal,et al.  Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta‐analysis , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  A. Nishimoto,et al.  Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent. , 2015, Pharmacotherapy.

[36]  J. Goodwin,et al.  Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis , 2015, Antimicrobial Agents and Chemotherapy.

[37]  R. Orel,et al.  Are probiotics useful in Helicobacter pylori eradication? , 2015, World journal of gastroenterology.

[38]  M. Arendrup,et al.  In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order , 2015, Antimicrobial Agents and Chemotherapy.

[39]  A. Chowdhary,et al.  Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species , 2015, Antimicrobial Agents and Chemotherapy.

[40]  D. Kelvin,et al.  Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model , 2015, Antimicrobial Agents and Chemotherapy.

[41]  N. Srivali,et al.  Diagnosis and treatment of Lemierre syndrome. , 2015, The American journal of emergency medicine.

[42]  R. Rajendran,et al.  Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. , 2015, International journal of antimicrobial agents.

[43]  K. Kavanagh,et al.  The innate immune response to Aspergillus fumigatus at the alveolar surface. , 2015, FEMS microbiology reviews.

[44]  A. Hollister,et al.  Population Pharmacokinetics of Peramivir in Healthy Volunteers and Influenza Patients , 2015, Antimicrobial Agents and Chemotherapy.

[45]  S. A. Abdool Karim,et al.  Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. , 2015, The New England journal of medicine.

[46]  G. Maartens,et al.  Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[47]  M. Liss,et al.  Comparative Effectiveness of Targeted vs Empirical Antibiotic Prophylaxis to Prevent Sepsis from Transrectal Prostate Biopsy: A Retrospective Analysis. , 2015, The Journal of urology.

[48]  M. Castanheira,et al.  Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values. , 2015, Diagnostic microbiology and infectious disease.

[49]  T. Khawcharoenporn,et al.  Lemierre's Syndrome Caused by Klebsiella pneumoniae in a Diabetic Patient: A Case Report and Review of the Literature. , 2015, Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health.

[50]  M. Ison,et al.  Peramivir: an intravenous neuraminidase inhibitor , 2015, Expert opinion on pharmacotherapy.

[51]  H. Noh,et al.  Lemierre syndrome: a rare complication of pharyngotonsillitis , 2015, Brazilian journal of otorhinolaryngology.

[52]  B. Cao,et al.  ARDS associated with pneumonia caused by avian influenza A H7N9 virus treated with extracorporeal membrane oxygenation , 2015, The clinical respiratory journal.

[53]  J. A. Ferreira,et al.  Molecular epidemiology of Aspergillus collected from cystic fibrosis patients. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[54]  R. Cohrs,et al.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. , 2015, The Journal of general virology.

[55]  D. Kontoyiannis,et al.  The ‘cephalosporin era’ of triazole therapy: isavuconazole, a welcomed newcomer for the treatment of invasive fungal infections , 2015, Expert opinion on pharmacotherapy.

[56]  E. Holbrook,et al.  Invasive fungal disease of the sinus and orbit: a comparison between mucormycosis and Aspergillus , 2015, British Journal of Ophthalmology.

[57]  P. Schlattmann,et al.  Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance , 2015, Antimicrobial Agents and Chemotherapy.

[58]  J. Meis,et al.  Multi‐triazole‐resistant Aspergillus fumigatus infections in Australia , 2015, Mycoses.

[59]  T. Walsh,et al.  Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single‐centre study with focus on emerging pathogens , 2015, Mycoses.

[60]  D. Kontoyiannis,et al.  Isavuconazole: a new extended spectrum triazole for invasive mold diseases. , 2015, Future microbiology.

[61]  D. Snider,et al.  Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. , 2015, The American review of respiratory disease.

[62]  R. Loudon,et al.  Cough frequency and infectivity in patients with pulmonary tuberculosis. , 2015, The American review of respiratory disease.

[63]  Garrett E. Schramm,et al.  An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance , 2015, Critical Care.

[64]  W. Lowrance,et al.  An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy , 2015, World Journal of Urology.

[65]  M. Duggins,et al.  Internal Jugular Vein Septic Thrombophlebitis (Lemierre Syndrome) as a Complication of Pharyngitis , 2015, The Journal of the American Board of Family Medicine.

[66]  M. J. Rabanaque-Hernández,et al.  Prevalence of concomitant medications in older HIV+ patients and comparison with general population , 2015, HIV clinical trials.

[67]  F. Oner,et al.  Extensive thoracolumbosacral vertebral osteomyelitis after Lemierre syndrome , 2015, European Spine Journal.

[68]  P. Le Pape,et al.  First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France , 2015, Antimicrobial Agents and Chemotherapy.

[69]  P. L. McCormack.  Isavuconazonium: First Global Approval , 2015, Drugs.

[70]  Andreas Dötsch,et al.  Constitutive production of c-di-GMP is associated with mutations in a variant of Pseudomonas aeruginosa with altered membrane composition , 2015, Science Signaling.

[71]  S. Piscitelli,et al.  Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol , 2015, The Annals of pharmacotherapy.

[72]  John Green,et al.  2014 UK national guideline for the management of anogenital herpes , 2015, International journal of STD & AIDS.

[73]  C. Charpentier,et al.  Pharmacokinetics of Dolutegravir in a Premature Neonate after HIV Treatment Intensification during Pregnancy , 2015, Antimicrobial Agents and Chemotherapy.

[74]  N. Khardori,et al.  Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model , 2015, Annals of Clinical Microbiology and Antimicrobials.

[75]  H. Zimmermann,et al.  Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir. , 2015, Antiviral research.

[76]  Wen-Sen Lee,et al.  Lemierre syndrome with cervical spondylodiscitis and epidural abscess associated with direct injection of heroin into the jugular vein. , 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[77]  Y. Ota,et al.  Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan , 2015, The clinical respiratory journal.

[78]  M. Hotz,et al.  Septic thrombosis of the internal jugular vein: Lemierre's syndrome revisited , 2015, The Laryngoscope.

[79]  M. Ramgopal,et al.  Dolutegravir versus Placebo in Subjects Harbouring HIV-1 with Integrase Inhibitor Resistance Associated Substitutions: 48-Week Results from VIKING-4, a Randomized Study , 2015, Antiviral therapy.

[80]  J. Campos,et al.  Combatting resistance in intensive care: the multimodal approach of the Spanish ICU “Zero Resistance” program , 2015, Critical Care.

[81]  P. Polgreen,et al.  The importance of considering different healthcare settings when estimating the burden of Clostridium difficile. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  C. Papadopoulou,et al.  Vancomycin-resistance phenotypes, vancomycin-resistance genes, and resistance to antibiotics of enterococci isolated from food of animal origin. , 2015, Foodborne pathogens and disease.

[83]  K. Ono,et al.  Exacerbation of myasthenia gravis by intravenous peramivir , 2015, Muscle & nerve.

[84]  N. Karahan,et al.  The effects of probiotics on treatment of Helicobacter pylori eradication in children , 2015, Saudi medical journal.

[85]  Masatsugu Nagahama,et al.  Liver abscessation and multiple septic pulmonary emboli associated with Lemierre’s syndrome: a case report , 2015, BMC Research Notes.

[86]  S. Marcella,et al.  An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States , 2015, Journal of medical economics.

[87]  S. Morré,et al.  Prevalence and macrolide resistance of Mycoplasma genitalium in South African women. , 2015, Sexually transmitted diseases.

[88]  F. Grenouillet,et al.  Evaluation of mold exposure in cystic fibrosis patients' dwellings and allergic bronchopulmonary risk. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[89]  B. Ramsey,et al.  Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[90]  T. Monaghan.  New perspectives in Clostridium difficile disease pathogenesis. , 2015, Infectious disease clinics of North America.

[91]  A. Schulz,et al.  Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[92]  P. Barie,et al.  Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI) , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  A. Beauvais,et al.  Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines , 2015, Scientific Reports.

[94]  M. Mrkobrada,et al.  CUA Guidelines on antibiotic prophylaxis for urologic procedures. , 2015, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[95]  S. Mella,et al.  Case 36-2014: A woman with fever, pharyngitis, and double vision. , 2015, The New England journal of medicine.

[96]  Wei Liu,et al.  A Novel New Delhi Metallo-β-Lactamase Variant, NDM-14, Isolated in a Chinese Hospital Possesses Increased Enzymatic Activity against Carbapenems , 2015, Antimicrobial Agents and Chemotherapy.

[97]  W. Hickerson,et al.  Linezolid Bladder Irrigation as Adjunctive Treatment for a Vancomycin-Resistant Enterococcus faecium Catheter-Associated Urinary Tract Infection , 2015, The Annals of pharmacotherapy.

[98]  F. Luciani,et al.  Naturally Occurring Dominant Drug Resistance Mutations Occur Infrequently in the Setting of Recently Acquired Hepatitis C , 2015, Antiviral therapy.

[99]  J. Pogliano,et al.  Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE. , 2015, The Journal of antimicrobial chemotherapy.

[100]  Mark W. Ball,et al.  Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis. , 2015, The Journal of urology.

[101]  C. Zala,et al.  Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks , 2015, Clinical Drug Investigation.

[102]  J. Lynch,et al.  Profile of delamanid for the treatment of multidrug-resistant tuberculosis , 2015, Drug design, development and therapy.

[103]  A. Schmitt-Hoffmann,et al.  Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study , 2015, Antimicrobial Agents and Chemotherapy.

[104]  K. McKeage.  Posaconazole: A Review of the Gastro-Resistant Tablet and Intravenous Solution in Invasive Fungal Infections , 2015, Drugs.

[105]  E. Caumes,et al.  Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[106]  A. Kreuter,et al.  2013 European guideline on the management of lymphogranuloma venereum , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[107]  J. Mullins,et al.  Lack of Resistance to Integrase Inhibitors among Antiretroviral-Naive Subjects with Primary HIV-1 Infection, 2007–2013 , 2015, Antiviral therapy.

[108]  S. Piscitelli,et al.  Pharmacokinetics of Dolutegravir When Administered With Mineral Supplements in Healthy Adult Subjects , 2014, Journal of clinical pharmacology.

[109]  W. Artibani,et al.  Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: a comparative evaluation at the same institution. , 2014, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[110]  M. Hosoya,et al.  Influenza Viral Load and Peramivir Kinetics after Single Administration and Proposal of Regimens for Peramivir Administration against Resistant Variants , 2014, Antimicrobial Agents and Chemotherapy.

[111]  J. Praestgaard,et al.  Pharmacokinetics of LFF571 and Vancomycin in Patients with Moderate Clostridium difficile Infections , 2014, Antimicrobial Agents and Chemotherapy.

[112]  R. Vilaichone,et al.  Improved eradication rate of standard triple therapy by adding bismuth and probiotic supplement for Helicobacter pylori treatment in Thailand. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[113]  L. Hartley-Tassell,et al.  Ferrets exclusively synthesize Neu5Ac and express naturally humanized influenza A virus receptors , 2014, Nature Communications.

[114]  A. Monto,et al.  Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[115]  Hsin-Yi Lin,et al.  Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis , 2014, BMC Infectious Diseases.

[116]  J. Hocking,et al.  Treatment of rectal chlamydia infection may be more complicated than we originally thought. , 2014, The Journal of antimicrobial chemotherapy.

[117]  S. Tzipori,et al.  Immune-based treatment and prevention of Clostridium difficile infection , 2014, Human vaccines & immunotherapeutics.

[118]  Blake Max,et al.  Dolutegravir: a new HIV integrase inhibitor for the treatment of HIV infection , 2014 .

[119]  D. Raoult,et al.  Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. , 2014, International journal of antimicrobial agents.

[120]  Tetsuya Matsumoto,et al.  A first case of New Delhi metallo-β-lactamase-7 in an Escherichia coli ST648 isolate in Japan. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[121]  B. Knoll.  Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery. , 2014, The Journal of antimicrobial chemotherapy.

[122]  J. Sznajder,et al.  Intratracheal administration of influenza virus is superior to intranasal administration as a model of acute lung injury. , 2014, Journal of virological methods.

[123]  T. Hummel,et al.  Study of Initial Colonization by Environmental Microorganisms in the Russian Segment of the International Space Station (ISS) , 2014 .

[124]  M. Bentley,et al.  Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza A pandemic. , 2014, International journal of clinical pharmacology and therapeutics.

[125]  J. Garnacho-Montero,et al.  How to treat VAP due to MDR pathogens in ICU patients , 2014, BMC Infectious Diseases.

[126]  Serge Morand,et al.  Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria , 2014, Front. Microbiol..

[127]  S. Chatterjee,et al.  A Five-Year Experience of Carbapenem Resistance in Enterobacteriaceae Causing Neonatal Septicaemia: Predominance of NDM-1 , 2014, PloS one.

[128]  K. Kazmierczak,et al.  Dissemination of NDM Metallo-β-Lactamase Genes among Clinical Isolates of Enterobacteriaceae Collected during the SMART Global Surveillance Study from 2008 to 2012 , 2014, Antimicrobial Agents and Chemotherapy.

[129]  Cheryl A Nickerson,et al.  Effects of sex and gender on adaptation to space: immune system. , 2014, Journal of women's health.

[130]  V. Papastergiou,et al.  Treatment of Helicobacter pylori infection: Past, present and future. , 2014, World journal of gastrointestinal pathophysiology.

[131]  P. Ruggiero.  Use of probiotics in the fight against Helicobacter pylori. , 2014, World journal of gastrointestinal pathophysiology.

[132]  P. Sly,et al.  Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. , 2014, American journal of respiratory and critical care medicine.

[133]  J. Shimada,et al.  Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[134]  H. Agut,et al.  Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism. , 2014, Antiviral research.

[135]  Z. Tandoğdu,et al.  Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate. , 2014, Urology.

[136]  M. O’Donnell,et al.  Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study. , 2014, The Journal of antimicrobial chemotherapy.

[137]  E. Poeschla,et al.  Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high‐risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin‐amphotericin combination therapies , 2014, Mycoses.

[138]  S. Hraiech,et al.  Respiratory infections in patients undergoing mechanical ventilation. , 2014, The Lancet. Respiratory medicine.

[139]  R. Porcher,et al.  Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[140]  Craig A. Martin,et al.  Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and Resistance , 2014, Pharmacotherapy.

[141]  MaryBeth Flynn Makic,et al.  Improving the assessment and treatment of pelvic inflammatory disease among adolescents in an urban children's hospital emergency department. , 2014, Journal of emergency nursing: JEN : official publication of the Emergency Department Nurses Association.

[142]  Ç. Çelikel,et al.  Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains? , 2014, European journal of gastroenterology & hepatology.

[143]  G. Bloemberg,et al.  A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment , 2014, European Respiratory Journal.

[144]  D. Raoult,et al.  Inhaled Lactonase Reduces Pseudomonas aeruginosa Quorum Sensing and Mortality in Rat Pneumonia , 2014, PloS one.

[145]  J. Armitage,et al.  Cyclic Di-GMP-Mediated Repression of Swarming Motility by Pseudomonas aeruginosa PA14 Requires the MotAB Stator , 2014, Journal of bacteriology.

[146]  K. Takamatsu,et al.  Safety and efficacy of peramivir for influenza treatment , 2014, Drug design, development and therapy.

[147]  S. Piscitelli,et al.  Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir , 2014, British journal of clinical pharmacology.

[148]  G. Raman,et al.  Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis , 2014, Antimicrobial Resistance and Infection Control.

[149]  P. Pitisuttithum,et al.  Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial , 2014, The Lancet.

[150]  T. Sawa,et al.  Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa , 2014, Human vaccines & immunotherapeutics.

[151]  D. Nathwani,et al.  Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[152]  Kelly R. Reveles,et al.  The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010. , 2014, American journal of infection control.

[153]  T. Betsuyaku,et al.  Pharmacokinetics of arbekacin in bronchial epithelial lining fluid of healthy volunteers. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[154]  C. Landelle,et al.  Infection control measures to decrease the burden of antimicrobial resistance in the critical care setting , 2014, Current opinion in critical care.

[155]  G. Barril,et al.  Renal tubular transporter-mediated interactions of HIV drugs: implications for patient management. , 2014, AIDS reviews.

[156]  J. Vincent,et al.  Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa* , 2014, Critical care medicine.

[157]  N. Yamakita,et al.  Lemierre syndrome caused by oral sex. , 2014, Journal of the Formosan Medical Association = Taiwan yi zhi.

[158]  A. Van Deun,et al.  Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[159]  S. Doudounakis,et al.  Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis. , 2014, Medical mycology.

[160]  Ronald N. Jones,et al.  Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. , 2014, International journal of antimicrobial agents.

[161]  A. Van Deun,et al.  High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[162]  V. Waters,et al.  Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. , 2014, Annals of the American Thoracic Society.

[163]  S. Morré,et al.  Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands , 2014, Sexually Transmitted Infections.

[164]  H. Perlman,et al.  Impaired Clearance of Influenza A Virus in Obese, Leptin Receptor Deficient Mice Is Independent of Leptin Signaling in the Lung Epithelium and Macrophages , 2014, PloS one.

[165]  D. Nicolau,et al.  Unexpected In Vivo Activity of Ceftazidime Alone and in Combination with Avibactam against New Delhi Metallo-β-Lactamase-Producing Enterobacteriaceae in a Murine Thigh Infection Model , 2014, Antimicrobial Agents and Chemotherapy.

[166]  Elizabeth A Torrone,et al.  Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010. , 2014, MMWR supplements.

[167]  Jason Madan,et al.  Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial , 2014, Trials.

[168]  F. Hayden,et al.  Antiviral combinations for severe influenza , 2014, The Lancet Infectious Diseases.

[169]  Antonio Gasbarrini,et al.  Helicobacter pylori and Extragastric Diseases , 2014, Helicobacter.

[170]  A. Corso,et al.  Emergence of genetically unrelated NDM-1-producing Acinetobacter pittii strains in Paraguay. , 2014, The Journal of antimicrobial chemotherapy.

[171]  P. Nordmann,et al.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[172]  N. Lawrentschuk,et al.  Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy? , 2014, BJU international.

[173]  Thomas A Casey,et al.  Finding alternatives to antibiotics , 2014, Annals of the New York Academy of Sciences.

[174]  C. Riedi,et al.  MALDI-TOF: a useful tool for laboratory identification of uncommon glucose non-fermenting Gram-negative bacteria associated with cystic fibrosis. , 2014, Journal of medical microbiology.

[175]  F. Rossi,et al.  Horizontal gene transfer among microorganisms in food: current knowledge and future perspectives. , 2014, Food microbiology.

[176]  D. Tacke,et al.  Our 2014 approach to mucormycosis , 2014, Mycoses.

[177]  R. Killeen,et al.  Lemierre’s Syndrome: The Forgotten Disease? , 2015 .

[178]  Brent A. Johnson,et al.  The combination of pill count and self-reported adherence is a strong predictor of first-line ART failure for adults in South Africa. , 2014, Current HIV research.

[179]  S. Piscitelli,et al.  Effects of enzyme inducers efavirenz and tipranavir/ritonavir on the pharmacokinetics of the HIV integrase inhibitor dolutegravir , 2014, European Journal of Clinical Pharmacology.

[180]  E. Petinaki,et al.  Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients , 2014, Infection.

[181]  Paul Theodor Pyl,et al.  HTSeq – A Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[182]  T. Walsh,et al.  In Vitro Combination of Isavuconazole with Micafungin or Amphotericin B Deoxycholate against Medically Important Molds , 2014, Antimicrobial Agents and Chemotherapy.

[183]  M. Arendrup,et al.  EUCAST Testing of Isavuconazole Susceptibility in Aspergillus: Comparison of Results for Inoculum Standardization Using Conidium Counting versus Optical Density , 2014, Antimicrobial Agents and Chemotherapy.

[184]  C. Bartzavali,et al.  Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit , 2014, Scandinavian journal of infectious diseases.

[185]  V. Trkulja,et al.  Septic complications and hospital admissions after transrectal ultrasound-guided prostate biopsy: incidence rates and outcomes in 913 consecutive biopsies , 2014, International Urology and Nephrology.

[186]  Cherie Oubre,et al.  Microbial Monitoring of Crewed Habitats in Space—Current Status and Future Perspectives , 2014, Microbes and environments.

[187]  L. Trinquart,et al.  Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients. , 2014, The Cochrane database of systematic reviews.

[188]  G. Bearman,et al.  Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literature. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[189]  S. Gorman,et al.  Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation , 2014, Pathogens.

[190]  D. Engelthaler,et al.  Cryptococcus gattii in North American Pacific Northwest: Whole-Population Genome Analysis Provides Insights into Species Evolution and Dispersal , 2014, mBio.

[191]  P. L. McCormack.  Dolutegravir: A Review of Its Use in the Management of HIV-1 Infection in Adolescents and Adults , 2014, Drugs.

[192]  D. Nathwani,et al.  Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria. , 2014, International journal of antimicrobial agents.

[193]  Patty W. Wright,et al.  Iatrogenic Cushing Syndrome Secondary to a Probable Interaction Between Voriconazole and Budesonide , 2014, Pharmacotherapy.

[194]  J. Jensen,et al.  Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[195]  M. Falagas,et al.  Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections , 2014, Emerging infectious diseases.

[196]  Qi Wang,et al.  Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China. , 2014, International journal of antimicrobial agents.

[197]  N. Woodford,et al.  NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. , 2014, The Journal of antimicrobial chemotherapy.

[198]  S. Seyedmousavi,et al.  The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside. , 2014, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[199]  Y. Chuang,et al.  A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[200]  Fangfang Xia,et al.  Genome-scale bacterial transcriptional regulatory networks: reconstruction and integrated analysis with metabolic models , 2014, Briefings Bioinform..

[201]  N. Grover,et al.  A case of septicemia due to Chyresobacterium indologenes producing blaNDM-1 , 2014, Avicenna Journal of Medicine.

[202]  T. Mertens,et al.  Single nucleotide polymorphisms of thymidine kinase and DNA polymerase genes in clinical herpes simplex virus type 1 isolates associated with different resistance phenotypes. , 2014, Antiviral research.

[203]  N. McElvaney,et al.  Fungi in the cystic fibrosis lung: bystanders or pathogens? , 2014, The international journal of biochemistry & cell biology.

[204]  T. Doering,et al.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. , 2014, Cold Spring Harbor perspectives in medicine.

[205]  B. Clotet,et al.  Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study , 2014, The Lancet.

[206]  J. Pogliano,et al.  Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis , 2014, Antimicrobial Agents and Chemotherapy.

[207]  James W. Wilson,et al.  Conservation of the Low-shear Modeled Microgravity Response in Enterobacteriaceae and Analysis of the trp Genes in this Response , 2014, The open microbiology journal.

[208]  B. Chun,et al.  Active Surveillance of the Trachea or Throat for MRSA Is More Sensitive than Nasal Surveillance and a Better Predictor of MRSA Infections among Patients in Intensive Care , 2014, PloS one.

[209]  H. D. de Vries,et al.  Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review , 2014, Expert review of anti-infective therapy.

[210]  A. Kreuter,et al.  2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens , 2014, International journal of STD & AIDS.

[211]  S. Diggle,et al.  Development of an Ex Vivo Porcine Lung Model for Studying Growth, Virulence, and Signaling of Pseudomonas aeruginosa , 2014, Infection and Immunity.

[212]  B. Sellman,et al.  A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models , 2014, Antimicrobial Agents and Chemotherapy.

[213]  J. Rello,et al.  Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study , 2014, Critical Care.

[214]  M. Höglund,et al.  Economic Evaluation of Posaconazole Versus Fluconazole or Itraconazole in the Prevention of Invasive Fungal Infection in High-Risk Neutropenic Patients in Sweden , 2014, Clinical Drug Investigation.

[215]  C. Dunyach-Rémy,et al.  Epidemiology of Carbapenemase-Producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean Countries , 2014, BioMed research international.

[216]  H. Péré,et al.  Diagnosis of genital herpes simplex virus infection in the clinical laboratory , 2014, Virology Journal.

[217]  P. Griffiths,et al.  Taming the transplantation troll by targeting terminase. , 2014, The New England journal of medicine.

[218]  H. Einsele,et al.  Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. , 2014, The New England journal of medicine.

[219]  H. Waskin,et al.  Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects , 2014, Antimicrobial Agents and Chemotherapy.

[220]  M. Ison,et al.  Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients , 2014, Antiviral therapy.

[221]  R. Lane,et al.  Treatment of Skin and Soft Tissue Infections in a Pediatric Observation Unit , 2014, Clinical pediatrics.

[222]  I. Stock.  [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy]. , 2014, Medizinische Monatsschrift fur Pharmazeuten.

[223]  R. Nation,et al.  Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae , 2014, Innate immunity.

[224]  L. Webster,et al.  A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4. , 2014, Journal of hepatology.

[225]  Marc Lipsitch,et al.  Ethical Alternatives to Experiments with Novel Potential Pandemic Pathogens , 2014, PLoS medicine.

[226]  Q. C. Truong-Bolduc,et al.  Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin. , 2014, The Journal of infectious diseases.

[227]  H. D. de Vries,et al.  Pitfalls in the diagnosis and management of inguinal lymphogranuloma venereum: important lessons from a case series , 2014, Sexually Transmitted Infections.

[228]  Ronald N. Jones,et al.  Ceftobiprole Activity against over 60,000 Clinical Bacterial Pathogens Isolated in Europe, Turkey, and Israel from 2005 to 2010 , 2014, Antimicrobial Agents and Chemotherapy.

[229]  Paul van Helden,et al.  Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study , 2014, The Lancet.

[230]  S. Richter,et al.  Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[231]  R. Gardiner,et al.  Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis. , 2014, International journal of antimicrobial agents.

[232]  N. nørskov-lauritsen,et al.  Classification, Identification, and Clinical Significance of Haemophilus and Aggregatibacter Species with Host Specificity for Humans , 2014, Clinical Microbiology Reviews.

[233]  P. Nordmann,et al.  Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria , 2014, BioMed research international.

[234]  A. Karimi,et al.  Lemierre’s syndrome with double heterozygote status in the methylenetetrahydrofolate reductase gene , 2014, World Journal of Pediatrics.

[235]  A. Kosaka,et al.  Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat , 2014, Kidney international.

[236]  S. Gatermann,et al.  Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from Germany , 2014, Journal of Clinical Microbiology.

[237]  A. Palucka,et al.  Development and function of human innate immune cells in a humanized mouse model , 2014, Nature Biotechnology.

[238]  C. Contreras,et al.  The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[239]  R. Čeović,et al.  Chancroid, lymphogranuloma venereum, granuloma inguinale, genital herpes simplex infection, and molluscum contagiosum. , 2014, Clinics in dermatology.

[240]  H. Barrios,et al.  Detection of a NDM-1-producing Klebsiella pneumoniae (ST22) clinical isolate at a pediatric hospital in Mexico. , 2014, The Pediatric infectious disease journal.

[241]  M. P. Bauer,et al.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[242]  A. Zeng,et al.  Comparative physiological study of the wild type and the small colony variant of Pseudomonas aeruginosa 20265 under controlled growth conditions , 2014, World journal of microbiology & biotechnology.

[243]  C. Bai,et al.  PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury , 2014, Respiratory Physiology & Neurobiology.

[244]  J. Sreedharan,et al.  Patterns of antimicrobial therapy in acute tonsillitis: A cross-sectional hospital-based study from UAE. , 2014, Anais da Academia Brasileira de Ciencias.

[245]  N. Bhadelia,et al.  Management of urinary tract infections from multidrug-resistant organisms. , 2014, Infectious disease clinics of North America.

[246]  H. Jürgens,et al.  Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit. , 2014, The Journal of antimicrobial chemotherapy.

[247]  B. Lamy,et al.  Advances toward the Elucidation of Hypertonic Saline Effects on Pseudomonas aeruginosa from Cystic Fibrosis Patients , 2014, PloS one.

[248]  J. Jensen,et al.  Direct Detection of Macrolide Resistance in Mycoplasma genitalium Isolates from Clinical Specimens from France by Use of Real-Time PCR and Melting Curve Analysis , 2014, Journal of Clinical Microbiology.

[249]  S. Keshavjee,et al.  Pretransplant Aspergillus Colonization of Cystic Fibrosis Patients and the Incidence of Post–Lung Transplant Invasive Aspergillosis , 2014, Transplantation.

[250]  G. Fichant,et al.  Bacterial transformation: distribution, shared mechanisms and divergent control , 2014, Nature Reviews Microbiology.

[251]  A. Ibrahim,et al.  Isavuconazole Therapy Protects Immunosuppressed Mice from Mucormycosis , 2014, Antimicrobial Agents and Chemotherapy.

[252]  G. Zadeh,et al.  Endoscopic sphenoid sinus drainage in Lemierre syndrome , 2014, Journal of Clinical Neuroscience.

[253]  E. Adams,et al.  Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! , 2014, Current opinion in infectious diseases.

[254]  L. Desbonnet,et al.  The microbiome: stress, health and disease , 2013, Mammalian Genome.

[255]  D. Curcio.  Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge? , 2014, Current clinical pharmacology.

[256]  A. Goesmann,et al.  Genome Sequence of the Small-Colony Variant Pseudomonas aeruginosa MH27, Isolated from a Chronic Urethral Catheter Infection , 2014, Genome Announcements.

[257]  J. Engelstädter,et al.  Adaptation through genetic time travel? Fluctuating selection can drive the evolution of bacterial transformation , 2014, Proceedings of the Royal Society B: Biological Sciences.

[258]  J. Nachega,et al.  Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[259]  C. Mammina,et al.  tst1-positive ST22-MRSA-IVa in healthy Italian preschool children , 2014, Infection.

[260]  R. Garten,et al.  Antiviral Susceptibility of Variant Influenza A(H3N2)v Viruses Isolated in the United States from 2011 to 2013 , 2014, Antimicrobial Agents and Chemotherapy.

[261]  R. Haubrich,et al.  Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study , 2014, The Journal of infectious diseases.

[262]  M. Rudolf,et al.  Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes , 2014, Critical Care.

[263]  T. Pilot‐Matias,et al.  Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1. , 2014, The New England journal of medicine.

[264]  M. Tashiro,et al.  A community cluster of influenza A(H1N1)pdm09 virus exhibiting cross-resistance to oseltamivir and peramivir in Japan, November to December 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[265]  O. Cars,et al.  Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae by In Vitro Time-Kill Experiments , 2014, Antimicrobial Agents and Chemotherapy.

[266]  D. Parekh,et al.  Prevention and Treatment of Biopsy-Related Complications , 2014, Current Urology Reports.

[267]  U. Thisyakorn,et al.  Latest developments and future directions in dengue vaccines , 2014, Therapeutic advances in vaccines.

[268]  G. Nair,et al.  In Silico Analysis of Antibiotic Resistance Genes in the Gut Microflora of Individuals from Diverse Geographies and Age-Groups , 2013, PloS one.

[269]  R. Bonomo,et al.  New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World , 2013, Antimicrobial Agents and Chemotherapy.

[270]  Ronald N. Jones,et al.  Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Organisms Collected from U.S. Medical Centers in 2012 , 2013, Antimicrobial Agents and Chemotherapy.

[271]  P. Nordmann,et al.  In Vivo Efficacy of Human Simulated Regimens of Carbapenems and Comparator Agents against NDM-1-Producing Enterobacteriaceae , 2013, Antimicrobial Agents and Chemotherapy.

[272]  V. Nizet,et al.  Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium , 2013, Antimicrobial Agents and Chemotherapy.

[273]  C. Rice,et al.  Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource , 2013, Hepatology.

[274]  Timothy J. Foster,et al.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus , 2013, Nature Reviews Microbiology.

[275]  D. Nicolau,et al.  Efficacies of Ceftazidime-Avibactam and Ceftazidime against Pseudomonas aeruginosa in a Murine Lung Infection Model , 2013, Antimicrobial Agents and Chemotherapy.

[276]  Gathsaurie Neelika Malavige,et al.  T cell responses in dengue viral infections. , 2013, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[277]  J. Farrar,et al.  Corticosteroids for Dengue – Why Don't They Work? , 2013, PLoS neglected tropical diseases.

[278]  Matthew Wheatley,et al.  Protocol-driven emergency department observation units offer savings, shorter stays, and reduced admissions. , 2013, Health affairs.

[279]  A. Shtannikov,et al.  Prevalence of borreliosis, anaplasmosis, ehrlichiosis and Dirofilaria immitis in dogs and vectors in Voronezh Reserve (Russia). , 2013, Comparative immunology, microbiology and infectious diseases.

[280]  M. Bourlière,et al.  An update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trials , 2013, Therapeutic advances in infectious disease.

[281]  Jacinta Bustamante,et al.  Primary immunodeficiencies underlying fungal infections , 2013, Current opinion in pediatrics.

[282]  T. Uyeki,et al.  Neuraminidase Inhibitors for Critically Ill Children With Influenza , 2013, Pediatrics.

[283]  D. Falci,et al.  Isolation of NDM-producing Providencia rettgeri in Brazil. , 2013, The Journal of antimicrobial chemotherapy.

[284]  R. Grech,et al.  Lemierre syndrome: more than just a sore throat , 2013, BMJ Case Reports.

[285]  E. Bateman,et al.  Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages , 2013, Thorax.

[286]  L. Stodieck,et al.  Effects of microgravity on the virulence of Listeria monocytogenes, Enterococcus faecalis, Candida albicans, and methicillin-resistant Staphylococcus aureus. , 2013, Astrobiology.

[287]  David A. Rasko,et al.  Bacterial genome sequencing in the clinic: bioinformatic challenges and solutions , 2013, Nature Reviews Genetics.

[288]  A. Witney,et al.  High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[289]  Mary L. Ehlenbach,et al.  Hospitalized but not admitted: characteristics of patients with "observation status" at an academic medical center. , 2013, JAMA internal medicine.

[290]  S. Miyakis,et al.  Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia , 2013, Antimicrobial Agents and Chemotherapy.

[291]  S. Paul,et al.  Lemierre's syndrome: the importance of early detection. , 2013, British journal of nursing.

[292]  M. Carrington,et al.  The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs , 2013, Nature Immunology.

[293]  Yufei Wang,et al.  High severity and fatality of human infections with avian influenza A(H7N9) infection in China. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[294]  F. D. Smith,et al.  Prevalence of Babesia and Anaplasma in ticks infesting dogs in Great Britain. , 2013, Veterinary parasitology.

[295]  A. Carattoli,et al.  Isolation of NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[296]  T. Balslev,et al.  Arterial Ischemic Stroke As a Complication to Disseminated Infection with Fusobacterium necrophorum , 2013, Neuropediatrics.

[297]  S. Maurer-Stroh,et al.  Peramivir and laninamivir susceptibility of circulating influenza A and B viruses , 2013, Influenza and other respiratory viruses.

[298]  Farah K. Tengra,et al.  Effect of spaceflight on Pseudomonas aeruginosa final cell density is modulated by nutrient and oxygen availability , 2013, BMC Microbiology.

[299]  H. Zimmermann,et al.  Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants Selected In Vitro after Letermovir (AIC246) Exposure , 2013, Antimicrobial Agents and Chemotherapy.

[300]  J. Versalovic,et al.  Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection: A Randomized, Double-Blind, Placebo-Controlled Study , 2013, Journal of clinical gastroenterology.

[301]  S. Hopkins,et al.  Antimicrobial stewardship: English Surveillance Programme for Antimicrobial Utilization and Resistance (ESPAUR). , 2013, The Journal of antimicrobial chemotherapy.

[302]  J. Gatell,et al.  Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. , 2013, The Lancet. Infectious diseases.

[303]  C. Schmerk,et al.  Generation of protection against Francisella novicida in mice depends on the pathogenicity protein PdpA, but not PdpC or PdpD. , 2013, Microbes and infection.

[304]  L. Thomachot,et al.  Spontaneous regression of multiple Rasmussen aneurysms in a child with Lemierre syndrome and pulmonary abscesses. , 2013, The Pediatric infectious disease journal.

[305]  J. Vincent,et al.  Can changes in renal function predict variations in β-lactam concentrations in septic patients? , 2013, International journal of antimicrobial agents.

[306]  B. Grady,et al.  The sexual transmission rate of HCV among heterosexual couples , 2013, Hepatology.

[307]  D. Cooper,et al.  SPRING-2 the future of antiretroviral therapy. , 2013, The Lancet. Infectious diseases.

[308]  Alexander D. MacKerell,et al.  Turning Defense into Offense: Defensin Mimetics as Novel Antibiotics Targeting Lipid II , 2013, PLoS pathogens.

[309]  S. Gong,et al.  Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children–a multicentre, open‐labelled study , 2013, Alimentary pharmacology & therapeutics.

[310]  H. Ostermann,et al.  Posaconazole prophylaxis – impact on incidence of invasive fungal disease and antifungal treatment in haematological patients , 2013, Mycoses.

[311]  R. Handgretinger,et al.  Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[312]  C. Harwood,et al.  Cyclic diguanosine monophosphate represses bacterial flagella synthesis by interacting with the Walker A motif of the enhancer-binding protein FleQ , 2013, Proceedings of the National Academy of Sciences.

[313]  Jane D. Single....  Management of Multidrug- resistant organisms in Healthcare settings , 2013 .

[314]  J. Rello,et al.  Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century , 2013, Intensive Care Medicine.

[315]  D. Falci,et al.  Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections , 2013 .

[316]  M. Golden,et al.  Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study , 2013, Sexually Transmitted Infections.

[317]  D. Andes,et al.  Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus , 2013, Antimicrobial Agents and Chemotherapy.

[318]  S. Piscitelli,et al.  Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment , 2013, European Journal of Clinical Pharmacology.

[319]  R. Sidman,et al.  An Antimicrobial Peptidomimetic Induces Mucorales Cell Death through Mitochondria-Mediated Apoptosis , 2013, PloS one.

[320]  M. Jung,et al.  Posaconazole Therapeutic Drug Monitoring in the Real‐life Setting: A Single‐Center Experience and Review of the Literature , 2013, Pharmacotherapy.

[321]  K. Murthy,et al.  The 'forgotten disease' (or the never known). , 2013, The Journal of the Association of Physicians of India.

[322]  E. Lavelle,et al.  Nlrp-3-Driven Interleukin 17 Production by γδT Cells Controls Infection Outcomes during Staphylococcus aureus Surgical Site Infection , 2013, Infection and Immunity.

[323]  Woojun Park,et al.  Insight into norfloxacin resistance of Acinetobacter oleivorans DR1: target gene mutation, persister, and RNA-Seq analyses. , 2013, Journal of microbiology and biotechnology.

[324]  B. Kuehn.  CDC estimates 300,000 US cases of Lyme disease annually. , 2013, JAMA.

[325]  C. Moore,et al.  In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole , 2013, Antimicrobial Agents and Chemotherapy.

[326]  S. Cosgrove,et al.  The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[327]  Weixu Meng,et al.  Visualizing influenza virus infection in living mice , 2013, Nature Communications.

[328]  D. Di Pasquale,et al.  Actinomycosis mimicking sinonasal malignant disease , 2013, BMJ Case Reports.

[329]  B. Molitoris.  Measuring glomerular filtration rate in the intensive care unit: no substitutes please , 2013, Critical Care.

[330]  D. Vugia,et al.  Cryptococcus gattii in the United States: Genotypic Diversity of Human and Veterinary Isolates , 2013, PloS one.

[331]  Hui Wang,et al.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. , 2013, The Lancet. Infectious diseases.

[332]  Leif E. Peterson,et al.  Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. , 2013, Archives of pathology & laboratory medicine.

[333]  N. Meanwell,et al.  Characterizations of HCV NS5A replication complex inhibitors. , 2013, Virology.

[334]  Zhi-xiang Shen,et al.  Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study. , 2013, International journal of clinical pharmacology and therapeutics.

[335]  C. Bertelli,et al.  Rapid bacterial genome sequencing: methods and applications in clinical microbiology. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[336]  D. Kasper,et al.  The atypical lipopolysaccharide of Francisella. , 2013, Carbohydrate research.

[337]  M. Bassetti,et al.  New antibiotics for bad bugs: where are we? , 2013, Annals of Clinical Microbiology and Antimicrobials.

[338]  T. Grossman,et al.  Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens , 2013, Antimicrobial Agents and Chemotherapy.

[339]  S. Piscitelli,et al.  Lack of Pharmacokinetic Interaction between Rilpivirine and Integrase Inhibitors Dolutegravir and GSK1265744 , 2013, Antimicrobial Agents and Chemotherapy.

[340]  P. Touraine,et al.  Iatrogenic Cushing's Syndrome Induced by Posaconazole , 2013, Antimicrobial Agents and Chemotherapy.

[341]  P. Cahn,et al.  Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study , 2013, The Lancet.

[342]  W. Chung,et al.  Different CXCR4 Expression According to Various Histologic Subtype of Papillary Thyroid Carcinoma , 2013, Endocrine Pathology.

[343]  C. R. Clark.  Antimicrobial Drug Use in Sheep and Goats , 2013 .

[344]  Nihar Shah,et al.  Review of direct-acting antiviral agents for the treatment of chronic hepatitis C , 2013, Expert opinion on investigational drugs.

[345]  J. Karlowsky,et al.  In Vitro Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007 to 2012 , 2013, Antimicrobial Agents and Chemotherapy.

[346]  Leen Stougie,et al.  Ancient Dispersal of the Human Fungal Pathogen Cryptococcus gattii from the Amazon Rainforest , 2013, PloS one.

[347]  I. Gould,et al.  Maximizing the impact of antimicrobial stewardship: the role of diagnostics, national and international efforts , 2013, Current opinion in infectious diseases.

[348]  D. Cooper,et al.  A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection: 96-Week Results , 2013, Journal of acquired immune deficiency syndromes.

[349]  K. Marr,et al.  Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis , 2013, Current opinion in infectious diseases.

[350]  R. Ireland,et al.  Francisella tularensis SchuS4 and SchuS4 Lipids Inhibit IL-12p40 in Primary Human Dendritic Cells by Inhibition of IRF1 and IRF8 , 2013, The Journal of Immunology.

[351]  M. Trent,et al.  National trends in pelvic inflammatory disease among adolescents in the emergency department. , 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[352]  W. van Schaik,et al.  Antibiotic resistant enterococci-tales of a drug resistance gene trafficker. , 2013, International journal of medical microbiology : IJMM.

[353]  I. Butler,et al.  Severe narrowing of left cavernous carotid artery associated with Fusobacterium necrophorum infection. , 2013, Anaerobe.

[354]  J. Pawlotsky.  NS5A inhibitors in the treatment of hepatitis C. , 2013, Journal of hepatology.

[355]  R. Hammami,et al.  Anti-infective properties of bacteriocins: an update , 2013, Cellular and Molecular Life Sciences.

[356]  Ingvild Dalen,et al.  Improving antibiotic prescribing in acute respiratory tract infections: cluster randomised trial from Norwegian general practice (prescription peer academic detailing (Rx-PAD) study) , 2013, BMJ.

[357]  D. Daniels,et al.  2013 UK National Guideline for the management of lymphogranuloma venereum , 2013, International journal of STD & AIDS.

[358]  Jian Wang,et al.  Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota , 2013, Nature Communications.

[359]  H. Mo,et al.  Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885 , 2013, Antimicrobial Agents and Chemotherapy.

[360]  Yufei Wang,et al.  Deaths Associated With Avian Influenza A(H7N9) Virus in China , 2013, Annals of Internal Medicine.

[361]  S. Conti,et al.  Lymphogranuloma venereum diagnoses among men who have sex with men in the UK: interpreting a cross-sectional study using an epidemic phase-specific framework , 2013, Sexually Transmitted Infections.

[362]  Kay Nieselt,et al.  Genome-Wide Comparison of Medieval and Modern Mycobacterium leprae , 2013, Science.

[363]  E. Garvey,et al.  Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744). , 2013, Journal of medicinal chemistry.

[364]  N. Roche,et al.  Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy , 2013, Annals of Intensive Care.

[365]  A. Marra,et al.  Nosocomial Bloodstream Infections in Brazilian Pediatric Patients: Microbiology, Epidemiology, and Clinical Features , 2013, PloS one.

[366]  A. Kashuba,et al.  Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir , 2013, Clinical Pharmacokinetics.

[367]  K. Murthy,et al.  Effect of high dose of steroid on plateletcount in acute stage of dengue Fever with thrombocytopenia. , 2013, Journal of clinical and diagnostic research : JCDR.

[368]  M. Moore.  Antibiotics: time to act. , 2013, The British journal of general practice : the journal of the Royal College of General Practitioners.

[369]  S. Koley,et al.  Saxophone penis after unilateral inguinal bubo of lymphogranuloma venereum. , 2013, Indian journal of sexually transmitted diseases and AIDS.

[370]  Brendan De Marco,et al.  Risk factors for development of methicillin-resistant Staphylococcus aureus infection among colonized patients. , 2013, American journal of infection control.

[371]  J. Chander,et al.  Optimization of multiple muco-cutaneous site sampling method for screening MRSA colonization in ICU , 2013, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.

[372]  D. Hui,et al.  A Clinical Trial of Intravenous Peramivir Compared with Oral Oseltamivir for the Treatment of Seasonal Influenza in Hospitalized Adults , 2013, Antiviral therapy.

[373]  Didier Raoult,et al.  Postgenomic analysis of bacterial pathogens repertoire reveals genome reduction rather than virulence factors. , 2013, Briefings in functional genomics.

[374]  Robert J. Clifford,et al.  Bacterial Peritonitis Due to Acinetobacter baumannii Sequence Type 25 with Plasmid-Borne New Delhi Metallo-β-Lactamase in Honduras , 2013, Antimicrobial Agents and Chemotherapy.

[375]  L. Frost,et al.  F conjugation: back to the beginning. , 2013, Plasmid.

[376]  A. Webb,et al.  Itraconazole and inhaled fluticasone causing hypothalamic-pituitary-adrenal axis suppression in adults with cystic fibrosis. , 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[377]  A. Aghemo,et al.  Selection of resistant-associated variants to the NS5A inhibitor daclatasvir: revenge of the hepatitis C virus. , 2013, Gastroenterology.

[378]  Keith A. Jolley,et al.  Genome-wide association study identifies vitamin B5 biosynthesis as a host specificity factor in Campylobacter , 2013, Proceedings of the National Academy of Sciences.

[379]  D. Zelterman,et al.  Natural ventilation reduces high TB transmission risk in traditional homes in rural KwaZulu-Natal, South Africa , 2013, BMC Infectious Diseases.

[380]  R. Pararajasingam,et al.  Outcomes of methicillin-resistant Staphylococcus aureus infection after kidney and/or pancreas transplantation. , 2013, Transplantation proceedings.

[381]  M. Peiris,et al.  Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance , 2013, The Lancet.

[382]  C. Saegerman,et al.  Antimicrobial Resistance in the Food Chain: A Review , 2013, International journal of environmental research and public health.

[383]  A. Darwish,et al.  Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Kingdom of Bahrain: Efficacy, Patient Satisfaction and Cost Effectiveness , 2013 .

[384]  R. Weyant,et al.  Biosafety Recommendations for Work with Influenza Viruses Containing a Hemagglutinin from the A/goose/Guangdong/1/96 Lineage. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[385]  Agarwal Abhishek,et al.  Lemierre syndrome from a neck abscess due to methicillin-resistant Staphylococcus aureus , 2013, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[386]  Claude Saegerman,et al.  Ticks and associated pathogens collected from dogs and cats in Belgium , 2013, Parasites & Vectors.

[387]  S. Cosgrove,et al.  Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections , 2013, Antimicrobial Agents and Chemotherapy.

[388]  C. Cao,et al.  AApeptides as a new class of antimicrobial agents. , 2013, Organic & biomolecular chemistry.

[389]  Louis M Bell,et al.  Effect of an outpatient antimicrobial stewardship intervention on broad-spectrum antibiotic prescribing by primary care pediatricians: a randomized trial. , 2013, JAMA.

[390]  Jian He,et al.  Clinical findings in 111 cases of influenza A (H7N9) virus infection. , 2013, The New England journal of medicine.

[391]  G. Gao,et al.  Live-animal markets and influenza A (H7N9) virus infection. , 2013, The New England journal of medicine.

[392]  M. Zervos,et al.  Endocarditis Caused by Resistant Enterococcus: An Overview , 2013, Current Infectious Disease Reports.

[393]  Ralf Bartenschlager,et al.  The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.

[394]  Ronald N. Jones,et al.  In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds , 2013, Journal of Clinical Microbiology.

[395]  O. Dosekun,et al.  Lymphogranuloma venereum detected from the pharynx in four London men who have sex with men , 2013, International journal of STD & AIDS.

[396]  Chang-Pan Liu,et al.  Lemierre's syndrome in a patient with habitual toothpick usage. , 2013, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[397]  R. Kullar,et al.  Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[398]  J. Zak,et al.  Natural transformation as a mechanism of horizontal gene transfer among environmental Aeromonas species. , 2013, Systematic and applied microbiology.

[399]  F. Aragona,et al.  Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores. , 2013, Urology.

[400]  T. Wiemken,et al.  Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[401]  D. Hensel,et al.  Pelvic Inflammatory Disease in the Adolescent: Understanding Diagnosis and Treatment as a Health Care Provider , 2013, Pediatric emergency care.

[402]  H. Lehmann,et al.  Clinician perspectives on management of adolescents with pelvic inflammatory disease using standardized patient scenarios. , 2013, Sexually transmitted diseases.

[403]  E. De Clercq.  Selective Anti-Herpesvirus Agents , 2013, Antiviral chemistry & chemotherapy.

[404]  B. Ghaly,et al.  Lemierre's syndrome: a serious complication of a routine dental procedure. , 2013, Australian dental journal.

[405]  C. Thompson,et al.  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10‐year, single‐center experience , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[406]  E. Hildt,et al.  TIP47 plays a crucial role in the life cycle of hepatitis C virus. , 2013, Journal of hepatology.

[407]  Mimi Y. Kim,et al.  Repeating blood cultures in neutropenic children with persistent fevers when the initial blood culture is negative , 2013, Pediatric blood & cancer.

[408]  T. Forouzanfar,et al.  Treatment of Cervicofacial Actinomycosis: A report of 19 cases and review of literature , 2013, Medicina oral, patologia oral y cirugia bucal.

[409]  C. Tseng,et al.  Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis , 2013, PloS one.

[410]  L. Pagano,et al.  Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries , 2013, Haematologica.

[411]  P. Hugenholtz,et al.  Genome sequences of rare, uncultured bacteria obtained by differential coverage binning of multiple metagenomes , 2013, Nature Biotechnology.

[412]  S. Abedon,et al.  Phage cocktails and the future of phage therapy. , 2013, Future microbiology.

[413]  H. Lillehoj,et al.  Alternatives to antibiotics: a symposium on the challenges and solutions for animal production , 2013, Animal Health Research Reviews.

[414]  J. Kwak,et al.  Pulmonary actinomycosis during the first decade of 21st century: cases of 94 patients , 2013, BMC Infectious Diseases.

[415]  M. Christner,et al.  cyp51A-Based Mechanisms of Aspergillus fumigatus Azole Drug Resistance Present in Clinical Samples from Germany , 2013, Antimicrobial Agents and Chemotherapy.

[416]  J. Mell,et al.  The availability of purine nucleotides regulates natural competence by controlling translation of the competence activator Sxy , 2013, Molecular microbiology.

[417]  D. Livermore,et al.  Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance , 2013, The Lancet.

[418]  Steven Salzberg,et al.  GAGE-B: an evaluation of genome assemblers for bacterial organisms , 2013, Bioinform..

[419]  J. Collins,et al.  Antibiotic Treatment Expands the Resistance Reservoir and Ecological Network of the Phage Metagenome , 2013, Nature.

[420]  G. Feierl,et al.  Modified culture method detects a high diversity of fungal species in cystic fibrosis patients. , 2013, Medical mycology.

[421]  D. Nicolau,et al.  Human Simulated Studies of Aztreonam and Aztreonam-Avibactam To Evaluate Activity against Challenging Gram-Negative Organisms, Including Metallo-β-Lactamase Producers , 2013, Antimicrobial Agents and Chemotherapy.

[422]  Peter Schlattmann,et al.  Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[423]  Y. Yazdanpanah,et al.  Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK , 2013, Journal of acquired immune deficiency syndromes.

[424]  T. Bronich,et al.  Antiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infection. , 2013, Biomaterials.

[425]  D. Kadouri,et al.  Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens , 2013, PloS one.

[426]  J. De La Torre,et al.  Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[427]  L. Salomon,et al.  Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow‐up from a prospective trial , 2013, BJU international.

[428]  R. Long,et al.  Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007 , 2013, Emerging infectious diseases.

[429]  Y. Amako,et al.  The C terminus of NS5A domain II is a key determinant of hepatitis C virus genome replication, but is not required for virion assembly and release , 2013, The Journal of general virology.

[430]  S. Kauppinen,et al.  Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.

[431]  R. Hayes,et al.  Natural history of Mycoplasma genitalium Infection in a Cohort of Female Sex Workers in Kampala, Uganda , 2013, Sexually transmitted diseases.

[432]  David Griffiths,et al.  Detection of Mixed Infection from Bacterial Whole Genome Sequence Data Allows Assessment of Its Role in Clostridium difficile Transmission , 2013, PLoS Comput. Biol..

[433]  I. Popescu,et al.  Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, Phase II trial. , 2013, The Journal of antimicrobial chemotherapy.

[434]  T. Sandrin,et al.  MALDI TOF MS profiling of bacteria at the strain level: a review. , 2013, Mass spectrometry reviews.

[435]  K. Dooley,et al.  World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential? , 2013, The Journal of infectious diseases.

[436]  M. Christner,et al.  Rapid Discrimination of Haemophilus influenzae, H. parainfluenzae, and H. haemolyticus by Fluorescence In Situ Hybridization (FISH) and Two Matrix-Assisted Laser-Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF-MS) Platforms , 2013, PloS one.

[437]  L. Fortier,et al.  Importance of prophages to evolution and virulence of bacterial pathogens , 2013, Virulence.

[438]  Robert J. Clifford,et al.  Enhanced De Novo Assembly of High Throughput Pyrosequencing Data Using Whole Genome Mapping , 2013, PloS one.

[439]  J. D. De Waele,et al.  Identifying patients at risk for augmented renal clearance in the ICU - limitations and challenges , 2013, Critical Care.

[440]  D. Marriott,et al.  Skeletal Muscle Toxicity Associated With Raltegravir-Based Combination Antiretroviral Therapy in HIV-Infected Adults , 2013, Journal of acquired immune deficiency syndromes.

[441]  W. Kamps,et al.  Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia—species distribution and susceptibility patterns , 2013, Supportive Care in Cancer.

[442]  J. Jensen,et al.  Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic , 2013, PloS one.

[443]  Andrew G. Watts,et al.  Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity , 2013, Science.

[444]  Stefan Fischer,et al.  Severe ARDS Induced by Fusobacterial Infections: A Rare Clinical Presentation of Lemierre Syndrome , 2013, Thoracic and Cardiovascular Surgeon.

[445]  B. Bein,et al.  Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock , 2013, BMC Infectious Diseases.

[446]  W. Rawlinson,et al.  Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[447]  C. Thompson,et al.  Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients , 2013, Transplant infectious disease : an official journal of the Transplantation Society.

[448]  W. Greene,et al.  Lipid Droplet-Binding Protein TIP47 Regulates Hepatitis C Virus RNA Replication through Interaction with the Viral NS5A Protein , 2013, PLoS pathogens.

[449]  M. Boeckh,et al.  Combination Therapy with Amantadine, Oseltamivir and Ribavirin for Influenza a Infection: Safety and Pharmacokinetics , 2013, Antiviral therapy.

[450]  Navneet R. Hakhu,et al.  Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[451]  K. Lacombe,et al.  Hepatoxicity of new antiretrovirals: a systematic review. , 2013, Clinics and research in hepatology and gastroenterology.

[452]  J. Nettles,et al.  Synthesis and evaluation of non-dimeric HCV NS5A inhibitors. , 2013, Bioorganic & medicinal chemistry letters.

[453]  V. Perreten,et al.  Genetic characterization of antimicrobial resistance in coagulase-negative staphylococci from bovine mastitis milk. , 2013, Journal of dairy science.

[454]  H. Netter,et al.  Identification of specific regions in hepatitis C virus core, NS2 and NS5A that genetically interact with p7 and co‐ordinate infectious virus production , 2013, Journal of viral hepatitis.

[455]  R. Leclercq,et al.  Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? , 2013, The Journal of antimicrobial chemotherapy.

[456]  D. M. Palma,et al.  Daptomycin in the treatment of invasive Gram-positive bacterial infections in children: personal experience. , 2013, Minerva pediatrica.

[457]  S. Piscitelli,et al.  A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects. , 2013, British journal of clinical pharmacology.

[458]  R. Mattar,et al.  Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study , 2013, BMC Gastroenterology.

[459]  D. Paterson,et al.  Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae. , 2013, Microbial drug resistance.

[460]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[461]  Janette M. Harro,et al.  Clearance of Staphylococcus aureus Nasal Carriage Is T Cell Dependent and Mediated through Interleukin-17A Expression and Neutrophil Influx , 2013, Infection and Immunity.

[462]  Julian Parkhill,et al.  Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture , 2013, Genome research.

[463]  S. Kuo,et al.  Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients? , 2013, BMC Infectious Diseases.

[464]  W. De-Eknamkul,et al.  Recent progress and challenges in the discovery of new neuraminidase inhibitors , 2013, Expert opinion on therapeutic patents.

[465]  G. Dbaibo,et al.  Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial , 2013, Drugs & Aging.

[466]  A. Kessel,et al.  The new UK antimicrobial resistance strategy and action plan , 2013, BMJ.

[467]  Richard Smith,et al.  The true cost of antimicrobial resistance , 2013, BMJ.

[468]  A. Mantovani,et al.  Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients , 2013, Innate immunity.

[469]  M. Duvdevani,et al.  Sustained-release antibacterial varnish-coated biopsy needle for reduction of infection rates following prostate biopsy-in vitro model. , 2013, Journal of endourology.

[470]  A. Turner,et al.  Tuberculosis Incidence Correlates with Sunshine: An Ecological 28-Year Time Series Study , 2013, PloS one.

[471]  Z. Memish,et al.  Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study , 2013, BMC Infectious Diseases.

[472]  R. Kaul,et al.  Polymyxin Resistance of Pseudomonas aeruginosa phoQ Mutants Is Dependent on Additional Two-Component Regulatory Systems , 2013, Antimicrobial Agents and Chemotherapy.

[473]  Clare Brennan,et al.  Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study , 2013, The Lancet.

[474]  B. Koskella,et al.  Understanding Bacteriophage Specificity in Natural Microbial Communities , 2013, Viruses.

[475]  P. Bessong,et al.  Genetic Analysis of HIV-1 Integrase Sequences from Treatment Naive Individuals in Northeastern South Africa , 2013, International journal of molecular sciences.

[476]  J. Anim,et al.  Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. , 2013, The Journal of urology.

[477]  C. Chidiac,et al.  Bilateral bisphosphonate-related osteonecrosis of the jaw with left chronic infection in an 82-year-old woman , 2013, BMJ Case Reports.

[478]  C. Kvasnovsky,et al.  Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection , 2013, Emerging infectious diseases.

[479]  M. Alter,et al.  Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study , 2013, Hepatology.

[480]  A. Kuttikat,et al.  Lemierre’s syndrome: a rare cause of septic polyarthritis , 2013, Rheumatology International.

[481]  I. Petrakis,et al.  Posaconazole vs fluconazole/itraconazole in the prophylaxis of invasive fungal infections in immunocompromised patients: A cost-effectiveness analysis in Greece , 2013, Journal of medical economics.

[482]  G. Andersen,et al.  Lemierre’s syndrome in systemic lupus erythematosus: a report of two cases , 2013, Scandinavian journal of rheumatology.

[483]  Y. Morita,et al.  A rare case of Lemierre`s syndrome caused by Porphyromonas asaccharolytica , 2013, Infection.

[484]  D. Winkler,et al.  Optimizing Identification of Clinically Relevant Gram-Positive Organisms by Use of the Bruker Biotyper Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry System , 2013, Journal of Clinical Microbiology.

[485]  P. Jacinto,et al.  Safety of posaconazole , 2013, Expert opinion on drug safety.

[486]  Robert V Farese,et al.  Diacylglycerol Acyltransferase-1 Localizes Hepatitis C Virus NS5A Protein to Lipid Droplets and Enhances NS5A Interaction with the Viral Capsid Core* , 2013, The Journal of Biological Chemistry.

[487]  Jack Brown,et al.  Rapid testing for methicillin-resistant Staphylococcus aureus: implications for antimicrobial stewardship. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[488]  P. Savelkoul,et al.  Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[489]  E. Grohmann,et al.  Comparison of Antibiotic Resistance, Biofilm Formation and Conjugative Transfer of Staphylococcus and Enterococcus Isolates from International Space Station and Antarctic Research Station Concordia , 2013, Microbial Ecology.

[490]  E. Poveda,et al.  Hepatitis C therapy: highlights from the 2012 annual meeting of the European Association for the Study of the Liver. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[491]  J. Frelinger,et al.  Identification of Francisella novicida mutants that fail to induce prostaglandin E2 synthesis by infected macrophages , 2013, Front. Microbio..

[492]  R. Sockett,et al.  Nucleases in Bdellovibrio bacteriovorus contribute towards efficient self-biofilm formation and eradication of preformed prey biofilms , 2013, FEMS microbiology letters.

[493]  M. Bakkali.  Could DNA uptake be a side effect of bacterial adhesion and twitching motility? , 2013, Archives of Microbiology.

[494]  J. Gatell,et al.  Creatine kinase elevation in HIV-1-infected patients receiving raltegravir-containing antiretroviral therapy: a cohort study. , 2013, The Journal of antimicrobial chemotherapy.

[495]  N. Hammersley,et al.  A case report of Lemierre’s Syndrome associated with dental sepsis , 2013, Scottish medical journal.

[496]  A. Herford,et al.  Lemierre syndrome: two cases requiring surgical intervention. , 2013, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[497]  A. Koluman,et al.  Antimicrobial resistance of emerging foodborne pathogens: Status quo and global trends , 2013, Critical reviews in microbiology.

[498]  N. Petrosillo,et al.  Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art , 2013, Expert review of anti-infective therapy.

[499]  H. Yoshikawa,et al.  Atypical Lemierre syndrome, thrombophlebitis of the facial vein. , 2013, The American journal of emergency medicine.

[500]  Ronald N. Jones,et al.  Update on the prevalence and genetic characterization of NDM-1-producing Enterobacteriaceae in Indian hospitals during 2010. , 2013, Diagnostic microbiology and infectious disease.

[501]  Michael Kube,et al.  MRSA Transmission on a Neonatal Intensive Care Unit: Epidemiological and Genome-Based Phylogenetic Analyses , 2013, PloS one.

[502]  S. Dholakia,et al.  Doctor, I have a sore throat , 2013, BMJ Case Reports.

[503]  D. Long,et al.  An Adjuvanted Herpes Simplex Virus 2 Subunit Vaccine Elicits a T Cell Response in Mice and Is an Effective Therapeutic Vaccine in Guinea Pigs , 2013, Journal of Virology.

[504]  J. Miller,et al.  Whole-Genome Mapping: a New Paradigm in Strain-Typing Technology , 2013, Journal of Clinical Microbiology.

[505]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[506]  M. Niederman,et al.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors , 2013, Intensive Care Medicine.

[507]  J. Ariza,et al.  Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality , 2013, European Journal of Clinical Microbiology & Infectious Diseases.

[508]  R. Sidman,et al.  Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic , 2013, Proceedings of the National Academy of Sciences.

[509]  M. Kumar,et al.  Atypical presentation of Lemierre syndrome: role of imaging , 2013, BMJ Case Reports.

[510]  M. Hellmann,et al.  Vancomycin-resistant Enterococcus faecium meningitis in adults: Case series and review of the literature , 2013, Scandinavian journal of infectious diseases.

[511]  M. Falagas,et al.  Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[512]  G. Reynolds,et al.  Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion , 2013, The Journal of experimental medicine.

[513]  M. Knuf,et al.  Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study , 2013, European Journal of Pediatrics.

[514]  A. Wensing,et al.  Clinical Use of HIV Integrase Inhibitors: A Systematic Review and Meta-Analysis , 2013, PloS one.

[515]  J. Kaldor,et al.  Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[516]  Barbara Rehermann,et al.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus , 2013, Nature Genetics.

[517]  R. Akkina,et al.  New generation humanized mice for virus research: comparative aspects and future prospects. , 2013, Virology.

[518]  H. Bürgmann,et al.  A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota , 2013, Front. Microbiol..

[519]  Diane S. Lauderdale,et al.  Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus in the United States: A Meta-Analysis , 2013, PloS one.

[520]  J. McKimm-Breschkin,et al.  Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance , 2013, Influenza and other respiratory viruses.

[521]  E. Govorkova.  Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir‐resistant influenza A viruses , 2013, Influenza and other respiratory viruses.

[522]  K. Dooley,et al.  Safety, Tolerability, and Pharmacokinetics of the HIV Integrase Inhibitor Dolutegravir Given Twice Daily With Rifampin or Once Daily With Rifabutin: Results of a Phase 1 Study Among Healthy Subjects , 2013, Journal of acquired immune deficiency syndromes.

[523]  Carlos Alonso-Calleja,et al.  Antibiotic-Resistant Bacteria: A Challenge for the Food Industry , 2013, Critical reviews in food science and nutrition.

[524]  C. Beck,et al.  Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic , 2013, Influenza and other respiratory viruses.

[525]  W. Craig,et al.  In Vivo Activities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum β-Lactamases, in the Thighs of Neutropenic Mice , 2012, Antimicrobial Agents and Chemotherapy.

[526]  Jian Wang,et al.  SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler , 2012, GigaScience.

[527]  J. Croxtall,et al.  Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™) , 2012, Drugs.

[528]  R. Moss,et al.  A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. , 2012, The Journal of infectious diseases.

[529]  Y. Kim,et al.  An overview of thoracic actinomycosis: CT features , 2012, Insights into Imaging.

[530]  E. Mupere,et al.  Childhood tuberculosis and malnutrition. , 2012, The Journal of infectious diseases.

[531]  F. Askin,et al.  Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation. , 2012, American journal of respiratory and critical care medicine.

[532]  K. Floyd,et al.  Multidrug-resistant tuberculosis in children: evidence from global surveillance , 2012, European Respiratory Journal.

[533]  B. Ledergerber,et al.  Multidrug-resistant bacteria in travellers hospitalized abroad: prevalence, characteristics, and influence on clinical outcome. , 2012, The Journal of hospital infection.

[534]  S. Mueller,et al.  Intraventricular Daptomycin and Intravenous Linezolid for the Treatment of External Ventricular-Drain–Associated Ventriculitis Due to Vancomycin-Resistant Enterococcus faecium , 2012, The Annals of pharmacotherapy.

[535]  O. Karcioglu,et al.  A woman with headache and ptosis. , 2012, The Journal of emergency medicine.

[536]  P. Targett-Adams,et al.  Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein. , 2012, Virus research.

[537]  M. Than,et al.  Lemierre's syndrome: Diagnosis in the emergency department , 2012, Emergency medicine Australasia : EMA.

[538]  E. Ricci,et al.  Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational study , 2012, AIDS.

[539]  Yu-Huan Gu,et al.  Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cells , 2012, Oncology letters.

[540]  K. Brayton,et al.  Comparative genomics and transcriptomics of trait-gene association , 2012, BMC Genomics.

[541]  R. Striker,et al.  Subtype Specific Differences in NS5A Domain II Reveals Involvement of Proline at Position 310 in Cyclosporine Susceptibility of Hepatitis C Virus , 2012, Viruses.

[542]  S. Jonjić,et al.  The Human Cytomegalovirus UL51 Protein Is Essential for Viral Genome Cleavage-Packaging and Interacts with the Terminase Subunits pUL56 and pUL89 , 2012, Journal of Virology.

[543]  P. Xu,et al.  Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. , 2012, World journal of gastroenterology.

[544]  S. Futaki,et al.  CXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIV. , 2012, Chemistry & biology.

[545]  A. Sjöstedt,et al.  Unique Substrates Secreted by the Type VI Secretion System of Francisella tularensis during Intramacrophage Infection , 2012, PloS one.

[546]  G. Zhanel,et al.  Erratum to New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin , 2012, Drugs.

[547]  K. Bennett,et al.  The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. , 2012, American journal of respiratory and critical care medicine.

[548]  G. Papatheodoridis,et al.  Current progress in the treatment of chronic hepatitis C. , 2012, World journal of gastroenterology.

[549]  C. Sable,et al.  Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study , 2012, Current medical research and opinion.

[550]  C. Flateau,et al.  Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[551]  C. Mcnulty,et al.  European Antibiotic Awareness Day 2012: general practitioners encouraged to TARGET antibiotics through guidance, education and tools. , 2012, The Journal of antimicrobial chemotherapy.

[552]  J. Stockley.  European Antibiotic Awareness Day 2012: getting smart about antibiotics, a public-professional partnership. , 2012, The Journal of infection.

[553]  D. Podzamczer,et al.  LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy. , 2012, Atherosclerosis.

[554]  E. Bassily,et al.  Safety and Immunogenicity of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants and Toddlers: Three Multicenter Phase III Studies , 2012, The Pediatric infectious disease journal.

[555]  J. Pilewski,et al.  Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[556]  Seth D. Crockett,et al.  Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.

[557]  D. van Soolingen,et al.  Helminths and skewed cytokine profiles increase tuberculin skin test positivity in Warao Amerindians. , 2012, Tuberculosis.

[558]  B. Cowie,et al.  Effect of Latitude on Seasonality of Tuberculosis, Australia, 2002–2011 , 2012, Emerging infectious diseases.

[559]  C. Leport,et al.  Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections. , 2012, Antiviral research.

[560]  S. Pereyre,et al.  Detection of macrolide resistance in Mycoplasma genitalium in France. , 2012, The Journal of antimicrobial chemotherapy.

[561]  R. Takimoto,et al.  Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies , 2012, International Journal of Hematology.

[562]  Kenneth A. Matreyek,et al.  Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration , 2012, Journal of Virology.

[563]  P. Johann,et al.  Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation , 2012, BMC Infectious Diseases.

[564]  J. Fillaux,et al.  Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients , 2012, Scandinavian journal of infectious diseases.

[565]  S. Bentley,et al.  Developing insights into the mechanisms of evolution of bacterial pathogens from whole-genome sequences. , 2012, Future microbiology.

[566]  D. Follmann,et al.  Linezolid for treatment of chronic extensively drug-resistant tuberculosis. , 2012, The New England journal of medicine.

[567]  R. C. Layton,et al.  Neurovirulence of H5N1 Infection in Ferrets Is Mediated by Multifocal Replication in Distinct Permissive Neuronal Cell Regions , 2012, PloS one.

[568]  Richard J. Roberts,et al.  The methylomes of six bacteria , 2012, Nucleic acids research.

[569]  T. Vesikari,et al.  A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years , 2012, Human vaccines & immunotherapeutics.

[570]  T. Vesikari,et al.  Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers , 2012, Human vaccines & immunotherapeutics.

[571]  M. Bassetti,et al.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[572]  J. Roberts,et al.  Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation , 2012, Current opinion in critical care.

[573]  S. Peacock,et al.  Rapid whole-genome sequencing of bacterial pathogens in the clinical microbiology laboratory--pipe dream or reality? , 2012, The Journal of antimicrobial chemotherapy.

[574]  A. Siddiqui,et al.  Phosphoinositides in the Hepatitis C Virus Life Cycle , 2012, Viruses.

[575]  D. Blair,et al.  Actinomyces meyeri infection: case report and review of the literature. , 2012, The Journal of infection.

[576]  O. Rezahosseini,et al.  Randomized control trial: Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication , 2012, Iranian Red Crescent medical journal.

[577]  J. Claverys,et al.  Induction of competence for genetic transformation by antibiotics: convergent evolution of stress responses in distant bacterial species lacking SOS? , 2012, Current opinion in microbiology.

[578]  H. Shokoohi,et al.  Lemierre's syndrome and rapidly deteriorating respiratory failure in the emergency department. , 2012, The American journal of emergency medicine.

[579]  J. Timsit,et al.  Update on bloodstream infections in ICUs , 2012, Current opinion in critical care.

[580]  G. Ogg,et al.  Pathogenesis of severe dengue infection. , 2012, The Ceylon medical journal.

[581]  V. Leimane,et al.  Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis , 2012, European Respiratory Journal.

[582]  M. Antonelli,et al.  Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study , 2012, Intensive Care Medicine.

[583]  R. Razonable,et al.  Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment , 2012, Current Infectious Disease Reports.

[584]  Virna J. A. Schuck,et al.  Comparative In Vitro and In Vivo Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa , 2012, Antimicrobial Agents and Chemotherapy.

[585]  S. Nadel.  Prospects for eradication of meningococcal disease , 2012, Archives of Disease in Childhood.

[586]  J. Edwards,et al.  Device-Associated Infection Rates, Device Utilization, and Antimicrobial Resistance in Long-Term Acute Care Hospitals Reporting to the National Healthcare Safely Network, 2010 , 2012, Infection Control & Hospital Epidemiology.

[587]  J. Turnidge,et al.  Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole , 2012, Antimicrobial Agents and Chemotherapy.

[588]  C. Winnard,et al.  Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. , 2012, The Journal of antimicrobial chemotherapy.

[589]  H. Teppler,et al.  Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection: Final Results of a Randomized, Controlled, Phase II Study (Protocol 004) , 2012, Journal of acquired immune deficiency syndromes.

[590]  Fei Zhao,et al.  Recent Advances in Neuraminidase Inhibitor Development as Anti‐influenza Drugs , 2012, ChemMedChem.

[591]  A. Carr,et al.  Tolerability of HIV integrase inhibitors , 2012, Current opinion in HIV and AIDS.

[592]  S. Paul,et al.  Lemierre's syndrome: a sinister sore throat every clinician should remember. , 2012, The Turkish journal of pediatrics.

[593]  R. Hall.  Integrons and gene cassettes: hotspots of diversity in bacterial genomes , 2012, Annals of the New York Academy of Sciences.

[594]  C. Hamilton,et al.  Ethanol lock therapy in reducing catheter-related bloodstream infections in adult home parenteral nutrition patients: results of a retrospective study. , 2012, JPEN. Journal of parenteral and enteral nutrition.

[595]  Nivedita Gupta,et al.  Dengue in India , 2012, The Indian journal of medical research.

[596]  J. Pépin,et al.  Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? , 2012, European urology.

[597]  E. Kurbatova,et al.  Predictors of poor outcomes among patients treated for multidrug-resistant tuberculosis at DOTS-plus projects. , 2012, Tuberculosis.

[598]  F. Wagenlehner,et al.  Words of wisdom. Re: Complications After Prostate Biopsy: Data From SEER-Medicare. , 2012, European urology.

[599]  D. Assis,et al.  New Pharmacotherapy for Hepatitis C , 2012, Clinical pharmacology and therapeutics.

[600]  I. Raad,et al.  Comparison of Posaconazole Versus Weekly Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in Hematopoietic Stem-Cell Transplantation , 2012, Transplantation.

[601]  R. Basu Roy,et al.  Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study. , 2012, American journal of respiratory and critical care medicine.

[602]  H. Sørum,et al.  Prevalence of antibiotic resistance genes in the bacterial flora of integrated fish farming environments of Pakistan and Tanzania. , 2012, Environmental science & technology.

[603]  Jason A. Rosenzweig,et al.  The effect of low shear force on the virulence potential of Yersinia pestis: new aspects that space-like growth conditions and the final frontier can teach us about a formidable pathogen , 2012, Front. Cell. Inf. Microbio..

[604]  A. Wong-Beringer,et al.  Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa , 2012, PloS one.

[605]  J. Gathe,et al.  Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study. , 2012, AIDS research and human retroviruses.

[606]  C. T. Tam,et al.  Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[607]  M. Struelens,et al.  Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics. , 2012, The Journal of antimicrobial chemotherapy.

[608]  M. Kollef,et al.  Use of Adjunctive Aerosolized Antimicrobial Therapy in the Treatment of Pseudomonas aeruginosa and Acinetobacter baumannii Ventilator-Associated Pneumonia , 2012, Respiratory Care.

[609]  Sonya S. Shin,et al.  Risk Factors for In-Hospital Mortality Among Children With Tuberculosis: The 25-Year Experience in Peru , 2012, Pediatrics.

[610]  J. Raman,et al.  Complications following prostate needle biopsy requiring hospital admission or emergency department visits – experience from 1000 consecutive cases , 2012, BJU international.

[611]  C. Leen,et al.  7.0 Managing virological failure , 2012, HIV medicine.

[612]  K. Laserson,et al.  Tuberculosis among children in Kenya: epidemiology and impact of HIV in two provinces. , 2012, Journal of tropical pediatrics.

[613]  S. Madhi,et al.  Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance , 2012, Paediatrics and international child health.

[614]  A. Mebazaa,et al.  Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: A randomized,double-blind, placebo-controlled trial* , 2012, Critical care medicine.

[615]  M. Bourlière,et al.  Hepatitis C therapy in non‐genotype 1 patients: the near future , 2012, Journal of viral hepatitis.

[616]  G. Dbaibo,et al.  The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[617]  T. Tan,et al.  Comparison of phenotypic methods and matrix-assisted laser desorption ionisation time-of-flight mass spectrometry for the identification of aero-tolerant Actinomyces spp. isolated from soft-tissue infections , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[618]  S. Stefani,et al.  Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. , 2012, Future microbiology.

[619]  R. Preston,et al.  A new solid oral tablet formulation of posaconazole: a randomized clinical trial to investigate rising single- and multiple-dose pharmacokinetics and safety in healthy volunteers , 2012, The Journal of antimicrobial chemotherapy.

[620]  H. Swerdlow,et al.  A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers , 2012, BMC Genomics.

[621]  C. Rodrigo,et al.  Treatment of dengue fever , 2012, Infection and drug resistance.

[622]  Y. Yau,et al.  Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species. , 2012, Medical mycology.

[623]  C. Cameron,et al.  Correlation between NS5A Dimerization and Hepatitis C Virus Replication* , 2012, The Journal of Biological Chemistry.

[624]  M. Meschiari,et al.  96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience , 2012, PloS one.

[625]  A. Keshavarzian,et al.  Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease. , 2012, World journal of gastroenterology.

[626]  K. Meyer,et al.  Hepatitis C Virus-Mediated Inhibition of Cathepsin S Increases Invariant-Chain Expression on Hepatocyte Surface , 2012, Journal of Virology.

[627]  A. Molloy,et al.  The Changing Face of an Old Disease: Case Report of Nonclassical Lemierre's Syndrome Caused by a Panton-Valentine Leucocidin-Positive Methicillin-Susceptible Staphylococcus aureus Isolate , 2012, Journal of Clinical Microbiology.

[628]  P. Jorens,et al.  Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin? , 2012, Annals of Intensive Care.

[629]  C. Mcnulty,et al.  Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then Focus. , 2012, The Journal of antimicrobial chemotherapy.

[630]  T. Chirwa,et al.  Urethritis/Cervicitis Pathogen Prevalence and Associated Risk Factors Among Asymptomatic HIV-Infected Patients in South Africa , 2012, Sexually transmitted diseases.

[631]  H. Mo,et al.  A phase 1, randomized, placebo-controlled, 3-day, dose-ranging study of GS-5885, an NS5A inhibitor, in patients with genotype 1 hepatitis C. , 2012, Journal of hepatology.

[632]  A. Corso,et al.  Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. , 2012, The Journal of antimicrobial chemotherapy.

[633]  G. D. Dal Pan,et al.  Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[634]  J. Roberts,et al.  Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. , 2012, Chest.

[635]  R. Chiang,et al.  A Lemierre syndrome variant caused by Klebsiella pneumoniae. , 2012, Journal of the Formosan Medical Association = Taiwan yi zhi.

[636]  A. Neubauer,et al.  Value of herpes simplex virus type-specific serology: a case report. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[637]  C. Drinkwater,et al.  Hematogenous infection of total hip arthroplasty with Actinomyces following a noninvasive dental procedure. , 2012, Orthopedics.

[638]  V. Tam,et al.  Correlation of Hospital Carbapenem Consumption and Resistance Trends in Selected Gram-Negative Bacteria , 2012, The Annals of pharmacotherapy.

[639]  M. Pearle,et al.  Cost‐effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)‐guided prostate biopsy prophylaxis , 2012, BJU international.

[640]  T. Victor,et al.  The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[641]  T. Uyeki,et al.  Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09 , 2012, PloS one.

[642]  S. Lawn,et al.  Indoor Social Networks in a South African Township: Potential Contribution of Location to Tuberculosis Transmission , 2012, PloS one.

[643]  Bradley A Sharpe.  Putting a critical pathway into practice: the devil is in the implementation details. , 2012, Archives of internal medicine.

[644]  Y. Liew,et al.  Utility and safety of procalcitonin in an antimicrobial stewardship program (ASP) in patients with malignancies , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[645]  Claudia Schmidt-Dannert,et al.  Stochastic simulations of a synthetic bacteria-yeast ecosystem , 2012, BMC Systems Biology.

[646]  P. Dasgupta,et al.  Infection after transrectal ultrasonography‐guided prostate biopsy: increased relative risks after recent international travel or antibiotic use , 2012, BJU international.

[647]  J. Campos,et al.  Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain. , 2012, Journal of medical microbiology.

[648]  Caitlin E. Mullarkey,et al.  T-Cell Responses in Children to Internal Influenza Antigens, 1 Year After Immunization With Pandemic H1N1 Influenza Vaccine, and Response to Revaccination With Seasonal Trivalent–inactivated Influenza Vaccine , 2012, The Pediatric infectious disease journal.

[649]  A. Perelson,et al.  Combination antiviral therapy for influenza: predictions from modeling of human infections. , 2012, The Journal of infectious diseases.

[650]  A. Amendola,et al.  Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy , 2012, European journal of haematology.

[651]  M. Roobol,et al.  Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. , 2012, European urology.

[652]  B. Arulanandam,et al.  Mast Cell TLR2 Signaling Is Crucial for Effective Killing of Francisella tularensis , 2012, The Journal of Immunology.

[653]  J. Botha,et al.  Staphylococcus aureus infections after liver transplantation , 2012, Infection.

[654]  D. Livermore.  Current Epidemiology and Growing Resistance of Gram-Negative Pathogens , 2012, The Korean journal of internal medicine.

[655]  M. Schatz,et al.  Hybrid error correction and de novo assembly of single-molecule sequencing reads , 2012, Nature Biotechnology.

[656]  E. Gupta,et al.  Circulation of Dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after Dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. , 2012, Journal of vector borne diseases.

[657]  M. Tsegaye,et al.  A case of craniocervical abscess with sinus thrombosis in Lemierre's syndrome , 2012, British journal of neurosurgery.

[658]  J. Lipuma,et al.  Use of matrix assisted laser desorption ionisation–time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients , 2012, Journal of Clinical Pathology.

[659]  Adriano S. Arantes,et al.  Comparing thousands of circular genomes using the CGView Comparison Tool , 2012, BMC Genomics.

[660]  E. O'Mara,et al.  Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension , 2012, Antimicrobial Agents and Chemotherapy.

[661]  Lena E. Friberg,et al.  Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill , 2012, Antimicrobial Agents and Chemotherapy.

[662]  W. Hope,et al.  Evaluation of the pharmacokinetics and clinical utility of isavuconazole for treatment of invasive fungal infections , 2012, Expert opinion on drug metabolism & toxicology.

[663]  S. Ishido,et al.  Francisella tularensis Elicits IL-10 via a PGE2-Inducible Factor, to Drive Macrophage MARCH1 Expression and Class II Down-Regulation , 2012, PloS one.

[664]  P. Schuetz,et al.  Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). , 2012, Archives of internal medicine.

[665]  M. Parsek,et al.  The FleQ protein from Pseudomonas aeruginosa functions as both a repressor and an activator to control gene expression from the pel operon promoter in response to c-di-GMP , 2012, Nucleic acids research.

[666]  J. Mell,et al.  Natural Transformation of Gallibacterium anatis , 2012, Applied and Environmental Microbiology.

[667]  L. Katz,et al.  Haemophilus haemolyticus Isolates Causing Clinical Disease , 2012, Journal of Clinical Microbiology.

[668]  Susanne Hempel,et al.  Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. , 2012, JAMA.

[669]  H. Goossens,et al.  Priority actions to fight antibiotic resistance: results of an international meeting , 2012, Antimicrobial Resistance and Infection Control.

[670]  P. Hawkey,et al.  High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK. , 2012, The Journal of antimicrobial chemotherapy.

[671]  R. Bellomo,et al.  Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: A multicentre pharmacokinetic study* , 2012, Critical care medicine.

[672]  D. Nathwani,et al.  Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. , 2012, The Journal of hospital infection.

[673]  V. Papaevangelou,et al.  MenACWY-TT vaccine for active immunization against invasive meningococcal disease , 2012, Expert review of vaccines.

[674]  Duane J. Gubler,et al.  The Economic Burden of Dengue , 2012, The American journal of tropical medicine and hygiene.

[675]  G. Samonis,et al.  Linezolid versus Vancomycin Antibiotic Lock Solution for the Prevention of Nontunneled Catheter‐related Blood Stream Infections in Hemodialysis Patients: A Prospective Randomized Study , 2012, Seminars in dialysis.

[676]  M. Broderick,et al.  Meningococcal polysaccharide vaccine failure in a patient with C7 deficiency and a decreased anti-capsular antibody response , 2012, Human vaccines & immunotherapeutics.

[677]  J. Tupesis,et al.  Disseminated Lemierre syndrome presenting as septic arthritis. , 2012, The Journal of emergency medicine.

[678]  W. F. Wright,et al.  Lemierre Syndrome , 2012, Southern medical journal.

[679]  J. M. Dow,et al.  When the PilZ don't work: effectors for cyclic di-GMP action in bacteria. , 2012, Trends in microbiology.

[680]  M. Dark,et al.  Determining the Repertoire of Immunodominant Proteins via Whole-Genome Amplification of Intracellular Pathogens , 2012, PloS one.

[681]  S. Aaron,et al.  Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study , 2012, PloS one.

[682]  S. Leroy,et al.  The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.

[683]  R. Wunderink,et al.  The Effect of Rosuvastatin in a Murine Model of Influenza A Infection , 2012, PloS one.

[684]  S. Garland,et al.  Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt Analysis , 2012, PloS one.

[685]  P. Sendi,et al.  Lemierre’s syndrome in the liver , 2012, Infection.

[686]  E. Hiltunen-Back,et al.  Genotyping of Chlamydia trachomatis in rectal and pharyngeal specimens: identification of LGV genotypes in Finland , 2012, Sexually Transmitted Infections.

[687]  J. Schildbach,et al.  Assembly and mechanisms of bacterial type IV secretion machines , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[688]  R. Seaton,et al.  Outpatient parenteral antimicrobial therapy with ceftriaxone, a review , 2012, International Journal of Clinical Pharmacy.

[689]  L. Shaw,et al.  Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents. , 2012, Journal of medicinal chemistry.

[690]  Rongsheng E. Wang,et al.  Cellular translocation of a γ-AApeptide mimetic of Tat peptide. , 2012, Molecular pharmaceutics.

[691]  C. Charpentier,et al.  Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial , 2012, Journal of acquired immune deficiency syndromes.

[692]  T. Shim,et al.  Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis , 2012, European Respiratory Journal.

[693]  C. Arias,et al.  Transferable Plasmid-Mediated Resistance to Linezolid Due to cfr in a Human Clinical Isolate of Enterococcus faecalis , 2012, Antimicrobial Agents and Chemotherapy.

[694]  M. Knuf,et al.  Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children , 2012, Human vaccines & immunotherapeutics.

[695]  S. Berndt,et al.  Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. , 2012, The Journal of urology.

[696]  J. Margolick,et al.  A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. , 2012, The Journal of urology.

[697]  S. L. Lee,et al.  Clinicians' knowledge, beliefs and acceptance of intravenous-to-oral antibiotic switching, Hospital Pulau Pinang. , 2012, The Medical journal of Malaysia.

[698]  H. Krumholz,et al.  Building hospital management capacity to improve patient flow for cardiac catheterization at a cardiovascular hospital in Egypt. , 2012, Joint Commission journal on quality and patient safety.

[699]  A. Kumar,et al.  Awareness of changing trends in epidemiology of dengue fever is essential for epidemiological surveillance. , 2012, Indian journal of medical microbiology.

[700]  M. Gibbons,et al.  Lemierre syndrome complicating otitis externa: case report and literature review. , 2012, The Journal of emergency medicine.

[701]  A. Prince,et al.  Cystic fibrosis: a mucosal immunodeficiency syndrome , 2012, Nature Medicine.

[702]  N. Caroff,et al.  Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora. , 2012, The Journal of antimicrobial chemotherapy.

[703]  M. Carr,et al.  Acute neck pain referred to the surgeon: Lemierre's syndrome as a differential diagnosis. , 2012, Annals of the Royal College of Surgeons of England.

[704]  Edward Y Lee,et al.  Case of the season: Lemierre syndrome. , 2012, Seminars in roentgenology.

[705]  Herman Tse,et al.  Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned? , 2012, Clinical Microbiology Reviews.

[706]  D. Smee,et al.  Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice. , 2012, Antiviral research.

[707]  R. Foà,et al.  Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience , 2012, Haematologica.

[708]  J. Masters,et al.  TRAVEL‐ASSOCIATED EXTENDED‐SPECTRUM β‐LACTAMASE‐PRODUCING ESCHERICHIA COLI BLOODSTREAM INFECTION FOLLOWING TRANSRECTAL ULTRASOUND‐GUIDED PROSTATE BIOPSY , 2012, BJU international.

[709]  J. Cashy,et al.  Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. , 2012, The Journal of urology.

[710]  Jason Barker,et al.  Francisella tularensis Inhibits the Intrinsic and Extrinsic Pathways To Delay Constitutive Apoptosis and Prolong Human Neutrophil Lifespan , 2012, The Journal of Immunology.

[711]  R. Khandelwal,et al.  Primary actinomycosis of the thigh – a rare soft tissue infection with review of literature , 2012, JRSM short reports.

[712]  E. Hershberger,et al.  Pharmacokinetics and Safety of Intravenous Ceftolozane-Tazobactam in Healthy Adult Subjects following Single and Multiple Ascending Doses , 2012, Antimicrobial Agents and Chemotherapy.

[713]  K. Chan,et al.  Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient , 2012, Scandinavian journal of infectious diseases.

[714]  A. Nisalak,et al.  Comparison of Seven Commercial Antigen and Antibody Enzyme-Linked Immunosorbent Assays for Detection of Acute Dengue Infection , 2012, Clinical and Vaccine Immunology.

[715]  J. Eron,et al.  Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naïve HIV-Infected Patients , 2012, Antimicrobial Agents and Chemotherapy.

[716]  J. Guarro,et al.  Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine , 2012, Antimicrobial Agents and Chemotherapy.

[717]  S. Higgins,et al.  Complicated lymphogranuloma venereum infection mimicking deep vein thrombosis in an HIV-positive man , 2012, International journal of STD & AIDS.

[718]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[719]  C. Recule,et al.  Outcome of central venous catheter-related bacteraemia according to compliance with guidelines: experience with 91 episodes. , 2012, The Journal of hospital infection.

[720]  Michael Shaw,et al.  Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. , 2012, Antiviral research.

[721]  M. Eriksson,et al.  Pediatric Tuberculosis in Stockholm: A Mirror to the World , 2012, The Pediatric infectious disease journal.

[722]  C. Gomersall,et al.  How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics. , 2012, International journal of antimicrobial agents.

[723]  N. McElvaney,et al.  Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. , 2012, European journal of radiology.

[724]  O. Dekkers,et al.  Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. , 2012, The Journal of antimicrobial chemotherapy.

[725]  R. De Francesco,et al.  Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity , 2012, PLoS pathogens.

[726]  L. Carmignani,et al.  Bacterial sepsis following prostatic biopsy , 2012, International Urology and Nephrology.

[727]  S. Morré,et al.  The first case record of a female patient with bubonic lymphogranuloma venereum (LGV), serovariant L2b , 2012, Sexually Transmitted Infections.

[728]  Naoko Hikita,et al.  Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients , 2012, International journal of pediatrics.

[729]  B. Ursø,et al.  Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A , 2012, PloS one.

[730]  M. Unemo,et al.  In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea? , 2012, Antimicrobial Agents and Chemotherapy.

[731]  J. Fox,et al.  Decoding the Distribution of Glycan Receptors for Human-Adapted Influenza A Viruses in Ferret Respiratory Tract , 2012, PloS one.

[732]  M. Cormican,et al.  Isolation of NDM-1-producing Klebsiella pnemoniae in Ireland, July 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[733]  Y. Kumeda,et al.  Isolation and characterization of vanA genotype vancomycin-resistant Enterococcus cecorum from retail poultry in Japan. , 2012, International journal of food microbiology.

[734]  Stuart Johnson,et al.  Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[735]  S. Choi,et al.  Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial , 2012, Critical Care.

[736]  Rongsheng E. Wang,et al.  Cellular uptake of an α-AApeptide. , 2012, Organic & biomolecular chemistry.

[737]  P. Savelkoul,et al.  A Case of New Delhi Metallo-β-Lactamase 1 (NDM-1)-Producing Klebsiella pneumoniae with Putative Secondary Transmission from the Balkan Region in the Netherlands , 2012, Antimicrobial Agents and Chemotherapy.

[738]  Mamoru Ito,et al.  Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.

[739]  J. Wasserheit,et al.  The emerging threat of untreatable gonococcal infection. , 2012, The New England journal of medicine.

[740]  D. Nathwani,et al.  Antimicrobial stewardship in Scotland: impact of a national programme , 2012, Antimicrobial Resistance and Infection Control.

[741]  Anthony S Fauci,et al.  The perpetual challenge of infectious diseases. , 2012, The New England journal of medicine.

[742]  E. Clementi,et al.  Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects. , 2012, The Journal of antimicrobial chemotherapy.

[743]  Tianhong Dai,et al.  Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? , 2012, Expert review of anti-infective therapy.

[744]  C. Ison.  Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment , 2012, Current opinion in infectious diseases.

[745]  M. Sparo,et al.  High‐level resistance to gentamicin: genetic transfer between Enterococcus faecalis isolated from food of animal origin and human microbiota , 2012, Letters in applied microbiology.

[746]  R. Mitchell,et al.  The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. , 2012, BMB reports.

[747]  I. Jacobson,et al.  Advances in the treatment of hepatitis C virus infection. , 2012, Gastroenterology & hepatology.

[748]  D. Smee,et al.  Efficacy of Combined Therapy with Amantadine, Oseltamivir, and Ribavirin In Vivo against Susceptible and Amantadine-Resistant Influenza A Viruses , 2012, PloS one.

[749]  C. West,et al.  A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: an open, randomised, controlled trial. , 2012, Vaccine.

[750]  D. Paterson,et al.  Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens , 2012, Antimicrobial Agents and Chemotherapy.

[751]  Todd M. Allen,et al.  Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence , 2012, The Journal of experimental medicine.

[752]  H. Zákoucká,et al.  First detection of Chlamydia trachomatis LGV biovar in the Czech Republic, 2010-2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[753]  M. Alsina,et al.  Lymphogranuloma venereum: a hidden emerging problem, Barcelona, 2011. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[754]  D. Bernstein,et al.  Efficacy results of a trial of a herpes simplex vaccine. , 2012, The New England journal of medicine.

[755]  H. Goossens,et al.  In Vitro Antibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates , 2012, Antimicrobial Agents and Chemotherapy.

[756]  J. McVernon,et al.  A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers , 2012, The Pediatric infectious disease journal.

[757]  Wuyuan Lu,et al.  α‐Defensins in human innate immunity , 2012, Immunological reviews.

[758]  A. Perelson,et al.  Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus , 2011, PloS one.

[759]  C. Haggerty,et al.  Mycoplasma genitalium: An Emerging Cause of Pelvic Inflammatory Disease , 2011, Infectious diseases in obstetrics and gynecology.

[760]  S. Piscitelli,et al.  Effect of Food on the Pharmacokinetics of the Integrase Inhibitor Dolutegravir , 2011, Antimicrobial Agents and Chemotherapy.

[761]  S. Lockhart,et al.  Fatal Disseminated Cryptococcus gattii Infection in New Mexico , 2011, PloS one.

[762]  C. Bébéar,et al.  First case of Chlamydia trachomatis L2b proctitis in a woman. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[763]  B. Franklin,et al.  Patients' views and experience of intravenous and oral antimicrobial therapy: room for change. , 2011, Injury.

[764]  Jing Zhao,et al.  Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial. , 2011, The Lancet. Infectious diseases.

[765]  G. Forrest,et al.  Single center experience of a vancomycin resistant enterococcal endocarditis cohort. , 2011, The Journal of infection.

[766]  P. Nordmann,et al.  Emergence of NDM-1-producing Klebsiella pneumoniae in Morocco. , 2011, The Journal of antimicrobial chemotherapy.

[767]  S. Bababeygy,et al.  Isolated abducens nerve palsy secondary to Lemierre syndrome. , 2011, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[768]  L. Drago,et al.  In Vitro Selection and Transferability of Antibiotic Resistance in the Probiotic Strain Lactobacillus reuteri DSM 17938 , 2011, Journal of chemotherapy.

[769]  Xin Huang,et al.  Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS‐790052 in Humans: In Vitro and In Vivo Correlations , 2011, Hepatology.

[770]  P. Hsueh,et al.  Pelvic abscess caused by New Delhi metallo-β-lactamase-1-producing Klebsiella oxytoca in Taiwan in a patient who underwent renal transplantation in China. , 2011, Diagnostic microbiology and infectious disease.

[771]  R. Webster,et al.  Fitness of neuraminidase inhibitor-resistant influenza A viruses. , 2011, Current opinion in virology.

[772]  S. Pournaras,et al.  Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[773]  Min Gao,et al.  Multiple ascending dose study of BMS‐790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1 , 2011, Hepatology.

[774]  J. Elborn,et al.  Effect of Aspergillus fumigatus and Candida albicans on pro-inflammatory response in cystic fibrosis epithelium. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[775]  K. Hueffer,et al.  The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins IglA, IglB, IglC, PdpB and DotU suggest roles in type VI secretion. , 2011, Microbiology.

[776]  Qingsong Liu,et al.  Anti-HCV drugs in the pipeline. , 2011, Current opinion in virology.

[777]  I-Min A. Chen,et al.  The Genomes OnLine Database (GOLD) v.4: status of genomic and metagenomic projects and their associated metadata , 2011, Nucleic Acids Res..

[778]  J. Rello,et al.  The relevance of drug volume of distribution in antibiotic dosing. , 2011, Current pharmaceutical biotechnology.

[779]  Miguel A. R. B. Castanho,et al.  Dengue Virus Capsid Protein Binding to Hepatic Lipid Droplets (LD) Is Potassium Ion Dependent and Is Mediated by LD Surface Proteins , 2011, Journal of Virology.

[780]  A. D. de Silva,et al.  The Human Antibody Response to Dengue Virus Infection , 2011, Viruses.

[781]  M. Hulscher,et al.  Non-adherence to antimicrobial treatment guidelines results in more broad-spectrum but not more appropriate therapy , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[782]  M. Marschall,et al.  In Vitro Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses , 2011, Antimicrobial Agents and Chemotherapy.

[783]  R. Warrington,et al.  Primary immunodeficiency , 2011, Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology.

[784]  B. Walenz,et al.  A Rickettsia Genome Overrun by Mobile Genetic Elements Provides Insight into the Acquisition of Genes Characteristic of an Obligate Intracellular Lifestyle , 2011, Journal of bacteriology.

[785]  H. Vogel,et al.  Relative Spatial Positions of Tryptophan and Cationic Residues in Helical Membrane-active Peptides Determine Their Cytotoxicity* , 2011, The Journal of Biological Chemistry.

[786]  A. Lombardi,et al.  Lymphogranuloma venereum variant L2b-specific polymerase chain reaction: insertion used to close an epidemiological gap. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[787]  N. Woodford,et al.  Breakthrough bacteraemia due to tigecycline-resistant Escherichia coli with New Delhi metallo-β-lactamase (NDM)-1 successfully treated with colistin in a patient with calciphylaxis. , 2011, The Journal of antimicrobial chemotherapy.

[788]  G. Dore,et al.  What Is Killing People with Hepatitis C Virus Infection? , 2011, Seminars in liver disease.

[789]  L. Shaw,et al.  Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity. , 2011, Chemical communications.

[790]  Matthias Meyer,et al.  A draft genome of Yersinia pestis from victims of the Black Death , 2011, Nature.

[791]  Lakshmi Putcha,et al.  Biopharmaceutical challenges of therapeutics in space: formulation and packaging considerations. , 2011, Therapeutic delivery.

[792]  Jessina C. McGregor,et al.  Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia , 2011, BMC infectious diseases.

[793]  R. Briandet,et al.  Resistance of bacterial biofilms to disinfectants: a review , 2011, Biofouling.

[794]  Harold P Lehmann,et al.  Adolescent and parental utilities for the health states associated with pelvic inflammatory disease , 2011, Sexually Transmitted Infections.

[795]  Nicolas Blondiaux,et al.  Cost-Effectiveness of Switch to Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Routine Bacterial Identification , 2011, Journal of Clinical Microbiology.

[796]  U. Schumacher,et al.  Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4. , 2011, Journal of medicinal chemistry.

[797]  Yves Pommier,et al.  Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572) , 2011, Molecular Pharmacology.

[798]  Hajo Grundmann,et al.  Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe , 2011, PLoS medicine.

[799]  D. Enarson,et al.  Incomplete registration and reporting of culture-confirmed childhood tuberculosis diagnosed in hospital. , 2011, Public health action.

[800]  J. Gonçalves-Pereira,et al.  Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams , 2011, Critical care.

[801]  G. Varani,et al.  γ-AApeptides bind to RNA by mimicking RNA-binding proteins. , 2011, Organic & biomolecular chemistry.

[802]  C. Delaugerre,et al.  Efficacy and safety of raltegravir in treatment-experienced HIV-1-infected patients switching from enfuvirtide-based regimens: 48 week results of the randomized EASIER ANRS 138 trial. , 2011, The Journal of antimicrobial chemotherapy.

[803]  S. Stefani,et al.  Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[804]  S. Zeuzem,et al.  IL28B single nucleotide polymorphisms in the treatment of hepatitis C. , 2011, Journal of hepatology.

[805]  C. Cameron,et al.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION. , 2011, Drugs of the future.

[806]  J. Heitman,et al.  A Diverse Population of Cryptococcus gattii Molecular Type VGIII in Southern Californian HIV/AIDS Patients , 2011, PLoS pathogens.

[807]  J. Rello,et al.  Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE Organisms. , 2011, Chest.

[808]  M. Trent,et al.  Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. , 2011, Sexually transmitted diseases.

[809]  Rowena A. Bull,et al.  Sequential Bottlenecks Drive Viral Evolution in Early Acute Hepatitis C Virus Infection , 2011, PLoS pathogens.

[810]  M. Bonten,et al.  Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[811]  P. Arbogast,et al.  Comparative Effectiveness of Antibiotic Treatment Strategies for Pediatric Skin and Soft-Tissue Infections , 2011, Pediatrics.

[812]  S. Khader,et al.  Francisella tularensis LVS-induced Interleukin-12 p40 cytokine production mediates dendritic cell migration through IL-12 Receptor β1. , 2011, Cytokine.

[813]  S. Telford,et al.  Differential mortality of dog tick vectors due to infection by diverse Francisella tularensis tularensis genotypes. , 2011, Vector borne and zoonotic diseases.

[814]  P. Barie,et al.  Use of meropenem by continuous infusion to treat a patient with a Bla(kpc-2)-positive Klebsiella pneumoniae blood stream infection. , 2011, Surgical infections.

[815]  Louisa Degenhardt,et al.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.

[816]  Todd M. Allen,et al.  HIV-1 adaptation to NK cell mediated immune pressure , 2011, Nature.

[817]  M. Dryden,et al.  Reduction in antibiotic use through procalcitonin testing in patients in the medical admission unit or intensive care unit with suspicion of infection. , 2011, The Journal of hospital infection.

[818]  Frédéric Barbut,et al.  Epidemiology and control of Clostridium difficile infections in healthcare settings: an update , 2011, Current opinion in infectious diseases.

[819]  G. Daikos,et al.  Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[820]  R. Leclercq,et al.  d-Ala-d-Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium , 2011, Antimicrobial Agents and Chemotherapy.

[821]  B. Akduman,et al.  Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. , 2011, Urology.

[822]  M. Moneer,et al.  Antibiotic resistance is associated with longer bacteremic episodes and worse outcome in febrile neutropenic children with cancer , 2011, Pediatric blood & cancer.

[823]  E. Bernasconi,et al.  A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study) , 2011, AIDS.

[824]  M. Galleni,et al.  OXA-198, an Acquired Carbapenem-Hydrolyzing Class D β-Lactamase from Pseudomonas aeruginosa , 2011, Antimicrobial Agents and Chemotherapy.

[825]  H. Goossens,et al.  Society's failure to protect a precious resource: antibiotics , 2011, The Lancet.

[826]  B. Sahay,et al.  Host-Adaptation of Francisella tularensis Alters the Bacterium's Surface-Carbohydrates to Hinder Effectors of Innate and Adaptive Immunity , 2011, PloS one.

[827]  B. Limbago,et al.  Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[828]  H. Zimmermann,et al.  The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase , 2011, Journal of Virology.

[829]  R. Webster,et al.  Novel Genotyping and Quantitative Analysis of Neuraminidase Inhibitor Resistance-Associated Mutations in Influenza A Viruses by Single-Nucleotide Polymorphism Analysis , 2011, Antimicrobial Agents and Chemotherapy.

[830]  Pramod Kumar,et al.  Bactericidal effect of ultraviolet C (UVC), direct and filtered through transparent plastic, on gram-positive cocci: an in vitro study. , 2011, Ostomy/wound management.

[831]  B. Ha,et al.  96-Week Results of a Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: The SHIELD Trial , 2011, HIV clinical trials.

[832]  C. Gaydos,et al.  O3-S6.04 Multi-site screening for lymphogranuloma venereum (LGV) in the USA , 2011, Sexually Transmitted Infections.

[833]  T. Kuiken,et al.  Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. , 2011, The American journal of pathology.

[834]  G. Dumyati,et al.  Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[835]  P. Savelkoul,et al.  Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands , 2011, Emerging infectious diseases.

[836]  Jyotika Sharma,et al.  Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strain. , 2011, Microbial pathogenesis.

[837]  D. Taylor-Robinson,et al.  Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.

[838]  J. Kuehl,et al.  The Gut as Reservoir of Antibiotic Resistance: Microbial Diversity of Tetracycline Resistance in Mother and Infant , 2011, PloS one.

[839]  R. Sockett,et al.  Effects of Orally Administered Bdellovibrio bacteriovorus on the Well-Being and Salmonella Colonization of Young Chicks , 2011, Applied and Environmental Microbiology.

[840]  Won Chul Kim,et al.  Clinical Features of Abdominal Actinomycosis: A 15-year Experience of A Single Institute , 2011, Journal of Korean medical science.

[841]  D. Diop,et al.  Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. , 2011, The New England journal of medicine.

[842]  David W. Smith,et al.  Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[843]  J. Roberts,et al.  A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance , 2011, Critical care.

[844]  M. Yasuda,et al.  Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin , 2011, Sexually Transmitted Infections.

[845]  J. Vincent,et al.  Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy , 2011, Critical care.

[846]  M. Knuf,et al.  An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old children. , 2011, Vaccine.

[847]  D. Frank,et al.  Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria , 2011, Front. Microbio..

[848]  H. J. de Silva,et al.  Effect of a single dose of methyl prednisolone as rescue medication for patients who develop hypotensive dengue shock syndrome during the febrile phase: a retrospective observational study. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[849]  E. Zell,et al.  Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine , 2011, The Pediatric infectious disease journal.

[850]  M. Barton,et al.  Bacteriophage‐mediated transduction of antibiotic resistance in enterococci , 2011, Letters in applied microbiology.

[851]  M. Maley,et al.  Utility of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry following Introduction for Routine Laboratory Bacterial Identification , 2011, Journal of Clinical Microbiology.

[852]  M. Leroi,et al.  Successful antibiotic stewardship: are we a victim of our own success? , 2011, ANZ journal of surgery.

[853]  L. Bossi,et al.  Bacteriophage Crosstalk: Coordination of Prophage Induction by Trans-Acting Antirepressors , 2011, PLoS genetics.

[854]  M. Drumm,et al.  Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. , 2011, American journal of respiratory cell and molecular biology.

[855]  G. Krishnaswamy,et al.  Chronic granulomatous disease: a review of the infectious and inflammatory complications , 2011, Clinical and molecular allergy : CMA.

[856]  J. Mathew,et al.  Clinical Pearls in Pediatric Infections , 2011, Indian journal of pediatrics.

[857]  S. Khakoo,et al.  KIR/HLA Interactions and Pathogen Immunity , 2011, Journal of biomedicine & biotechnology.

[858]  Alison M Wilson,et al.  Impact of a Multimodal Antimicrobial Stewardship Program on Pseudomonas aeruginosa Susceptibility and Antimicrobial Use in the Intensive Care Unit Setting , 2011, Critical care research and practice.

[859]  P. Klenerman,et al.  Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection , 2011, Gut.

[860]  W. M. Mac Kenzie,et al.  Seasonality of tuberculosis in the United States, 1993-2008. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[861]  Soo-Yon Rhee,et al.  HIV-1 Integrase Inhibitor Resistance and Its Clinical Implications , 2011, The Journal of infectious diseases.

[862]  H. Zimmermann,et al.  First Report of Successful Treatment of Multidrug‐Resistant Cytomegalovirus Disease with the Novel Anti‐CMV Compound AIC246 , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[863]  R. Webster,et al.  Competitive transmissibility and fitness of oseltamivirsensitive and resistant pandemic influenza H1N1 viruses in ferrets. , 2011, Influenza and other respiratory viruses.

[864]  Wangxue Chen,et al.  Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice. , 2011, Microbes and infection.

[865]  M. Rudolf,et al.  Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia. , 2011, The Journal of antimicrobial chemotherapy.

[866]  C. Gudiol,et al.  Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation , 2011, Bone Marrow Transplantation.

[867]  S. Piscitelli,et al.  Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteers. , 2011, The Journal of antimicrobial chemotherapy.

[868]  D. Annane.  Corticosteroids for severe sepsis: an evidence-based guide for physicians , 2011, Annals of intensive care.

[869]  Matthew Samore,et al.  Intervention to reduce transmission of resistant bacteria in intensive care. , 2011, The New England journal of medicine.

[870]  N. Fujii,et al.  Design and synthesis of amidine-type peptide bond isosteres: application of nitrile oxide derivatives as active ester equivalents in peptide and peptidomimetics synthesis. , 2011, Organic & biomolecular chemistry.

[871]  Lakshmi Putcha,et al.  Evaluation of Physical and Chemical Changes in Pharmaceuticals Flown on Space Missions , 2011, The AAPS Journal.

[872]  Christopher H. Contag,et al.  Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis , 2011, Antimicrobial Agents and Chemotherapy.

[873]  M. Mizuguchi,et al.  Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients , 2011, Antimicrobial Agents and Chemotherapy.

[874]  Y. Hsieh,et al.  Poor Provider Adherence to the Centers for Disease Control and Prevention Treatment Guidelines in US Emergency Department Visits With a Diagnosis of Pelvic Inflammatory Disease , 2011, Sexually transmitted diseases.

[875]  Ahwon Lee,et al.  Computed tomography for the preoperative diagnosis of pelvic actinomycosis , 2011, The journal of obstetrics and gynaecology research.

[876]  A. Einarson,et al.  Safety of antiviral medication for the treatment of herpes during pregnancy. , 2011, Canadian family physician Medecin de famille canadien.

[877]  A. Dubey,et al.  Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2- to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile , 2011, The Pediatric infectious disease journal.

[878]  Charles-Edouard Luyt1 , 2,et al.  Value of the Serum Procalcitonin Level to Guide Antimicrobial Therapy for Patients with Ventilator-Associated Pneumonia , 2011 .

[879]  M. Arendrup,et al.  Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. , 2011, Medical mycology.

[880]  Y. Yılmaz,et al.  Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. , 2011, Journal of medicinal food.

[881]  J. Celli,et al.  Phagocytic Receptors Dictate Phagosomal Escape and Intracellular Proliferation of Francisella tularensis , 2011, Infection and Immunity.

[882]  A. Spormann,et al.  Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms , 2011, Antimicrobial Agents and Chemotherapy.

[883]  Avinash K. Shetty,et al.  Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[884]  C. O’Farrelly,et al.  Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection , 2011, Proceedings of the National Academy of Sciences.

[885]  S. Oliver,et al.  Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review. , 2011, Foodborne pathogens and disease.

[886]  A. Sundsfjord,et al.  Identification of NDM-1-producing Enterobacteriaceae in Norway. , 2011, The Journal of antimicrobial chemotherapy.

[887]  H. Smidt,et al.  Probiotics - do they have a role in the pig industry? , 2011, Animal : an international journal of animal bioscience.

[888]  H. Qu,et al.  Knowledge gaining by human genetic studies on tuberculosis susceptibility , 2011, Journal of Human Genetics.

[889]  A. Charlett,et al.  Adding amikacin to fluoroquinolone‐based antimicrobial prophylaxis reduces prostate biopsy infection rates , 2011, BJU international.

[890]  D. Slain,et al.  A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis. , 2011, International journal of antimicrobial agents.

[891]  J. Poolman,et al.  Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines , 2011, Expert review of vaccines.

[892]  R. Baxter,et al.  Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal ACWY Tetanus Toxoid Conjugate Vaccine in Healthy Adolescents and Young Adults 10 to 25 Years of Age , 2011, The Pediatric infectious disease journal.

[893]  Steven Z. Kassakian,et al.  Impact of Chlorhexidine Bathing on Hospital-Acquired Infections among General Medical Patients , 2011, Infection Control & Hospital Epidemiology.

[894]  T. Anderson,et al.  Induced Macrolide Resistance in Mycoplasma genitalium Isolates from Patients with Recurrent Nongonococcal Urethritis , 2011, Journal of Clinical Microbiology.

[895]  J. Farrar,et al.  Kinetics of Plasma Viremia and Soluble Nonstructural Protein 1 Concentrations in Dengue: Differential Effects According to Serotype and Immune Status , 2011, The Journal of infectious diseases.

[896]  D. Paterson,et al.  Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-β-lactamase. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[897]  M. John,et al.  Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity , 2011, PloS one.

[898]  Y. Lim,et al.  Hepatitis C Virus NS5A Protein Interacts with Phosphatidylinositol 4-Kinase Type IIIα and Regulates Viral Propagation* , 2011, The Journal of Biological Chemistry.

[899]  G. Peirano,et al.  New Delhi Metallo-β-Lactamase from Traveler Returning to Canada , 2011, Emerging infectious diseases.

[900]  S. Cosgrove,et al.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[901]  W. Meyer,et al.  Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[902]  A. Dubey,et al.  Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults , 2011, Human vaccines.

[903]  Jyotika Sharma,et al.  Defect in efferocytosis leads to alternative activation of macrophages in Francisella infections , 2011, Immunology and cell biology.

[904]  S. Piscitelli,et al.  The Effect of Lopinavir/Ritonavir and Darunavir/Ritonavir on the HIV Integrase Inhibitor S/GSK1349572 in Healthy Participants , 2011, Journal of clinical pharmacology.

[905]  M. Fyfe,et al.  Risk Factors for Cryptococcus gattii Infection, British Columbia, Canada , 2011, Emerging infectious diseases.

[906]  A. Bhagat,et al.  Detection of dengue-4 virus in pune, western india after an absence of 30 years - its association with two severe cases , 2011, Virology Journal.

[907]  Terry H Wu,et al.  Antibodies Contribute to Effective Vaccination against Respiratory Infection by Type A Francisella tularensis Strains , 2011, Infection and Immunity.

[908]  P. French,et al.  Lymphogranuloma venereum presenting as perianal ulceration: an emerging clinical presentation? , 2011, Sexually Transmitted Infections.

[909]  A. Murphy,et al.  Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung , 2011, Proceedings of the National Academy of Sciences.

[910]  Thomas Lengauer,et al.  Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.

[911]  N. McCallum,et al.  Induction kinetics of the Staphylococcus aureus cell wall stress stimulon in response to different cell wall active antibiotics , 2011, BMC Microbiology.

[912]  L. Lopez,et al.  Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[913]  Timothy B. Stockwell,et al.  Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. , 2011, The Journal of infectious diseases.

[914]  N. McCallum,et al.  Mutational Analyses of Open Reading Frames within the vraSR Operon and Their Roles in the Cell Wall Stress Response of Staphylococcus aureus , 2011, Antimicrobial Agents and Chemotherapy.

[915]  L. Mermel,et al.  Methicillin-Resistant Staphylococcus aureus Colonization at Different Body Sites: a Prospective, Quantitative Analysis , 2011, Journal of Clinical Microbiology.

[916]  Teresa Gonçalves,et al.  Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[917]  M. Trent,et al.  Adverse adolescent reproductive health outcomes after pelvic inflammatory disease. , 2011, Archives of pediatrics & adolescent medicine.

[918]  K. Walker-Bone,et al.  Acute seronegative polyarthritis associated with lymphogranuloma venereum infection in a patient with prevalent HIV infection , 2011, International journal of STD & AIDS.

[919]  L. Pagano,et al.  Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies , 2011, Haematologica.

[920]  C. Baugh,et al.  Emergency department observation units: A clinical and financial benefit for hospitals , 2011, Health care management review.

[921]  M. Niederman,et al.  Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[922]  Jonathan R. McDaniel,et al.  Drug delivery to solid tumors by elastin-like polypeptides. , 2010, Advanced drug delivery reviews.

[923]  K. Mathee,et al.  Pseudomonas aeruginosa β-lactamase induction requires two permeases, AmpG and AmpP , 2010, BMC Microbiology.

[924]  A. Sjöstedt,et al.  Iron Content Differs between Francisella tularensis Subspecies tularensis and Subspecies holarctica Strains and Correlates to Their Susceptibility to H2O2-Induced Killing , 2010, Infection and Immunity.

[925]  D. Schneider,et al.  Antibiotics and UV Radiation Induce Competence for Natural Transformation in Legionella pneumophila , 2010, Journal of bacteriology.

[926]  C. Mark Ott,et al.  Transcriptional and Proteomic Responses of Pseudomonas aeruginosa PAO1 to Spaceflight Conditions Involve Hfq Regulation and Reveal a Role for Oxygen , 2010, Applied and Environmental Microbiology.

[927]  T. Welte,et al.  Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. , 2010, American journal of respiratory and critical care medicine.

[928]  A. Srinivasan,et al.  Increasing prevalence of nasal and rectal colonization with methicillin‐resistant Staphylococcus aureus in children with cancer , 2010, Pediatric blood & cancer.

[929]  T. File,et al.  Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[930]  D. Weiss,et al.  A survey of knowledge, attitudes, and beliefs of medical students concerning antimicrobial use and resistance. , 2010, Microbial drug resistance.

[931]  J. Cooke,et al.  Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals. , 2010, The Journal of antimicrobial chemotherapy.

[932]  E. Clementi,et al.  Exposure-Related Effects of Atazanavir on the Pharmacokinetics of Raltegravir in HIV-1-Infected Patients , 2010, Therapeutic drug monitoring.

[933]  R. Geskus,et al.  Anal Lymphogranuloma Venereum Infection Screening With IgA Anti-Chlamydia trachomatis-Specific Major Outer Membrane Protein Serology , 2010, Sexually transmitted diseases.

[934]  G. Diamond,et al.  Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity. , 2010, Molecular oral microbiology.

[935]  M. Putti,et al.  Incidence of bacteremias and invasive mycoses in children with acute non‐lymphoblastic leukemia: Results from a multi‐center Italian study , 2010, Pediatric blood & cancer.

[936]  J. Heesemann,et al.  Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.

[937]  D. Gerding,et al.  Management of Clostridium difficile infection: thinking inside and outside the box. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[938]  M. Mone,et al.  Antibiotic prophylaxis in the placement of totally implanted central venous access ports. , 2010, American journal of surgery.

[939]  Mei-ho Lee,et al.  The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected Individuals , 2010, Journal of acquired immune deficiency syndromes.

[940]  M. May,et al.  Meningococcal carriage by age: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[941]  F. Penin,et al.  Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly , 2010, PLoS pathogens.

[942]  P. Moore,et al.  Why do viruses cause cancer? Highlights of the first century of human tumour virology , 2010, Nature Reviews Cancer.

[943]  R. Bonomo,et al.  Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan , 2010, Antimicrobial Agents and Chemotherapy.

[944]  T. Tamura,et al.  Identification of Oseltamivir Resistance among Pandemic and Seasonal Influenza A (H1N1) Viruses by an His275Tyr Genotyping Assay Using the Cycling Probe Method , 2010, Journal of Clinical Microbiology.

[945]  P. Brandtzæg,et al.  Tuberculosis among children in Oslo, Norway, from 1998 to 2009 , 2010, Scandinavian journal of infectious diseases.

[946]  F. Vermeulen,et al.  Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis , 2010, European Respiratory Journal.

[947]  W. DeGrado,et al.  Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. , 2010, Angewandte Chemie.

[948]  M. Trent,et al.  Estimating the Direct Costs of Pelvic Inflammatory Disease in Adolescents: A Within-System Analysis , 2010, Sexually transmitted diseases.

[949]  S. Antinori,et al.  Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature , 2010, International journal of STD & AIDS.

[950]  Joshua A. Doherty,et al.  Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. , 2010, Journal of hospital medicine.

[951]  P. Burgel,et al.  Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France. , 2010, Medical mycology.

[952]  S. Ranque,et al.  Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. , 2010, Medical mycology.

[953]  N. Woodford,et al.  Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae , 2010, Antimicrobial Agents and Chemotherapy.

[954]  Min Chen,et al.  ANCA-associated vasculitides—advances in pathogenesis and treatment , 2010, Nature Reviews Rheumatology.

[955]  J. Schrenzel,et al.  Application and use of various mass spectrometry methods in clinical microbiology. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[956]  F. Tubach,et al.  Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial , 2010, PLoS medicine.

[957]  R. Guillemain,et al.  Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients. , 2010, Medical mycology.

[958]  A. Severini,et al.  Evaluation of a Novel Serology Algorithm to Detect Herpes Simplex Virus 1 or 2 Antibodies , 2010, Sexually transmitted diseases.

[959]  G. Diamond,et al.  Activity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicans. , 2010, Molecular oral microbiology.

[960]  B. Whipp,et al.  Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? , 2010, Thorax.

[961]  B. Samten,et al.  Exposure to Cigarette Smoke Inhibits the Pulmonary T-Cell Response to Influenza Virus and Mycobacterium tuberculosis , 2010, Infection and Immunity.

[962]  S. Lemon,et al.  Hepatitis C Virus NS2 Protein Serves as a Scaffold for Virus Assembly by Interacting with both Structural and Nonstructural Proteins , 2010, Journal of Virology.

[963]  Sean P. Palecek,et al.  Short Alkylated Peptoid Mimics of Antimicrobial Lipopeptides , 2010, Antimicrobial Agents and Chemotherapy.

[964]  C. Cameron,et al.  Hepatitis C Virus Nonstructural Protein 5A: Biochemical Characterization of a Novel Structural Class of RNA-Binding Proteins , 2010, Journal of Virology.

[965]  P. Anderson,et al.  Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers , 2010, Antimicrobial Agents and Chemotherapy.

[966]  M. Levine.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine , 2010, BMC Biology.

[967]  J. Frère,et al.  Mechanistic Studies of the Inactivation of TEM-1 and P99 by NXL104, a Novel Non-β-Lactam β-Lactamase Inhibitor , 2010, Antimicrobial Agents and Chemotherapy.

[968]  S. Chou,et al.  Antiviral Drug Resistance of Human Cytomegalovirus , 2010, Clinical Microbiology Reviews.

[969]  P. Dull,et al.  Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[970]  S. Lindemann,et al.  Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis , 2010, Journal of leukocyte biology.

[971]  N. Cheung,et al.  Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections. , 2010, Journal of pediatric surgery.

[972]  Edward M. Marcotte,et al.  Parallel Evolution in Pseudomonas aeruginosa over 39,000 Generations In Vivo , 2010, mBio.

[973]  A. Winding,et al.  UVC fluencies for preventative treatment of Pseudomonas aeruginosa contaminated polymer tubes , 2010, Biofouling.

[974]  Jian Li,et al.  Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.

[975]  D. Relman,et al.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation , 2010, Proceedings of the National Academy of Sciences.

[976]  J. Stein,et al.  Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal Mutations , 2010, Antimicrobial Agents and Chemotherapy.

[977]  P. Nordmann,et al.  Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia , 2010, Antimicrobial Agents and Chemotherapy.

[978]  M. Parsek,et al.  Pseudomonas aeruginosa biofilm matrix polysaccharide Psl is regulated transcriptionally by RpoS and post-transcriptionally by RsmA , 2010, Molecular microbiology.

[979]  B. Yaşar,et al.  Efficacy of probiotics in Helicobacter pylori eradication therapy. , 2010, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[980]  Y. Abu Kwaik,et al.  Molecular complexity orchestrates modulation of phagosome biogenesis and escape to the cytosol of macrophages by Francisella tularensis. , 2010, Environmental microbiology.

[981]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[982]  P. Mas,et al.  Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain , 2010, Proceedings of the National Academy of Sciences.

[983]  A. Nekrutenko,et al.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences , 2010, Genome Biology.

[984]  R. Dargis,et al.  Mass spectrometry: Pneumococcal meningitis verified and Brucella species identified in less than half an hour , 2010, Scandinavian journal of infectious diseases.

[985]  M. Mizuguchi,et al.  Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection , 2010, Antimicrobial Agents and Chemotherapy.

[986]  S. Das,et al.  Evaluation of cardiovascular risk in HIV patients: clinical implication , 2010, International journal of clinical practice.

[987]  G. Aubert,et al.  Prospective Determination of Serum Ceftazidime Concentrations in Intensive Care Units , 2010, Therapeutic drug monitoring.

[988]  P. Parham,et al.  Primate‐specific regulation of natural killer cells , 2010, Journal of medical primatology.

[989]  J. Sarles,et al.  Risk Factors for Aspergillus Colonization and Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis , 2010, Pediatric pulmonology.

[990]  V. Tam,et al.  Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes , 2010, Expert review of pharmacoeconomics & outcomes research.

[991]  F. Gaggìa,et al.  Probiotics and prebiotics in animal feeding for safe food production. , 2010, International journal of food microbiology.

[992]  E. Y. Kim,et al.  Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit , 2010, BMC infectious diseases.

[993]  Sean P. Palecek,et al.  Polyelectrolyte multilayers fabricated from antifungal β-peptides: design of surfaces that exhibit antifungal activity against Candida albicans. , 2010, Biomacromolecules.

[994]  Nicole M. Bouvier,et al.  Animal Models for Influenza Virus Pathogenesis and Transmission , 2010, Viruses.

[995]  C. Rapp,et al.  Doxycycline failure in lymphogranuloma venereum , 2010, Sexually Transmitted Infections.

[996]  Hwei-Ling Peng,et al.  Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43 , 2010, Journal of Biomedical Science.

[997]  D. Lewis.  The Gonococcus fights back: is this time a knock out? , 2010, Sexually Transmitted Infections.

[998]  R. Sanjuán,et al.  Viral Mutation Rates , 2010, Journal of Virology.

[999]  J. Gatell,et al.  Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study , 2010, AIDS.

[1000]  C. Mcnulty,et al.  The English antibiotic awareness campaigns: did they change the public's knowledge of and attitudes to antibiotic use? , 2010, The Journal of antimicrobial chemotherapy.

[1001]  Frédérique Jacobs,et al.  Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock , 2010, Critical care.

[1002]  M. Hallek,et al.  Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort. , 2010, The Journal of antimicrobial chemotherapy.

[1003]  Diederik van de Beek,et al.  Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis , 2010, Clinical Microbiology Reviews.

[1004]  N. Stonehouse,et al.  All Three Domains of the Hepatitis C Virus Nonstructural NS5A Protein Contribute to RNA Binding , 2010, Journal of Virology.

[1005]  Ha T. Nguyen,et al.  Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays , 2010, Antimicrobial Agents and Chemotherapy.

[1006]  Min Gao,et al.  Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System , 2010, Antimicrobial Agents and Chemotherapy.

[1007]  Adel Dayarian,et al.  SOPRA: Scaffolding algorithm for paired reads via statistical optimization , 2010, BMC Bioinformatics.

[1008]  A. Shafferman,et al.  The Involvement of IL-17A in the Murine Response to Sub-Lethal Inhalational Infection with Francisella tularensis , 2010, PloS one.

[1009]  David Baltimore,et al.  Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance , 2010, Science.

[1010]  M. Cannon,et al.  Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1011]  C. Arias,et al.  Management of multidrug-resistant enterococcal infections. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1012]  P. Della‐Latta,et al.  Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. , 2010, Diagnostic microbiology and infectious disease.

[1013]  Kristian Fog Nielsen,et al.  Early adaptive developments of Pseudomonas aeruginosa after the transition from life in the environment to persistent colonization in the airways of human cystic fibrosis hosts. , 2010, Environmental microbiology.

[1014]  T. Scheper,et al.  The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies. , 2010, Journal of virological methods.

[1015]  J. Gerber,et al.  Antibiotic Management of Staphylococcus aureus Infections in US Children's Hospitals, 1999–2008 , 2010, Pediatrics.

[1016]  J. Hinds,et al.  Insertion of Epicatechin Gallate into the Cytoplasmic Membrane of Methicillin-resistant Staphylococcus aureus Disrupts Penicillin-binding Protein (PBP) 2a-mediated β-Lactam Resistance by Delocalizing PBP2 , 2010, The Journal of Biological Chemistry.

[1017]  F. Pietropaolo,et al.  Prostate cancer detection after one or more negative extended needle biopsy: results of a multicenter case-findings protocol. , 2010, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[1018]  C. Barry,et al.  Age and the epidemiology and pathogenesis of tuberculosis , 2010, The Lancet.

[1019]  C. Kvasnovsky,et al.  Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study , 2010, The Lancet.

[1020]  Alastair D Hay,et al.  Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[1021]  J. Frelinger,et al.  Lung CD4−CD8− Double-Negative T Cells Are Prominent Producers of IL-17A and IFN-γ during Primary Respiratory Murine Infection with Francisella tularensis Live Vaccine Strain , 2010, The Journal of Immunology.

[1022]  B. Volkman,et al.  Targeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug design. , 2010, Journal of the American Chemical Society.

[1023]  Prida Malasit,et al.  Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans , 2010, Science.

[1024]  G. Carlone,et al.  Advances in the development of vaccines against Neisseria meningitidis. , 2010, The New England journal of medicine.

[1025]  Y. Yılmaz,et al.  Does Washing the Biopsy Needle with Povidone-Iodine Have an Effect on Infection Rates after Transrectal Prostate Needle Biopsy? , 2010, Urologia Internationalis.

[1026]  S. Rajapakse,et al.  Corticosteroid Therapy in Dengue Infection- Opinions of Junior Doctors , 2010, Journal of global infectious diseases.

[1027]  D. Abramowicz,et al.  The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[1028]  R. Marquant,et al.  Insight into the structure of the pUL89 C‐terminal domain of the human cytomegalovirus terminase complex , 2010, Proteins.

[1029]  L. Miller,et al.  Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1030]  P. Moreillon,et al.  In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin. , 2010, International journal of antimicrobial agents.

[1031]  Steven D. Brown,et al.  Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges , 2010, Antimicrobial Agents and Chemotherapy.

[1032]  G. Kibiki,et al.  Childhood Tuberculosis in the Kilimanjaro region: lessons from and for the TB Programme , 2010, Tropical medicine & international health : TM & IH.

[1033]  D. Conrad,et al.  Phase 2b Study Of Inhaled MP-376 (Aeroquin, Levofloxacin Inhalation Solution) In Stable Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (PA) Lung Infection , 2010, ATS 2010.

[1034]  A. Imhof,et al.  Cost-Effectiveness of Posaconazole Compared with Standard Azole Therapy for Prevention of Invasive Fungal Infections in Patients at High Risk in Switzerland , 2010, Oncology.

[1035]  Wendy S. Schackwitz,et al.  One Bacterial Cell, One Complete Genome , 2010, PloS one.

[1036]  C. Bustos,et al.  Emerging agents to combat complicated and resistant infections: focus on ceftobiprole , 2010, Infection and drug resistance.

[1037]  E. Hunsperger,et al.  Utility of a Commercial Nonstructural Protein 1 Antigen Capture Kit as a Dengue Virus Diagnostic Tool , 2010, Clinical and Vaccine Immunology.

[1038]  Min Gao,et al.  Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect , 2010, Nature.

[1039]  E. Anaissie,et al.  Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1040]  L. Ferreira,et al.  Direct Identification of Urinary Tract Pathogens from Urine Samples by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry , 2010, Journal of Clinical Microbiology.

[1041]  J. Jansen,et al.  Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands , 2010, Annals of Hematology.

[1042]  S. Kerry,et al.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial , 2010, BMJ : British Medical Journal.

[1043]  Munish Goyal,et al.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department* , 2010, Critical care medicine.

[1044]  Thomas Bjarnsholt,et al.  Antibiotic resistance of bacterial biofilms. , 2010, International journal of antimicrobial agents.

[1045]  E. Pietras,et al.  IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. , 2010, The Journal of clinical investigation.

[1046]  R. Weinstein,et al.  Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1047]  A. Amorim,et al.  Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy. , 2010, International journal of antimicrobial agents.

[1048]  Yoon-S Lee,et al.  Pelvic actinomycosis confirmed after surgery: single center experience , 2010, Archives of Gynecology and Obstetrics.

[1049]  Vasiliy P. Mishin,et al.  In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses , 2010, Antimicrobial Agents and Chemotherapy.

[1050]  Robert E. Johnson,et al.  Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis Rectal Infections , 2010, Journal of Clinical Microbiology.

[1051]  A. Hidrón,et al.  Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006–2008 , 2010, Infection Control & Hospital Epidemiology.

[1052]  M. Macek,et al.  Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis , 2010, The Lancet.

[1053]  R. Knight,et al.  Forensic identification using skin bacterial communities , 2010, Proceedings of the National Academy of Sciences.

[1054]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[1055]  J. Rello,et al.  Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza , 2010, Canadian Medical Association Journal.

[1056]  Michael J Ackerman,et al.  Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. , 2010, Circulation.

[1057]  D Andrew Loblaw,et al.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. , 2010, The Journal of urology.

[1058]  G. Poland.  Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1059]  D. Granoff.  Review of meningococcal group B vaccines. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1060]  D. Livermore,et al.  AmpC induction by ceftaroline. , 2010, The Journal of antimicrobial chemotherapy.

[1061]  Satyajit Das.  Risk of cardiovascular disease in HIV-infected patients. , 2010, The Journal of antimicrobial chemotherapy.

[1062]  G. Boivin,et al.  Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. , 2010, The Journal of infectious diseases.

[1063]  Simon Daefler,et al.  Modulation of iron homeostasis in macrophages by bacterial intracellular pathogens , 2010, BMC Microbiology.

[1064]  John A. Robinson,et al.  Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa , 2010, Science.

[1065]  J. Meis,et al.  Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands. , 2010, The Journal of antimicrobial chemotherapy.

[1066]  J. Perfect,et al.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1067]  A. Mert,et al.  Clinical image: primary actinomycosis of the hand. , 2010, Arthritis and rheumatism.

[1068]  J. Celli,et al.  Restricted cytosolic growth of Francisella tularensis subsp. tularensis by IFN-gamma activation of macrophages. , 2010, Microbiology.

[1069]  M. Tameris,et al.  Age-related tuberculosis incidence and severity in children under 5 years of age in Cape Town, South Africa. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[1070]  J. Versalovic,et al.  Hospital-Acquired Staphylococcus aureus Infections at Texas Children's Hospital, 2001–2007 , 2010, Infection Control & Hospital Epidemiology.

[1071]  V. Miriagou,et al.  Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1072]  G. Weber,et al.  Characterization of the best anatomical sites in screening for methicillin-resistant Staphylococcus aureus colonization , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[1073]  Roger Baxter,et al.  Treatment with monoclonal antibodies against Clostridium difficile toxins. , 2010, The New England journal of medicine.

[1074]  T. Foster,et al.  Clumping Factor A Interaction with Complement Factor I Increases C3b Cleavage on the Bacterial Surface of Staphylococcus aureus and Decreases Complement-Mediated Phagocytosis , 2010, Infection and Immunity.

[1075]  A. Oliver,et al.  Activity of a New Cephalosporin, CXA-101 (FR264205), against β-Lactam-Resistant Pseudomonas aeruginosa Mutants Selected In Vitro and after Antipseudomonal Treatment of Intensive Care Unit Patients , 2010, Antimicrobial Agents and Chemotherapy.

[1076]  GREGORY N. TEW,et al.  De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. , 2010, Accounts of chemical research.

[1077]  R. Samudrala,et al.  Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix , 2010, Molecular microbiology.

[1078]  S. Kauppinen,et al.  Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection , 2010, Science.

[1079]  Guy Duportail,et al.  Consequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backbone. , 2010, Angewandte Chemie.

[1080]  H. Pennington.  The Role of the Media in Public Health Crises: Perspectives from the UK and Europe , 2010 .

[1081]  H. Zimmermann,et al.  InVitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246 , 2010, Antimicrobial Agents and Chemotherapy.

[1082]  M. Tvede,et al.  Disinfection of Pseudomonas aeruginosa biofilm contaminated tube lumens with ultraviolet C light emitting diodes , 2010, Biofouling.

[1083]  E. Lawler,et al.  Extranasal Methicillin-Resistant Staphylococcus aureus Colonization at Admission to an Acute Care Veterans Affairs Hospital , 2010, Infection Control & Hospital Epidemiology.

[1084]  R. Preston,et al.  Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment , 2010, Current medical research and opinion.

[1085]  V. Wiwanitkit.  Swine Flu and Pig Borne Diseases , 2009 .

[1086]  F. Schweizer,et al.  Cationic amphiphilic peptides with cancer-selective toxicity. , 2009, European journal of pharmacology.

[1087]  E. Ron,et al.  Biofouling control in water by various UVC wavelengths and doses , 2009, Biofouling.

[1088]  Guy Boivin,et al.  Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. , 2009, The New England journal of medicine.

[1089]  A. Srinivasan,et al.  Panton–Valentine leukocidin‐positive methicillin‐resistant Staphylococcus aureus infections in children with cancer , 2009, Pediatric blood & cancer.

[1090]  A. Srinivasan,et al.  Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. , 2009, AIDS research and human retroviruses.

[1091]  Tom Jefferson,et al.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[1092]  Jeffrey R. Barker,et al.  The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence , 2009, Molecular microbiology.

[1093]  T. Russo,et al.  Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1094]  S. Dixon,et al.  Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. , 2009, The Journal of antimicrobial chemotherapy.

[1095]  E. Denou,et al.  The putative role of the intestinal microbiota in the irritable bowel syndrome. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[1096]  J. Lorente,et al.  High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. , 2009, Urology.

[1097]  D. Raoult,et al.  Direct Identification of Bacteria in Positive Blood Culture Bottles by Matrix-Assisted Laser Desorption Ionisation Time-of-Flight Mass Spectrometry , 2009, PloS one.

[1098]  M. Adelson,et al.  Genital Herpes Simplex Virus Type 1 in Women: Detection in Cervicovaginal Specimens from Gynecological Practices in the United States , 2009, Journal of Clinical Microbiology.

[1099]  Shengchang Su,et al.  Gallium Disrupts Iron Uptake by Intracellular and Extracellular Francisella Strains and Exhibits Therapeutic Efficacy in a Murine Pulmonary Infection Model , 2009, Antimicrobial Agents and Chemotherapy.

[1100]  S. Han,et al.  Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial. , 2009, Vaccine.

[1101]  Allan Donner,et al.  Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial , 2009, The Lancet.

[1102]  D. Smee,et al.  Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice , 2009, Antimicrobial Agents and Chemotherapy.

[1103]  C. Thio,et al.  Host genetic determinants of spontaneous hepatitis C clearance. , 2009, Pharmacogenomics.

[1104]  S. Piscitelli,et al.  Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers , 2009, Antimicrobial Agents and Chemotherapy.

[1105]  J. Leiva,et al.  Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis. , 2009, International journal of antimicrobial agents.

[1106]  O. Manuel,et al.  Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[1107]  Joshua A. Doherty,et al.  Between Community and Hospital: Healthcare-Associated Gram-Negative Bacteremia among Hospitalized Patients , 2009, Infection Control & Hospital Epidemiology.

[1108]  Joshua A. Doherty,et al.  Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors , 2009, Infection Control & Hospital Epidemiology.

[1109]  C. Salgado,et al.  Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria , 2009, Antimicrobial Agents and Chemotherapy.

[1110]  M. Mcevoy,et al.  BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. , 2009, Vaccine.

[1111]  J. Torre-Cisneros.  Toward the individualization of cytomegalovirus control after solid-organ transplantation: the importance of the "individual pathogenic balance". , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1112]  C. Delaugerre,et al.  Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1113]  I. Karunasagar,et al.  Human health consequences of use of antimicrobial agents in aquaculture. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1114]  A. Kipnis,et al.  Molecular Epidemiology and Risk Factors for Nasal Carriage of Staphylococcus aureus and Methicillin-Resistant S. aureus in Infants Attending Day Care Centers in Brazil , 2009, Journal of Clinical Microbiology.

[1115]  David B. Goldstein,et al.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus , 2009, Nature.

[1116]  N. Meanwell,et al.  Identification of Hepatitis C Virus NS5A Inhibitors , 2009, Journal of Virology.

[1117]  K. Reisinger,et al.  Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra , 2009, Clinical and Vaccine Immunology.

[1118]  John Cowden,et al.  Escherichia coli O157 , 2009, BMJ : British Medical Journal.

[1119]  D. Bolton,et al.  Assessment of antimicrobial resistance transfer between lactic acid bacteria and potential foodborne pathogens using in vitro methods and mating in a food matrix. , 2009, Foodborne pathogens and disease.

[1120]  A. Gamarnik,et al.  Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation , 2009, PLoS pathogens.

[1121]  Thomas Berg,et al.  IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy , 2009, Nature Genetics.

[1122]  T. Jang,et al.  Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. , 2009, The Journal of hospital infection.

[1123]  C. Harrison.  Innate immunity as a key element in host defense against methicillin resistant Staphylococcus aureus. , 2009, Minerva pediatrica.

[1124]  V. Valentine,et al.  Clinical spectrum of gram‐positive infections in lung transplantation , 2009, Transplant infectious disease : an official journal of the Transplantation Society.

[1125]  J. Gong,et al.  Pharmacophore model of influenza neuraminidase inhibitors--a systematic review. , 2009, Die Pharmazie.

[1126]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[1127]  S. Kularatne,et al.  Efficacy of low dose dexamethasone in severe thrombocytopenia caused by dengue fever: a placebo controlled study , 2009, Postgraduate Medical Journal.

[1128]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[1129]  Jacques Fellay,et al.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance , 2009, Nature.

[1130]  D. Denning,et al.  Toxicodynamics of itraconazole: implications for therapeutic drug monitoring. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1131]  Adriano Lazzarin,et al.  Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial , 2009, The Lancet.

[1132]  S. Rajapakse.  Intravenous immunoglobulins in the treatment of dengue illness. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[1133]  R. Venezia,et al.  The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit. , 2009, The Journal of infectious diseases.

[1134]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[1135]  S. Cowley.  Editorial: Proinflammatory cytokines in pneumonic tularemia: too much too late? , 2009, Journal of leukocyte biology.

[1136]  D. Vinh,et al.  Linezolid: a review of safety and tolerability. , 2009, The Journal of infection.

[1137]  C. O'Morain,et al.  Review: Improving compliance with Helicobacter pylori eradication therapy: when and how? , 2009, Therapeutic advances in gastroenterology.

[1138]  J. M. García‐Lobo,et al.  First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. , 2009, Pathologie-biologie.

[1139]  G. Church,et al.  Functional Characterization of the Antibiotic Resistance Reservoir in the Human Microflora , 2009, Science.

[1140]  T. Narumi,et al.  Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids. , 2009, Organic & biomolecular chemistry.

[1141]  J. Drake,et al.  Francisella tularensis Induces Ubiquitin-Dependent Major Histocompatibility Complex Class II Degradation in Activated Macrophages , 2009, Infection and Immunity.

[1142]  H. A. Cook,et al.  Staphylococcus aureus in the Community: Colonization Versus Infection , 2009, PloS one.

[1143]  P. Holm.  Studies on the aetiology of human actinomycosis. , 2009, Acta pathologica et microbiologica Scandinavica. Supplementum.

[1144]  P. Holm.  Studies on the aetiology of human actinomycosis. II. Do the other microbes of actinomycosis possess virulence? , 2009, Acta pathologica et microbiologica Scandinavica.

[1145]  D. Raoult,et al.  Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1146]  J. Burns,et al.  Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis , 2009, The Journal of antimicrobial chemotherapy.

[1147]  Søren J. Sørensen,et al.  Conjugative plasmids: vessels of the communal gene pool , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[1148]  Sylvia Siebig,et al.  Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis , 2009, BMC infectious diseases.

[1149]  K. Stoeckel,et al.  Effect of Mild and Moderate Liver Disease on the Pharmacokinetics of Isavuconazole after Intravenous and Oral Administration of a Single Dose of the Prodrug BAL8557 , 2009, Antimicrobial Agents and Chemotherapy.

[1150]  D. Klein,et al.  Virologic Outcomes of Changing Enfuvirtide to Raltegravir in HIV-1 Patients Well Controlled on an Enfuvirtide Based Regimen: 24-Week Results of the CHEER Study , 2009, Journal of acquired immune deficiency syndromes.

[1151]  A. Maniatis,et al.  Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. , 2009, The Journal of antimicrobial chemotherapy.

[1152]  F. Wood,et al.  Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial , 2009, BMJ : British Medical Journal.

[1153]  N. Crum‐Cianflone,et al.  Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. , 2009, AIDS patient care and STDs.

[1154]  Sean P. Palecek,et al.  Effect of sequence and structural properties on 14-helical beta-peptide activity against Candida albicans planktonic cells and biofilms. , 2009, ACS chemical biology.

[1155]  Swu-Jane Lin,et al.  The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study. , 2009, Diagnostic microbiology and infectious disease.

[1156]  Chin‐Yun Lee,et al.  Safety and immunogenicity of a tetravalent polysaccharide vaccine against meningococcal disease. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[1157]  D. Denning,et al.  Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure , 2009, Emerging infectious diseases.

[1158]  K. Mayer,et al.  Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1159]  R. Borrow.  Meningococcal disease and prevention at the Hajj. , 2009, Travel medicine and infectious disease.

[1160]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1161]  A. Pollard,et al.  Quadrivalent meningococcal conjugate vaccines. , 2009, Vaccine.

[1162]  Lee H Harrison,et al.  Global epidemiology of meningococcal disease. , 2009, Vaccine.

[1163]  S. Ramos,et al.  Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers. , 2009, Vaccine.

[1164]  J. Jensen.  Single-dose azithromycin treatment for Mycoplasma genitalium-positive urethritis: best but not good enough. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1165]  M. Adams,et al.  Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System , 2009, Antimicrobial Agents and Chemotherapy.

[1166]  Djillali Annane,et al.  Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. , 2009, JAMA.

[1167]  J. Heitman,et al.  First Reported Case of Cryptococcus gattii in the Southeastern USA: Implications for Travel-Associated Acquisition of an Emerging Pathogen , 2009, PloS one.

[1168]  D. Paterson,et al.  Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007 , 2009, Antimicrobial Agents and Chemotherapy.

[1169]  I. Golovliov,et al.  Reintroduction of Two Deleted Virulence Loci Restores Full Virulence to the Live Vaccine Strain of Francisella tularensis , 2009, Infection and Immunity.

[1170]  A. Girard,et al.  In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases , 2009, The Journal of antimicrobial chemotherapy.

[1171]  T. Rushmore,et al.  Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms , 2009, Clinical pharmacology and therapeutics.

[1172]  O. Manuel,et al.  An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants. , 2009, The Journal of infectious diseases.

[1173]  Louis S Stodieck,et al.  Effects of spaceflight on innate immune function and antioxidant gene expression. , 2009, Journal of applied physiology.

[1174]  S. Ray,et al.  Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. , 2009, Gastroenterology.

[1175]  S. Griffin,et al.  Domain III of NS5A contributes to both RNA replication and assembly of hepatitis C virus particles. , 2009, The Journal of general virology.

[1176]  M. Mammen,et al.  Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II , 2009, Antimicrobial Agents and Chemotherapy.

[1177]  J. Chodakewitz,et al.  Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir , 2009, Antimicrobial Agents and Chemotherapy.

[1178]  S. Sorichter,et al.  Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease. , 2009, Vaccine.

[1179]  D. North,et al.  Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections. , 2009, International journal of antimicrobial agents.

[1180]  D. Geller.  Aerosol antibiotics in cystic fibrosis. , 2009, Respiratory care.

[1181]  J. Rello,et al.  Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies* , 2009, Critical care medicine.

[1182]  S. Lory,et al.  Determination of the regulon and identification of novel mRNA targets of Pseudomonas aeruginosa RsmA , 2009, Molecular microbiology.

[1183]  K. Subbarao,et al.  The Ferret Model for Influenza , 2009, Current protocols in microbiology.

[1184]  M. Battegay,et al.  Outcomes of early switching from intravenous to oral antibiotics on medical wards , 2009, The Journal of antimicrobial chemotherapy.

[1185]  W. DeGrado,et al.  De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers , 2009, Proceedings of the National Academy of Sciences.

[1186]  J. Wagner,et al.  Effect of Tipranavir-Ritonavir on Pharmacokinetics of Raltegravir , 2009, Antimicrobial Agents and Chemotherapy.

[1187]  C. Kane,et al.  The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner , 2009, The open biochemistry journal.

[1188]  Elena Anzivino,et al.  Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention , 2009, Virology Journal.

[1189]  Regine Hengge,et al.  Principles of c-di-GMP signalling in bacteria , 2009, Nature Reviews Microbiology.

[1190]  Maria Paola Costi,et al.  Anchors away , 2009, Nature.

[1191]  G. Höffken,et al.  Medical management of pulmonary actinomycosis: data from 49 consecutive cases. , 2009, The Journal of antimicrobial chemotherapy.

[1192]  J. van de Kassteele,et al.  Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season , 2009, Emerging infectious diseases.

[1193]  B. Levin,et al.  Episodic Selection and the Maintenance of Competence and Natural Transformation in Bacillus subtilis , 2009, Genetics.

[1194]  P. Nordmann,et al.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. , 2009, The Lancet. Infectious diseases.

[1195]  M. Struelens,et al.  Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[1196]  S. Torriani,et al.  Molecular diversity and transferability of the tetracycline resistance gene tet(M), carried on Tn916-1545 family transposons, in enterococci from a total food chain , 2009, Antonie van Leeuwenhoek.

[1197]  Matthew R. Parsek,et al.  Pseudomonas aeruginosa Rugose Small-Colony Variants Have Adaptations That Likely Promote Persistence in the Cystic Fibrosis Lung , 2009, Journal of bacteriology.

[1198]  B. Meyer,et al.  Specific and complete human genome amplification with improved yield achieved by phi29 DNA polymerase and a novel primer at elevated temperature , 2009, BMC Research Notes.

[1199]  N. Osna.  Hepatitis C virus and ethanol alter antigen presentation in liver cells. , 2009, World journal of gastroenterology.

[1200]  R. Gie,et al.  Mycobacterium tuberculosis Transmission Is Not Related to Household Genotype in a Setting of High Endemicity , 2009, Journal of Clinical Microbiology.

[1201]  P. Nordmann,et al.  Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa , 2009, Antimicrobial Agents and Chemotherapy.

[1202]  J. Tabibian,et al.  Doxycycline-Induced Pseudotumor Cerebri , 2009, Southern medical journal.

[1203]  F. DeLeo,et al.  Host defense and pathogenesis in Staphylococcus aureus infections. , 2009, Infectious disease clinics of North America.

[1204]  F. Müller,et al.  Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[1205]  R. Leclercq.  Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1206]  S. Garland,et al.  Mycoplasma genitalium in men who have sex with men at male-only saunas , 2009, Sexually Transmitted Infections.

[1207]  R. Hancock,et al.  Regulation of virulence and antibiotic resistance by two-component regulatory systems in Pseudomonas aeruginosa. , 2009, FEMS microbiology reviews.

[1208]  W. Bilker,et al.  Surveillance Cultures for Detection of Methicillin-Resistant Staphylococcus aureus: Diagnostic Yield of Anatomic Sites and Comparison of Provider- and Patient-Collected Samples , 2009, Infection Control & Hospital Epidemiology.

[1209]  J. Kennedy,et al.  Meningococcal polysaccharide vaccines: A review , 2009 .

[1210]  C. Bamia,et al.  Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections , 2009, Antimicrobial Agents and Chemotherapy.

[1211]  H. Ward,et al.  The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study , 2009, Sexually Transmitted Infections.

[1212]  H. Teppler,et al.  Effects of omeprazole on plasma levels of raltegravir. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1213]  James Versalovic,et al.  Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factors , 2009, BMC Microbiology.

[1214]  H. Albrecht,et al.  HIV and community-acquired MRSA. , 2009, Journal watch. AIDS clinical care.

[1215]  S. Rajapakse.  Corticosteroids in the treatment of dengue illness. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[1216]  J. Leiva,et al.  Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. , 2009, Diagnostic microbiology and infectious disease.

[1217]  Michel Bolla,et al.  [EAU guidelines on prostate cancer]. , 2009, Actas urologicas espanolas.

[1218]  Carole R. Baskin,et al.  Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection , 2009, PLoS pathogens.

[1219]  N. Jones,et al.  The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile-associated diarrhea. , 2009, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[1220]  Mauricio Valencia,et al.  Ventilator-associated pneumonia , 2009, Current opinion in critical care.

[1221]  M. Tvede,et al.  Dose requirements for UVC disinfection of catheter biofilms , 2009, Biofouling.

[1222]  N. T. Annan,et al.  Rectal chlamydia—a reservoir of undiagnosed infection in men who have sex with men , 2009, Sexually Transmitted Infections.

[1223]  D. Kasper,et al.  Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. , 2009, Vaccine.

[1224]  M. Papagianni,et al.  Pediocins: The bacteriocins of Pediococci. Sources, production, properties and applications , 2009, Microbial cell factories.

[1225]  L. Seeff.  The history of the “natural history” of hepatitis C (1968–2009) , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[1226]  D. Lavanchy,et al.  The global burden of hepatitis C , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[1227]  M. Hogardt,et al.  Prevalence and risk factors of nasal colonization with Staphylococcus aureus – Association with HIV infection in older patients , 2009, Scandinavian journal of infectious diseases.

[1228]  J. Fraile,et al.  Endocarditis Caused by Staphylococcus aureus: A Reappraisal of the Epidemiologic, Clinical, and Pathologic Manifestations With Analysis of Factors Determining Outcome , 2009, Medicine.

[1229]  U. Chaturvedi,et al.  Dengue and dengue haemorrhagic fever: Indian perspective , 2008, Journal of Biosciences.

[1230]  W. Glezen.  Clinical practice. Prevention and treatment of seasonal influenza. , 2008, The New England journal of medicine.

[1231]  N. T. Annan,et al.  Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome in men who have sex with men in London, UK , 2008, Sexually Transmitted Infections.

[1232]  C. Bouman.  Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration , 2008, Current opinion in critical care.

[1233]  C. Salgado.  The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. , 2008, American journal of infection control.

[1234]  Gregory N Tew,et al.  De novo designed synthetic mimics of antimicrobial peptides. , 2008, Current opinion in biotechnology.

[1235]  L. Frommelt,et al.  Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1236]  M. Cusini,et al.  Lymphogranuloma venereum: the Italian experience , 2008, Sexually Transmitted Infections.

[1237]  C. Fairley,et al.  Persistence of Mycoplasma genitalium Following Azithromycin Therapy , 2008, PloS one.

[1238]  J. Celli,et al.  Direct and Indirect Impairment of Human Dendritic Cell Function by Virulent Francisella tularensis Schu S4 , 2008, Infection and Immunity.

[1239]  A. Shafferman,et al.  Interrelationship between Dendritic Cell Trafficking and Francisella tularensis Dissemination following Airway Infection , 2008, PLoS pathogens.

[1240]  N. Woodford,et al.  NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases. , 2008, The Journal of antimicrobial chemotherapy.

[1241]  J. Janssens,et al.  An ecological analysis of incidence of tuberculosis and per capita gross domestic product , 2008, European Respiratory Journal.

[1242]  G. Lucas,et al.  The incidence of and risk factors for MRSA bacteraemia in an HIV‐infected cohort in the HAART era * , 2008, HIV medicine.

[1243]  R. Gibson,et al.  Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.

[1244]  J. E. Olsen,et al.  Natural transfer of sulphonamide and ampicillin resistance between Escherichia coli residing in the human intestine. , 2008, The Journal of antimicrobial chemotherapy.

[1245]  D. Andes,et al.  Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications , 2008, Antimicrobial Agents and Chemotherapy.

[1246]  Takanori Tomozawa,et al.  CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity , 2008, Antimicrobial Agents and Chemotherapy.

[1247]  M. Warner.  Activity of cephalosporin CXA-101 (FR264205) with β-Lactamase Inhibitors vs. Enterobacteriaceae , 2008 .

[1248]  Sergey Koren,et al.  Aggressive assembly of pyrosequencing reads with mates , 2008, Bioinform..

[1249]  Sonya S. Shin,et al.  Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study , 2008 .

[1250]  G. Pier.  On the greatly exaggerated reports of the death of infectious diseases. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1251]  J. Frelinger,et al.  Infected-Host-Cell Repertoire and Cellular Response in the Lung following Inhalation of Francisella tularensis Schu S4, LVS, or U112 , 2008, Infection and Immunity.

[1252]  H. Greenberg,et al.  Minimal Effects of Ritonavir and Efavirenz on the Pharmacokinetics of Raltegravir , 2008, Antimicrobial Agents and Chemotherapy.

[1253]  J. Wagner,et al.  Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects , 2008, Antimicrobial Agents and Chemotherapy.

[1254]  H. Zimmermann,et al.  Antiviral strategies to combat cytomegalovirus infections in transplant recipients. , 2008, Current opinion in pharmacology.

[1255]  G. Leung,et al.  Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong , 2008, Quality & Safety in Health Care.

[1256]  C. Arias,et al.  Emergence and management of drug-resistant enterococcal infections , 2008, Expert review of anti-infective therapy.

[1257]  M. Brundin,et al.  Building biofilms in vital host tissues: a survival strategy of Actinomyces radicidentis. , 2008, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[1258]  M. P. Rykova,et al.  Humoral and cellular immunity in cosmonauts after the ISS missions , 2008 .

[1259]  H. Moi,et al.  Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study , 2008, International journal of STD & AIDS.

[1260]  A. Keegan,et al.  Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism1 , 2008, The Journal of Immunology.

[1261]  D. Hazuda,et al.  Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. , 2008, Journal of medicinal chemistry.

[1262]  D. Pierson,et al.  Effect of Spaceflight on Ability of Monocytes To Respond to Endotoxins of Gram-Negative Bacteria , 2008, Clinical and Vaccine Immunology.

[1263]  P. Nordmann,et al.  Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1264]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[1265]  J. Rello,et al.  Hybrid Pathogenicity Island PAGI-5 Contributes to the Highly Virulent Phenotype of a Pseudomonas aeruginosa Isolate in Mammals , 2008, Journal of bacteriology.

[1266]  Carlene A. Muto,et al.  Genetic Basis of Multidrug Resistance in Acinetobacter baumannii Clinical Isolates at a Tertiary Medical Center in Pennsylvania , 2008, Antimicrobial Agents and Chemotherapy.

[1267]  D. Skiest,et al.  Prevalence of and Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Colonization in HIV-Infected Ambulatory Patients , 2008, Journal of acquired immune deficiency syndromes.

[1268]  K. Laupland,et al.  Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. , 2008, The Journal of infectious diseases.

[1269]  P. Varmanen,et al.  Ciprofloxacin induces mutagenesis to antibiotic resistance independent of UmuC in Streptococcus uberis. , 2008, Environmental microbiology.

[1270]  D. Hazuda,et al.  Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection. , 2008, The New England journal of medicine.

[1271]  D. Hazuda,et al.  Raltegravir with optimized background therapy for resistant HIV-1 infection. , 2008, The New England journal of medicine.

[1272]  G. Pier,et al.  Prophylactic and Therapeutic Efficacy of a Fully Human Immunoglobulin G1 Monoclonal Antibody to Pseudomonas aeruginosa Alginate in Murine Keratitis Infection , 2008, Infection and Immunity.

[1273]  P. Nordmann,et al.  Plasmid-Encoded Carbapenem-Hydrolyzing β-Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium , 2008, Antimicrobial Agents and Chemotherapy.

[1274]  J. Varma,et al.  Childhood TB epidemiology and treatment outcomes in Thailand: a TB active surveillance network, 2004 to 2006 , 2008, BMC infectious diseases.

[1275]  H. Teppler,et al.  Lack of a Significant Drug Interaction between Raltegravir and Tenofovir , 2008, Antimicrobial Agents and Chemotherapy.

[1276]  S. Bouaziz,et al.  Putative Functional Domains of Human Cytomegalovirus pUL56 Involved in Dimerization and Benzimidazole D-Ribonucleoside Activity , 2008, Antiviral therapy.

[1277]  W. Bridson,et al.  Atazanavir modestly increases plasma levels of raltegravir in healthy subjects. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1278]  Eli N. Perencevich,et al.  Detection of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci on the Gowns and Gloves of Healthcare Workers , 2008, Infection Control & Hospital Epidemiology.

[1279]  Francisco Acevedo,et al.  Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[1280]  S. Vesper,et al.  Mold species in dust from the International Space Station identified and quantified by mold-specific quantitative PCR. , 2008, Research in microbiology.

[1281]  M. Ward,et al.  Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. , 2008, The Journal of infectious diseases.

[1282]  C. Harwood,et al.  Identification of FleQ from Pseudomonas aeruginosa as a c‐di‐GMP‐responsive transcription factor , 2008, Molecular microbiology.

[1283]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[1284]  F. Gulmi,et al.  Multi-drug-resistant bacteremia after transrectal ultrasound guided prostate biopsies in hospital employees and their relatives. , 2008, Urology.

[1285]  A. Wilder-Smith.  Meningococcal disease: risk for international travellers and vaccine strategies. , 2008, Travel medicine and infectious disease.

[1286]  J. Svendsen,et al.  Synthetic antimicrobial peptidomimetics with therapeutic potential. , 2008, Journal of medicinal chemistry.

[1287]  K. Ishii,et al.  Interaction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus Particles , 2008, Journal of Virology.

[1288]  C. Jernberg,et al.  Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. , 2008, Anaerobe.

[1289]  D. Kontoyiannis,et al.  The changing epidemiology of invasive candidiasis , 2008, Cancer.

[1290]  A. Tuncel,et al.  Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy? , 2008, Urology.

[1291]  E. Topp,et al.  Effect of Subtherapeutic Administration of Antibiotics on the Prevalence of Antibiotic-Resistant Escherichia coli Bacteria in Feedlot Cattle , 2008, Applied and Environmental Microbiology.

[1292]  S. Vogel,et al.  Macrophage Proinflammatory Response to Francisella tularensis Live Vaccine Strain Requires Coordination of Multiple Signaling Pathways1 , 2008, The Journal of Immunology.

[1293]  Edward J Oakeley,et al.  Interferon signaling and treatment outcome in chronic hepatitis C , 2008, Proceedings of the National Academy of Sciences.

[1294]  E. Birney,et al.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs. , 2008, Genome research.

[1295]  David Hernández,et al.  De novo bacterial genome sequencing: millions of very short reads assembled on a desktop computer. , 2008, Genome research.

[1296]  A. Gascoigne,et al.  Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy , 2008, The Journal of antimicrobial chemotherapy.

[1297]  Gabriele Neumann,et al.  Human infection with highly pathogenic H5N1 influenza virus , 2008, The Lancet.

[1298]  N. Dziuba,et al.  Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). , 2008, Virology.

[1299]  G. Drusano,et al.  Telavancin Penetration into Human Epithelial Lining Fluid Determined by Population Pharmacokinetic Modeling and Monte Carlo Simulation , 2008, Antimicrobial Agents and Chemotherapy.

[1300]  L. Rice.  Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.

[1301]  D. Werber,et al.  Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1302]  M. Postelnick,et al.  Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption , 2008, Antimicrobial Agents and Chemotherapy.

[1303]  Rick L. Stevens,et al.  Functional metagenomic profiling of nine biomes , 2008, Nature.

[1304]  Pw Taylor,et al.  Manned Missions to Mars: The Likely Impact of Microbial Infection , 2008 .

[1305]  M. C. Padoveze,et al.  Staphylococcus aureus nasal colonization in HIV outpatients: persistent or transient? , 2008, American journal of infection control.

[1306]  W. Ko,et al.  Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study. , 2008, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[1307]  Jerome J. Schentag,et al.  Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. , 2008, International journal of antimicrobial agents.

[1308]  A. Lynne,et al.  Food animal-associated Salmonella challenges: pathogenicity and antimicrobial resistance. , 2008, Journal of animal science.

[1309]  Eduardo Pauls,et al.  Anti-HIV Activity and Resistance Profile of the CXC Chemokine Receptor 4 Antagonist POL3026 , 2008, Molecular Pharmacology.

[1310]  B. Arulanandam,et al.  The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[1311]  K. Mühlemann,et al.  Clinical Characteristics Associated with Isolation of Small-Colony Variants of Staphylococcus aureus and Pseudomonas aeruginosa from Respiratory Secretions of Patients with Cystic Fibrosis , 2008, Journal of Clinical Microbiology.

[1312]  J. Rello,et al.  Ventilator-associated pneumonia: impact of organisms on clinical resolution and medical resources utilization. , 2008, Chest.

[1313]  J. Farrar,et al.  The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.

[1314]  G. Rossi,et al.  Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. , 2008, The Journal of antimicrobial chemotherapy.

[1315]  M. de Pedro,et al.  Peptidoglycan structure and architecture. , 2008, FEMS microbiology reviews.

[1316]  Ralf Bartenschlager,et al.  Essential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle Assembly , 2008, PLoS pathogens.

[1317]  L. Flynn,et al.  Enhancing resource utilization among pregnant adolescents. , 2008, Public health nursing.

[1318]  A. C. Krueger,et al.  Synthesis of potent pyrrolidine influenza neuraminidase inhibitors. , 2008, Bioorganic & medicinal chemistry letters.

[1319]  O. Cars,et al.  Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. , 2008, The Lancet. Infectious diseases.

[1320]  J. Wagner,et al.  Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects , 2008, Clinical pharmacology and therapeutics.

[1321]  S. Morré,et al.  Lymphogranuloma Venereum Proctitis in Men Who Have Sex With Men Is Associated With Anal Enema Use and High-Risk Behavior , 2008, Sexually transmitted diseases.

[1322]  G. Oster,et al.  Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure Infections , 2008, Infection Control & Hospital Epidemiology.

[1323]  J. Clemens,et al.  The High Burden of Cholera in Children: Comparison of Incidence from Endemic Areas in Asia and Africa , 2008, PLoS neglected tropical diseases.

[1324]  R. Krishnamurthy,et al.  Thoracic Actinomycosis in Children: Case Report and Review of the Literature , 2008, The Pediatric infectious disease journal.

[1325]  Mark J. P. Chaisson,et al.  Short read fragment assembly of bacterial genomes. , 2008, Genome research.

[1326]  D. Antonopoulos,et al.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.

[1327]  V. Hall.  Actinomyces--gathering evidence of human colonization and infection. , 2008, Anaerobe.

[1328]  D. Hoskin,et al.  Studies on anticancer activities of antimicrobial peptides. , 2008, Biochimica et biophysica acta.

[1329]  E. Tacconelli,et al.  Vancomycin-resistant enterococci (VRE): transmission and control. , 2008, International journal of antimicrobial agents.

[1330]  K. Bush,et al.  Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of Klebsiella pneumoniae , 2008, Antimicrobial Agents and Chemotherapy.

[1331]  J. Kronstad,et al.  The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest , 2008, Current infectious disease reports.

[1332]  M. Zambon,et al.  Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[1333]  L. Hollier,et al.  Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. , 2008, The Cochrane database of systematic reviews.

[1334]  R. Olsen,et al.  Severe Necrotizing Fasciitis in a Human Immunodeficiency Virus-Positive Patient Caused by Methicillin-Resistant Staphylococcus aureus , 2008, Journal of Clinical Microbiology.

[1335]  S. Kabra,et al.  Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India , 2008, Virology Journal.

[1336]  N. Stern,et al.  Bacteriocins reduce Campylobacter jejuni colonization while bacteria producing bacteriocins are ineffective , 2008 .

[1337]  S. Bakhshi,et al.  INFECTIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: An Analysis of 222 Febrile Neutropenic Episodes , 2008, Pediatric hematology and oncology.

[1338]  B. Fireman,et al.  Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile–Associated Diarrhea in Hospitalized Patients , 2008, Infection Control & Hospital Epidemiology.

[1339]  John McLauchlan,et al.  Visualization of Double-Stranded RNA in Cells Supporting Hepatitis C Virus RNA Replication , 2007, Journal of Virology.

[1340]  R. Hopstaken,et al.  Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study. , 2007, The British journal of general practice : the journal of the Royal College of General Practitioners.

[1341]  I. Pinsk,et al.  Lymphogranuloma venereum as a cause of rectal stricture. , 2007, Canadian journal of surgery. Journal canadien de chirurgie.

[1342]  H. Grundmann,et al.  Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. , 2007, The Journal of antimicrobial chemotherapy.

[1343]  M. Kollef,et al.  Optimizing therapy for MRSA pneumonia. , 2007, Seminars in respiratory and critical care medicine.

[1344]  P. Linden.  Optimizing therapy for vancomycin-resistant enterococci (VRE). , 2007, Seminars in respiratory and critical care medicine.

[1345]  S. Kaplan,et al.  Increase of the USA300 Clone Among Community-Acquired Methicillin-Susceptible Staphylococcus aureus Causing Invasive Infections , 2007, The Pediatric infectious disease journal.

[1346]  V. Eldholm,et al.  Natural genetic transformation: prevalence, mechanisms and function. , 2007, Research in microbiology.

[1347]  L. Stanberry,et al.  VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection , 2007, International journal of nanomedicine.

[1348]  J. Sedgwick,et al.  Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth , 2007, The Journal of Immunology.

[1349]  A. Mejias,et al.  Daptomycin Therapy for Invasive Gram-Positive Bacterial Infections in Children , 2007, The Pediatric infectious disease journal.

[1350]  S. Gellman,et al.  Mimicry of antimicrobial host-defense peptides by random copolymers. , 2007, Journal of the American Chemical Society.

[1351]  M. Maciá,et al.  Pseudomonas aeruginosa RsmA Plays an Important Role during Murine Infection by Influencing Colonization, Virulence, Persistence, and Pulmonary Inflammation , 2007, Infection and Immunity.

[1352]  P. Gross,et al.  Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1353]  M. Paesmans,et al.  Bacteraemia in febrile neutropenic cancer patients. , 2007, International journal of antimicrobial agents.

[1354]  M. Binder,et al.  Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy , 2007, Hepatology.

[1355]  M. Cam,et al.  Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response , 2007, Hepatology.

[1356]  Y. Carmeli,et al.  Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[1357]  J. L. Iribarren,et al.  Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. , 2007, Clinical therapeutics.

[1358]  P. Appelbaum.  Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). , 2007, International journal of antimicrobial agents.

[1359]  A. Martner,et al.  Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. , 2007, The Journal of antimicrobial chemotherapy.

[1360]  M. Matsuoka,et al.  Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137) , 2007, Journal of Virology.

[1361]  J. Fitzgerald,et al.  Pulmonary actinomycosis complicating infliximab therapy for Crohn’s disease , 2007, Thorax.

[1362]  K. Pritchard-Jones,et al.  A prospective study of admissions for febrile neutropenia in secondary paediatric units in South East England , 2007, Pediatric blood & cancer.

[1363]  J. Jensen,et al.  Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial , 2007, Sexually Transmitted Infections.

[1364]  J. W. Wilson,et al.  Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq , 2007, Proceedings of the National Academy of Sciences.

[1365]  J. Shaw,et al.  Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other Antibiotics , 2007, Antimicrobial Agents and Chemotherapy.

[1366]  Benjamin A Lipsky,et al.  Skin, Soft Tissue, Bone, and Joint Infections in Hospitalized Patients: Epidemiology and Microbiological, Clinical, and Economic Outcomes , 2007, Infection Control & Hospital Epidemiology.

[1367]  J. Lieberman,et al.  Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen , 2007, Science.

[1368]  C. Crumpacker,et al.  Rapid and Durable Antiretroviral Effect of the HIV-1 Integrase Inhibitor Raltegravir as Part of Combination Therapy in Treatment-Naive Patients With HIV-1 Infection: Results of a 48-Week Controlled Study , 2007, Journal of acquired immune deficiency syndromes.

[1369]  H. Iwasaki,et al.  Frequent Detection of Multidrug-Resistant Pneumonia-Causing Bacteria in the Pneumonia Lung Tissues of Patients with Hematological Malignancies , 2007, International journal of hematology.

[1370]  G. Dubin,et al.  Seroprevalence of herpes simplex virus type 1 in children in the United States. , 2007, The Journal of pediatrics.

[1371]  A. Al-Ansari,et al.  Primary vesical actinomycosis: A case report and literature review , 2007, International journal of urology : official journal of the Japanese Urological Association.

[1372]  T. Riordan.  Human Infection with Fusobacterium necrophorum (Necrobacillosis), with a Focus on Lemierre's Syndrome , 2007, Clinical Microbiology Reviews.

[1373]  H. Yoon,et al.  Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded. , 2007, Biochemistry.

[1374]  R. Levy,et al.  Direct Effect of Human Immunodeficiency Virus Protease Inhibitors on Neutrophil Function and Apoptosis via Calpain Inhibition , 2007, Clinical and Vaccine Immunology.

[1375]  A. Maheshwari,et al.  Atypical manifestations of dengue , 2007, Tropical medicine & international health : TM & IH.

[1376]  I. Kurane.  Dengue hemorrhagic fever with special emphasis on immunopathogenesis. , 2007, Comparative immunology, microbiology and infectious diseases.

[1377]  I. Mcintosh,et al.  Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme , 2007, Drug Metabolism and Disposition.

[1378]  Chin‐Yun Lee,et al.  Tuberculosis in Children and Adolescents, Taiwan, 1996–2003 , 2007, Emerging infectious diseases.

[1379]  A. Flórez,et al.  Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. , 2007, Food microbiology.

[1380]  Yoshihiro Hayakawa,et al.  A cyclic-di-GMP receptor required for bacterial exopolysaccharide production , 2007, Molecular microbiology.

[1381]  Ian Jenkins.  Linezolid- and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin. , 2007, Journal of hospital medicine.

[1382]  J. Quinn,et al.  Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004 , 2007, Journal of Clinical Microbiology.

[1383]  J. Greenleaf,et al.  Sonication of removed hip and knee prostheses for diagnosis of infection. , 2007, The New England journal of medicine.

[1384]  Todd M. Allen,et al.  Viral Sequence Evolution in Acute Hepatitis C Virus Infection , 2007, Journal of Virology.

[1385]  J. Gilsdorf,et al.  Pharyngeal Colonization Dynamics of Haemophilus influenzae and Haemophilus haemolyticus in Healthy Adult Carriers , 2007, Journal of Clinical Microbiology.

[1386]  J A Wilson,et al.  Uniform: an evidence review of the microbiological significance of uniforms and uniform policy in the prevention and control of healthcare-associated infections. Report to the Department of Health (England). , 2007, The Journal of hospital infection.

[1387]  F. Lowy,et al.  Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1388]  A. Dursun,et al.  Efficacy and Safety of Saccharomyces boulardii in the 14‐day Triple Anti‐Helicobacter pylori Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind Study , 2007, Helicobacter.

[1389]  M. Allon,et al.  Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[1390]  L. Rombo,et al.  The true burden and risk of cholera: implications for prevention and control. , 2007, The Lancet. Infectious diseases.

[1391]  P. Vanhems,et al.  Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1392]  J. Rello,et al.  Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy* , 2007, Critical care medicine.

[1393]  K. Kaye,et al.  Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. , 2007, The Journal of trauma.

[1394]  P. Klenerman,et al.  Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection , 2007, PloS one.

[1395]  N. Cox,et al.  Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. , 2007, The Journal of infectious diseases.

[1396]  K. Bush,et al.  Carbapenemases: the Versatile β-Lactamases , 2007, Clinical Microbiology Reviews.

[1397]  F. Montorsi,et al.  Comparison of a 3‐day with a 1‐day regimen of an extended‐release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate , 2007, BJU international.

[1398]  R. Savaris,et al.  Comparing Ceftriaxone Plus Azithromycin or Doxycycline for Pelvic Inflammatory Disease: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[1399]  J. Benach,et al.  Francisella tularensis has a significant extracellular phase in infected mice. , 2007, The Journal of infectious diseases.

[1400]  P. Oyston,et al.  Vaccines Against Francisella Tularensis , 2007, Annals of the New York Academy of Sciences.

[1401]  Jordi Vila,et al.  Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. , 2007, The Journal of antimicrobial chemotherapy.

[1402]  D. Kwon,et al.  Posaconazole: a new broad-spectrum antifungal agent , 2007, Expert opinion on pharmacotherapy.

[1403]  M. Niederman,et al.  Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia , 2007, Infection Control & Hospital Epidemiology.

[1404]  V. Popov,et al.  Role of Primary Human Alveolar Epithelial Cells in Host Defense against Francisella tularensis Infection , 2007, Infection and Immunity.

[1405]  D. Monack,et al.  Type I interferon signaling is required for activation of the inflammasome during Francisella infection , 2007, The Journal of experimental medicine.

[1406]  D M Klaus,et al.  Clinostats and bioreactors. , 2007, Gravitational and space biology bulletin : publication of the American Society for Gravitational and Space Biology.

[1407]  J. Casanova,et al.  Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling , 2007, Journal of Virology.

[1408]  C. Knight,et al.  Adaptive Divergence in Experimental Populations of Pseudomonas fluorescens. III. Mutational Origins of Wrinkly Spreader Diversity , 2007, Genetics.

[1409]  G. Boivin,et al.  Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. , 2007, Antiviral research.

[1410]  J. Sung,et al.  Factors Associated with Early Hospital Discharge of Adult Influenza Patients , 2007, Antiviral therapy.

[1411]  O. Bilukha,et al.  Use of Meningococcal Vaccines in the United States , 2007, The Pediatric infectious disease journal.

[1412]  C. Angeletti,et al.  Role of previous hospitalization in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study , 2007, BMC infectious diseases.

[1413]  G. Kochs,et al.  Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene , 2007, Proceedings of the National Academy of Sciences.

[1414]  M. Gale,et al.  Functional and Therapeutic Analysis of Hepatitis C Virus NS3·4A Protease Control of Antiviral Immune Defense* , 2007, Journal of Biological Chemistry.

[1415]  G. Eliopoulos,et al.  Daptomycin Nonsusceptibility in Staphylococcus aureus with Reduced Vancomycin Susceptibility Is Independent of Alterations in MprF , 2007, Antimicrobial Agents and Chemotherapy.

[1416]  S. Chee,et al.  Dengue-associated maculopathy. , 2007, Archives of ophthalmology.

[1417]  F. Vandenesch,et al.  Global Distribution of Panton-Valentine Leukocidin–positive Methicillin-resistant Staphylococcus aureus, 2006 , 2007, Emerging infectious diseases.

[1418]  N. Greer.  Posaconazole (Noxafil): A New Triazole Antifungal Agent , 2007, Proceedings.

[1419]  J. Belisle,et al.  Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu41 , 2007, The Journal of Immunology.

[1420]  宮本 大伸.  Involvement of PA28γ-dependent pathway in insulin resistance induced by hepatitis C virus core protein , 2007 .

[1421]  P. V. van Helden,et al.  A Recently Evolved Sublineage of the Mycobacterium tuberculosis Beijing Strain Family Is Associated with an Increased Ability to Spread and Cause Disease , 2007, Journal of Clinical Microbiology.

[1422]  A. Widmer,et al.  Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1423]  D. Cardo,et al.  Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002 , 2007, Public health reports.

[1424]  M. Wiedmann,et al.  Antimicrobial resistance in nontyphoidal Salmonella. , 2007, Journal of food protection.

[1425]  F. Shanahan,et al.  Gut microbiota: mining for therapeutic potential. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[1426]  D. Goldmann,et al.  Healthcare-Associated Infection and Antimicrobial Resistance: Moving Beyond Description to Prevention , 2007, Infection Control & Hospital Epidemiology.

[1427]  M. Klepser,et al.  Tobramycin solution for inhalation in cystic fibrosis patients: a review of the literature , 2007, Expert opinion on pharmacotherapy.

[1428]  M. Maciá,et al.  Inactivation of the Mismatch Repair System in Pseudomonas aeruginosa Attenuates Virulence but Favors Persistence of Oropharyngeal Colonization in Cystic Fibrosis Mice , 2007, Journal of bacteriology.

[1429]  D. Metzger,et al.  Inactivated Francisella tularensis Live Vaccine Strain Protects against Respiratory Tularemia by Intranasal Vaccination in an Immunoglobulin A-Dependent Fashion , 2007, Infection and Immunity.

[1430]  R. Webster,et al.  Efficacy of Oseltamivir Therapy in Ferrets Inoculated with Different Clades of H5N1 Influenza Virus , 2007, Antimicrobial Agents and Chemotherapy.

[1431]  J. Patel,et al.  High Frequencies of Clindamycin and Tetracycline Resistance in Methicillin-Resistant Staphylococcus aureus Pulsed-Field Type USA300 Isolates Collected at a Boston Ambulatory Health Center , 2007, Journal of Clinical Microbiology.

[1432]  S. Bouaziz,et al.  New Functional Domains of Human Cytomegalovirus pUL89 predicted by Sequence Analysis and Three-Dimensional Modelling of the Catalytic Site DEXDc , 2007, Antiviral therapy.

[1433]  K. Kochanek,et al.  Annual Summary of Vital Statistics: 2005 , 2007, Pediatrics.

[1434]  Kenneth J. Smith,et al.  Hospitalization for Pelvic Inflammatory Disease: A Cost-Effectiveness Analysis , 2007, Sexually transmitted diseases.

[1435]  C. van Delden,et al.  Development and Persistence of Antimicrobial Resistance in Pseudomonas aeruginosa: a Longitudinal Observation in Mechanically Ventilated Patients , 2007, Antimicrobial Agents and Chemotherapy.

[1436]  J. Lipton,et al.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.

[1437]  J. Perfect,et al.  Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. , 2007, The New England journal of medicine.

[1438]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1439]  D. Stevens,et al.  Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. , 2007, The Journal of infectious diseases.

[1440]  A. Kiss,et al.  Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1441]  Anders Sjöstedt,et al.  Resistance of Francisella tularensis Strains against Reactive Nitrogen and Oxygen Species with Special Reference to the Role of KatG , 2007, Infection and Immunity.

[1442]  P. V. van Helden,et al.  Absence of an Association Between Mycobacterium tuberculosis Genotype and Clinical Features in Children With Tuberculous Meningitis , 2007, The Pediatric infectious disease journal.

[1443]  M. Ezzati,et al.  Tobacco Smoke, Indoor Air Pollution and Tuberculosis: A Systematic Review and Meta-Analysis , 2007, PLoS medicine.

[1444]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[1445]  Brian Chin,et al.  Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis , 2006, The Lancet.

[1446]  Piet Claus,et al.  Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. , 2006, European heart journal.

[1447]  M. Lennartz,et al.  Francisella tularensis LVS grown in macrophages has reduced ability to stimulate the secretion of inflammatory cytokines by macrophages in vitro. , 2006, Microbial pathogenesis.

[1448]  Richard D Moore,et al.  Incidence of, Risk Factors for, Clinical Presentation, and 1-Year Outcomes of Infective Endocarditis in an Urban HIV Cohort , 2006, Journal of acquired immune deficiency syndromes.

[1449]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[1450]  S. Gallati,et al.  Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. , 2006, American journal of respiratory and critical care medicine.

[1451]  L. Allen,et al.  Francisella tularensis LVS evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape , 2006, Journal of leukocyte biology.

[1452]  L. Meyn,et al.  The Associations Between Pelvic Inflammatory Disease, Trichomonas vaginalis Infection, and Positive Herpes Simplex Virus Type 2 Serology , 2006, Sexually transmitted diseases.

[1453]  M. Noursadeghi,et al.  HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. , 2006, The Lancet. Infectious diseases.

[1454]  M. Bonten,et al.  Growth Condition-Dependent Esp Expression by Enterococcus faecium Affects Initial Adherence and Biofilm Formation , 2006, Infection and Immunity.

[1455]  U. Jenal,et al.  Mechanisms of cyclic-di-GMP signaling in bacteria. , 2006, Annual review of genetics.

[1456]  E. Gupta,et al.  The changing epidemiology of dengue in Delhi, India , 2006, Virology Journal.

[1457]  B. Cunha.  Oral antibiotic therapy of serious systemic infections. , 2006, The Medical clinics of North America.

[1458]  M. Postelnick,et al.  Peritoneal Fluid Penetration of Tigecycline , 2006, The Annals of pharmacotherapy.

[1459]  S. Kaplan,et al.  Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1460]  Richard Platt,et al.  Risk of acquiring antibiotic-resistant bacteria from prior room occupants. , 2006, Archives of internal medicine.

[1461]  D. Metzgar,et al.  Rapid Evolution of Diminished Transformability in Acinetobacter baylyi , 2006, Journal of bacteriology.

[1462]  M. Ramsay,et al.  No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. , 2006, The Lancet. Infectious diseases.

[1463]  M. Lai,et al.  HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice , 2006, Hepatology.

[1464]  R. Hancock,et al.  Antibacterial peptides for therapeutic use: obstacles and realistic outlook. , 2006, Current opinion in pharmacology.

[1465]  T. Walsh.  Combinatorial genetic evolution of multiresistance. , 2006, Current opinion in microbiology.

[1466]  J. King,et al.  Bdellovibrio Predation in the Presence of Decoys: Three-Way Bacterial Interactions Revealed by Mathematical and Experimental Analyses , 2006, Applied and Environmental Microbiology.

[1467]  Y. Ishitsuka,et al.  Amphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertion. , 2006, Journal of the American Chemical Society.

[1468]  C. Fairley,et al.  Anorectal lymphogranuloma venereum in a Melbourne man. , 2006, Sexual health.

[1469]  M. Anagnostaki,et al.  Serum and Cerebrospinal Fluid Concentrations of Linezolid in Neurosurgical Patients , 2006, Antimicrobial Agents and Chemotherapy.

[1470]  Samuel I. Miller,et al.  Lack of In Vitro and In Vivo Recognition of Francisella tularensis Subspecies Lipopolysaccharide by Toll-Like Receptors , 2006, Infection and Immunity.

[1471]  M. Apicella,et al.  Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. , 2006, Annual review of microbiology.

[1472]  David J. Stevens,et al.  The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design , 2006, Nature.

[1473]  H. Hof,et al.  A new, broad‐spectrum azole antifungal: posaconazole – mechanisms of action and resistance, spectrum of activity , 2006, Mycoses.

[1474]  J. Boyce,et al.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.

[1475]  P. Nilsson,et al.  Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares , 2006, Journal of Clinical Microbiology.

[1476]  R. Bonomo,et al.  Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1477]  Meenakshi Malik,et al.  Superoxide Dismutase B Gene (sodB)-Deficient Mutants of Francisella tularensis Demonstrate Hypersensitivity to Oxidative Stress and Attenuated Virulence , 2006, Journal of bacteriology.

[1478]  D. Skiest,et al.  Community‐onset methicillin‐resistant Staphylococcus aureus in an urban HIV clinic , 2006, HIV medicine.

[1479]  Dan M. Kluger,et al.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.

[1480]  M. Doyle,et al.  Emerging microbiological food safety issues related to meat. , 2006, Meat science.

[1481]  R. Mendes,et al.  Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: an analysis of two case-control studies. , 2006, American journal of infection control.

[1482]  Neil Woodford,et al.  The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter , 2006 .

[1483]  N. Mohapatra,et al.  Characterization of the Receptor-Ligand Pathways Important for Entry and Survival of Francisella tularensis in Human Macrophages , 2006, Infection and Immunity.

[1484]  G. Schulert,et al.  Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor , 2006, Journal of leukocyte biology.

[1485]  G. Stein,et al.  Tigecycline: a critical analysis. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1486]  J. Stephenson,et al.  Risk factors associated with pelvic inflammatory disease , 2006, Sexually Transmitted Infections.

[1487]  J. Kelly,et al.  Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines. , 2006, Biochemical and biophysical research communications.

[1488]  A. Najafi,et al.  Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. , 2006, International journal of antimicrobial agents.

[1489]  P. Jeena,et al.  Lack of association between the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in HIV-1-infected South African children. , 2006, The Journal of infectious diseases.

[1490]  L. Pierini.  Uptake of serum‐opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors , 2006, Cellular microbiology.

[1491]  R. Panpanich,et al.  Corticosteroids for treating dengue shock syndrome. , 2006, The Cochrane database of systematic reviews.

[1492]  J. Claverys,et al.  Antibiotic Stress Induces Genetic Transformability in the Human Pathogen Streptococcus pneumoniae , 2006, Science.

[1493]  P. Langenberg,et al.  Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. , 2006, Diagnostic microbiology and infectious disease.

[1494]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[1495]  M. Pichichero.  Pathogen Shifts and Changing Cure Rates for Otitis Media and Tonsillopharyngitis , 2006, Clinical pediatrics.

[1496]  R. Gibson,et al.  Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis , 2006, Pediatric pulmonology.

[1497]  S. Garland,et al.  Azithromycin Failure in Mycoplasma genitalium Urethritis , 2006, Emerging infectious diseases.

[1498]  E. Kerem,et al.  Aspergillus bronchitis in cystic fibrosis. , 2006, Chest.

[1499]  Adolfo García-Sastre,et al.  The guinea pig as a transmission model for human influenza viruses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[1500]  M. Messerle,et al.  Identification of the interaction domain of the small terminase subunit pUL89 with the large subunit pUL56 of human cytomegalovirus. , 2006, Biochemistry.

[1501]  B. Murphy,et al.  Rhabdomyolysis during therapy with daptomycin. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1502]  B. Franklin,et al.  A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay , 2006, BMC infectious diseases.

[1503]  Robert A Bonomo,et al.  What's new in antibiotic resistance? Focus on beta-lactamases. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[1504]  G. Sensabaugh,et al.  Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. , 2006, The Journal of infectious diseases.

[1505]  D. Lalloo,et al.  Oral cholera vaccines: use in clinical practice. , 2006, The Lancet. Infectious diseases.

[1506]  B. Almirante,et al.  Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. , 2006, The Journal of antimicrobial chemotherapy.

[1507]  E. Anaissie,et al.  Pharmacokinetics and Safety of Oral Posaconazole in Neutropenic Stem Cell Transplant Recipients , 2006, Antimicrobial Agents and Chemotherapy.

[1508]  K. Lemmer,et al.  Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe. , 2006, FEMS yeast research.

[1509]  J. Rello,et al.  Impact of diversity of antibiotic use on the development of antimicrobial resistance. , 2006, The Journal of antimicrobial chemotherapy.

[1510]  D. Loebenberg,et al.  In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts , 2006, Antimicrobial Agents and Chemotherapy.

[1511]  K. Wood,et al.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.

[1512]  David L Paterson.  Resistance in gram-negative bacteria: enterobacteriaceae. , 2006, The American journal of medicine.

[1513]  R. Weinstein,et al.  Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1514]  M. Kieny,et al.  A review of vaccine research and development: meningococcal disease. , 2006, Vaccine.

[1515]  T. Holtz,et al.  Time to Sputum Culture Conversion in Multidrug-Resistant Tuberculosis: Predictors and Relationship to Treatment Outcome , 2006, Annals of Internal Medicine.

[1516]  N. Velathanthiri,et al.  Patterns of disease among adults hospitalized with dengue infections. , 2006, QJM : monthly journal of the Association of Physicians.

[1517]  D. Kotler,et al.  Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. , 2006, Journal of clinical gastroenterology.

[1518]  H. Loveday,et al.  A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the Joint MRSA Working Party (Subgroup A). , 2006, The Journal of hospital infection.

[1519]  R. Morrow,et al.  Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1520]  B. Kazmierczak,et al.  Analysis of FimX, a phosphodiesterase that governs twitching motility in Pseudomonas aeruginosa , 2006, Molecular microbiology.

[1521]  M. Fyfe,et al.  Emergence of Cryptococcus gattii in a Novel Environment Provides Clues to Its Incubation Period , 2006, Journal of Clinical Microbiology.

[1522]  S. Kaplan,et al.  Venous Thrombosis Associated With Staphylococcal Osteomyelitis in Children , 2006, Pediatrics.

[1523]  J. M. Dow,et al.  Cell-cell signaling in Xanthomonas campestris involves an HD-GYP domain protein that functions in cyclic di-GMP turnover. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[1524]  A. Rothman,et al.  Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatment. , 2006, The Journal of infectious diseases.

[1525]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[1526]  A. Rachlis,et al.  Lymphogranuloma venereum in North America: case reports and an update for gastroenterologists. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[1527]  R. Zbinden,et al.  16S rRNA Gene Sequencing versus the API 20 NE System and the VITEK 2 ID-GNB Card for Identification of Nonfermenting Gram-Negative Bacteria in the Clinical Laboratory , 2006, Journal of Clinical Microbiology.

[1528]  D. M. Klaus,et al.  Microbial antibiotic production aboard the International Space Station , 2006, Applied Microbiology and Biotechnology.

[1529]  Robin Patel,et al.  Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. , 2006, Mayo Clinic proceedings.

[1530]  R. Stahlmann,et al.  Drug interactions during therapy with three major groups of antimicrobial agents , 2006, Expert opinion on pharmacotherapy.

[1531]  O. Pybus,et al.  Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution , 2006, Hepatology.

[1532]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[1533]  V. Kalioras,et al.  Scalp actinomycosis mimicking soft tissue mass. , 2006, Dento maxillo facial radiology.

[1534]  F. Weber,et al.  A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. , 2006, Antiviral research.

[1535]  Z. Samra,et al.  Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. , 2006, The Journal of hospital infection.

[1536]  M. Grayson,et al.  Risk of Environmental and Healthcare Worker Contamination With Vancomycin-Resistant Enterococci During Outpatient Procedures and Hemodialysis , 2006, Infection Control & Hospital Epidemiology.

[1537]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[1538]  Daniel G. Lee,et al.  Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[1539]  S. Kaplan,et al.  Panton-Valentine Leukocidin Genes Are Associated With Enhanced Inflammatory Response and Local Disease in Acute Hematogenous Staphylococcus aureus Osteomyelitis in Children , 2006, Pediatrics.

[1540]  Natalia Ivanova,et al.  Metagenomic analysis of two enhanced biological phosphorus removal (EBPR) sludge communities , 2006, Nature Biotechnology.

[1541]  G. Marchetti,et al.  Nosocomial Bacterial Pneumonia in HIV-Infected Patients: Risk Factors for Adverse Outcome and Implications for Rational Empiric Antibiotic Therapy , 2006, Infection.

[1542]  A. Sjöstedt.  Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. , 2006, Microbes and infection.

[1543]  C. Ozakin,et al.  Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit. , 2006, The Journal of hospital infection.

[1544]  R. Gaynes,et al.  Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1545]  L. Lorente,et al.  Meropenem by Continuous Versus Intermittent Infusion in Ventilator-Associated Pneumonia due to Gram-Negative Bacilli , 2006, The Annals of pharmacotherapy.

[1546]  D. Hughes,et al.  Sampling the Antibiotic Resistome , 2006, Science.

[1547]  S. Morré,et al.  Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1548]  Cecile Viboud,et al.  Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data. , 2006, American journal of epidemiology.

[1549]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[1550]  S. Aaron,et al.  Multiple Combination Bactericidal Testing of Staphylococcal Biofilms from Implant-Associated Infections , 2006, Antimicrobial Agents and Chemotherapy.

[1551]  C. Beglinger,et al.  Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers , 2006, Antimicrobial Agents and Chemotherapy.

[1552]  Y. Guan,et al.  H5N1 Outbreaks and Enzootic Influenza , 2006, Emerging infectious diseases.

[1553]  M. Klepser,et al.  Aerosolised antibiotics: a critical appraisal of their use , 2006, Expert opinion on drug delivery.

[1554]  L. Harrison.  Prospects for Vaccine Prevention of Meningococcal Infection , 2006, Clinical Microbiology Reviews.

[1555]  Yehuda Carmeli,et al.  Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact , 2006, Antimicrobial Agents and Chemotherapy.

[1556]  Yi Guan,et al.  Oseltamivir resistance during treatment of influenza A (H5N1) infection. , 2005, The New England journal of medicine.

[1557]  A. Dittmer,et al.  Interaction of the Putative Human Cytomegalovirus Portal Protein pUL104 with the Large Terminase Subunit pUL56 and Its Inhibition by Benzimidazole-d-Ribonucleosides , 2005, Journal of Virology.

[1558]  E. Bernasconi,et al.  Evaluation of prescription practices of antibiotics in a medium-sized Swiss hospital. , 2005, Swiss medical weekly.

[1559]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[1560]  M. S. St. Louis,et al.  Trends in Pelvic Inflammatory Disease Hospital Discharges and Ambulatory Visits, United States, 1985–2001 , 2005, Sexually transmitted diseases.

[1561]  G. Smith.  Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. , 2005, Obstetrics and gynecology.

[1562]  Alex van Belkum,et al.  The role of nasal carriage in Staphylococcus aureus infections. , 2005, The Lancet. Infectious diseases.

[1563]  M. Rosenthal,et al.  Voriconazole therapy in children with cystic fibrosis. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[1564]  D. Hassett,et al.  The Exopolysaccharide Alginate Protects Pseudomonas aeruginosa Biofilm Bacteria from IFN-γ-Mediated Macrophage Killing1 , 2005, The Journal of Immunology.

[1565]  H. Tamamura,et al.  The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis , 2005, Expert opinion on therapeutic targets.

[1566]  S. Dow,et al.  Francisella tularensis Induces Aberrant Activation of Pulmonary Dendritic Cells1 , 2005, The Journal of Immunology.

[1567]  A. Kwong,et al.  In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061* , 2005, Journal of Biological Chemistry.

[1568]  T. Verheij,et al.  Determinants of antibiotic overprescribing in respiratory tract infections in general practice. , 2005, The Journal of antimicrobial chemotherapy.

[1569]  A. Francavilla,et al.  Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. , 2005, Gastroenterology.

[1570]  M. Yasuda,et al.  In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1571]  Christian Brander,et al.  Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution , 2005, Journal of Virology.

[1572]  R. Marchelli,et al.  Detection of the R553X DNA single point mutation related to cystic fibrosis by a “chiral box” D‐lysine‐peptide nucleic acid probe by capillary electrophoresis , 2005, Electrophoresis.

[1573]  Madhu Dyavaiah,et al.  Cryptococcus gattii in AIDS Patients, Southern California , 2005, Emerging infectious diseases.

[1574]  M. Joly-Guillou,et al.  Clinical impact and pathogenicity of Acinetobacter. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1575]  Victoria A. Castro,et al.  Changes in monocyte functions of astronauts , 2005, Brain, Behavior, and Immunity.

[1576]  G. Lyman,et al.  Length of stay and mortality associated with febrile neutropenia among children with cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[1577]  M. Yasuda,et al.  Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy , 2005, World Journal of Urology.

[1578]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[1579]  Ralf Bartenschlager,et al.  Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.

[1580]  S. Straus,et al.  Interventions to improve antibiotic prescribing practices in ambulatory care. , 2005, The Cochrane database of systematic reviews.

[1581]  W. Salzer,et al.  Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1582]  Timothy J. Harlow,et al.  Highways of gene sharing in prokaryotes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[1583]  A. Ihan,et al.  Evaluation of separate vs pooled swab cultures, different media, broth enrichment and anatomical sites of screening for the detection of methicillin-resistant Staphylococcus aureus from clinical specimens. , 2005, The Journal of hospital infection.

[1584]  Xiyan Xu,et al.  Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern , 2005, The Lancet.

[1585]  Robert A. Bonomo,et al.  Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .

[1586]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[1587]  G. Stein.  Antimicrobial Resistance in the Hospital Setting: Impact, Trends, and Infection Control Measures , 2005, Pharmacotherapy.

[1588]  A. Sharma,et al.  Febrile neutropenia in haematological malignancies. , 2005, Journal of postgraduate medicine.

[1589]  A. Moscona.  Neuraminidase inhibitors for influenza. , 2005, The New England journal of medicine.

[1590]  Jonathan R Edwards,et al.  Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1591]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[1592]  T. Verheij,et al.  Analysis of under- and overprescribing of antibiotics in acute otitis media in general practice. , 2005, The Journal of antimicrobial chemotherapy.

[1593]  Nicholas J White,et al.  Comparison of three fluid solutions for resuscitation in dengue shock syndrome. , 2005, The New England journal of medicine.

[1594]  S. Kularatne,et al.  Survey on the management of dengue infection in Sri Lanka: opinions of physicians and pediatricians. , 2005, The Southeast Asian journal of tropical medicine and public health.

[1595]  J. Leyden,et al.  Safety of doxycycline and minocycline: a systematic review. , 2005, Clinical therapeutics.

[1596]  A. Yılmaz,et al.  Nail discoloration induced by doxycycline. , 2005, The Pediatric infectious disease journal.

[1597]  D. Nixon,et al.  Impact of 2-Bromo-5,6-Dichloro-1-β-d-Ribofuranosyl Benzimidazole Riboside and Inhibitors of DNA, RNA, and Protein Synthesis on Human Cytomegalovirus Genome Maturation , 2005, Journal of Virology.

[1598]  P. Ambrose,et al.  The pharmacokinetic and pharmacodynamic profile of tigecycline. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1599]  P. Taylor,et al.  Towards rational treatment of bacterial infections during extended space travel. , 2005, International journal of antimicrobial agents.

[1600]  M. Horwitz,et al.  Francisella tularensis Enters Macrophages via a Novel Process Involving Pseudopod Loops , 2005, Infection and Immunity.

[1601]  P. Savelkoul,et al.  Widespread Transfer of Resistance Genes between Bacterial Species in an Intensive Care Unit: Implications for Hospital Epidemiology , 2005, Journal of Clinical Microbiology.

[1602]  M. Blaser,et al.  Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin , 2005, Emerging infectious diseases.

[1603]  M. Gale,et al.  Evasion of intracellular host defence by hepatitis C virus , 2005, Nature.

[1604]  Jerome J. Schentag,et al.  The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. , 2005, Archives of internal medicine.

[1605]  S. Morré,et al.  Real-time Polymerase Chain Reaction To Diagnose Lymphogranuloma Venereum , 2005, Emerging infectious diseases.

[1606]  Robert S. Dittus,et al.  Trends in antibiotic prescribing for adults in the United States—1995 to 2002 , 2005, Journal of General Internal Medicine.

[1607]  R. Adegbola,et al.  Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. , 2005, International journal of epidemiology.

[1608]  J. Myers,et al.  Actinomycotic infection of the oesophagus. , 2005, The Journal of infection.

[1609]  D. Torre,et al.  Phagocytic Activity in Human Immunodeficiency Virus Type 1 Infection , 2005, Clinical Diagnostic Laboratory Immunology.

[1610]  V. Nizet,et al.  Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity , 2005, The Journal of experimental medicine.

[1611]  J. Frelinger,et al.  CD4−CD8− T cells control intracellular bacterial infections both in vitro and in vivo , 2005, The Journal of experimental medicine.

[1612]  D. Sack,et al.  Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis , 2005, The Lancet.

[1613]  S. Morré,et al.  New Lymphogranuloma Venereum Chlamydia trachomatis Variant, Amsterdam , 2005, Emerging infectious diseases.

[1614]  Andrew J. Schmidt,et al.  The Ubiquitous Protein Domain EAL Is a Cyclic Diguanylate-Specific Phosphodiesterase: Enzymatically Active and Inactive EAL Domains , 2005, Journal of bacteriology.

[1615]  B. Michel,et al.  After 30 Years of Study, the Bacterial SOS Response Still Surprises Us , 2005, PLoS biology.

[1616]  K. Klose,et al.  The Francisella tularensis pathogenicity island protein IglC and its regulator MglA are essential for modulating phagosome biogenesis and subsequent bacterial escape into the cytoplasm , 2005, Cellular microbiology.

[1617]  M. Krohn,et al.  Comparison of Acute and Subclinical Pelvic Inflammatory Disease , 2005, Sexually transmitted diseases.

[1618]  N. Stern,et al.  Paenibacillus polymyxa purified bacteriocin to control Campylobacter jejuni in chickens. , 2005, Journal of food protection.

[1619]  L. Mortin,et al.  Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. , 2005, The Journal of infectious diseases.

[1620]  Michael Y. Galperin,et al.  A census of membrane-bound and intracellular signal transduction proteins in bacteria: Bacterial IQ, extroverts and introverts , 2005, BMC Microbiology.

[1621]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[1622]  Stuart C. Ray,et al.  Divergent and convergent evolution after a common-source outbreak of hepatitis C virus , 2005, The Journal of experimental medicine.

[1623]  P. Petiot,et al.  Possibly Linezolid-Induced Peripheral and Central Neurotoxicity: Report of Four Cases , 2005, Infection.

[1624]  Barry G. Hall,et al.  Revised Ambler classification of β-lactamases , 2005 .

[1625]  M. Zhan,et al.  Antimicrobial Resistance in Campylobacter , 2005, Emerging Infectious Diseases.

[1626]  K. Itani,et al.  Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections , 2005, Antimicrobial Agents and Chemotherapy.

[1627]  J. Ruhe,et al.  Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1628]  R. Seaton,et al.  Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone. , 2005, The Journal of antimicrobial chemotherapy.

[1629]  V K Ilyin,et al.  Microbiological status of cosmonauts during orbital spaceflights on Salyut and Mir orbital stations. , 2005, Acta astronautica.

[1630]  C. Ubeda,et al.  Antibiotic‐induced SOS response promotes horizontal dissemination of pathogenicity island‐encoded virulence factors in staphylococci , 2005, Molecular microbiology.

[1631]  R. Razonable.  Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. , 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[1632]  Brad Spellberg,et al.  Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. , 2005, The New England journal of medicine.

[1633]  J. Aguado,et al.  Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[1634]  Sumati Rajagopalan,et al.  Understanding how combinations of HLA and KIR genes influence disease , 2005, The Journal of experimental medicine.

[1635]  J. Stephenson.  Understanding dengue pathogenesis: implications for vaccine design. , 2005, Bulletin of the World Health Organization.

[1636]  F. Lowy,et al.  A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1637]  E. Schmidt,et al.  Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. , 2005, Gastroenterology.

[1638]  David L. Swerdlow,et al.  Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002 , 2005, Emerging infectious diseases.

[1639]  Y. Shai,et al.  Host defense peptides as new weapons in cancer treatment , 2005, Cellular and Molecular Life Sciences CMLS.

[1640]  C. Viscoli,et al.  Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1641]  G. Cook,et al.  A decade of community MRSA in New Zealand , 2005, Epidemiology and Infection.

[1642]  Andrew K. Sewell,et al.  Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA , 2005, The Journal of experimental medicine.

[1643]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[1644]  E. Hook,et al.  Confirming Positive Results of Nucleic Acid Amplification Tests (NAATs) for Chlamydia trachomatis: All NAATs Are Not Created Equal , 2005, Journal of Clinical Microbiology.

[1645]  Y. Pommier,et al.  Integrase inhibitors to treat HIV/Aids , 2005, Nature Reviews Drug Discovery.

[1646]  U. Romling,et al.  Effect of Heat, Acidification, and Chlorination on Salmonella enterica Serovar Typhimurium Cells in a Biofilm Formed at the Air-Liquid Interface , 2005, Applied and Environmental Microbiology.

[1647]  O. Sommerburg,et al.  Inquilinus limosus in Patients with Cystic Fibrosis, Germany , 2005, Emerging infectious diseases.

[1648]  R. Bartenschlager,et al.  Mutational Analysis of Hepatitis C Virus Nonstructural Protein 5A: Potential Role of Differential Phosphorylation in RNA Replication and Identification of a Genetically Flexible Domain , 2005, Journal of Virology.

[1649]  Richard Colgan,et al.  Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1650]  A. Jana,et al.  Emergence of dengue virus type-3 in northern India. , 2005, The Southeast Asian journal of tropical medicine and public health.

[1651]  K. Brogden.  Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[1652]  M. Trent,et al.  Use of an institutional intervention to improve quality of care for adolescents treated in pediatric ambulatory settings for pelvic inflammatory disease. , 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[1653]  H. Wertheim,et al.  Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections , 2005, Infection.

[1654]  Irene A. Doherty,et al.  Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections. , 2005, The Journal of infectious diseases.

[1655]  M. Zeitlinger,et al.  Pharmacokinetics and Pharmacodynamics of Cefpirome in Subcutaneous Adipose Tissue of Septic Patients , 2005, Antimicrobial Agents and Chemotherapy.

[1656]  S. Swan,et al.  Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease , 2005, Journal of clinical pharmacology.

[1657]  M. Patel,et al.  Polysaccharide vaccines for preventing serogroup A meningococcal meningitis. , 2005, The Cochrane database of systematic reviews.

[1658]  N. Khardori,et al.  In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci , 2005, Annals of Clinical Microbiology and Antimicrobials.

[1659]  S. Tringe,et al.  Comparative Metagenomics of Microbial Communities , 2004, Science.

[1660]  T. Boekhout,et al.  A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[1661]  A. Pollard.  Global Epidemiology of Meningococcal Disease and Vaccine Efficacy , 2004, The Pediatric infectious disease journal.

[1662]  A. Hauser,et al.  Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung , 2004, Infection and Immunity.

[1663]  A. Sjöstedt,et al.  Tularaemia: bioterrorism defence renews interest in Francisella tularensis , 2004, Nature Reviews Microbiology.

[1664]  W. Hong,et al.  Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity. , 2004, The Biochemical journal.

[1665]  J. Handelsman,et al.  Metagenomics: genomic analysis of microbial communities. , 2004, Annual review of genetics.

[1666]  R. De Gaudio,et al.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness , 2004, Intensive Care Medicine.

[1667]  S. Schwarz,et al.  Molecular basis of bacterial resistance to chloramphenicol and florfenicol. , 2004, FEMS microbiology reviews.

[1668]  P. Simmonds,et al.  Genetic diversity and evolution of hepatitis C virus--15 years on. , 2004, The Journal of general virology.

[1669]  Roland Grunow,et al.  Comparison of Enzyme-Linked Immunosorbent Assay, Western Blotting, Microagglutination, Indirect Immunofluorescence Assay, and Flow Cytometry for Serological Diagnosis of Tularemia , 2004, Clinical Diagnostic Laboratory Immunology.

[1670]  A. Gasbarrini,et al.  Bacillus clausii therapy to reduce side‐effects of anti‐Helicobacter pylori treatment: randomized, double‐blind, placebo controlled trial , 2004, Alimentary pharmacology & therapeutics.

[1671]  D. Metzger,et al.  Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. , 2004, Cellular immunology.

[1672]  J. Klausner,et al.  Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections , 2004, AIDS.

[1673]  B. Keevil,et al.  Adverse reactions to voriconazole. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1674]  H. Thio,et al.  Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1675]  D. Loebenberg,et al.  Posaconazole Is a Potent Inhibitor of Sterol 14α-Demethylation in Yeasts and Molds , 2004, Antimicrobial Agents and Chemotherapy.

[1676]  Na Zhang,et al.  A Francisella tularensis Pathogenicity Island Required for Intramacrophage Growth , 2004, Journal of bacteriology.

[1677]  Volker Brass,et al.  Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A* , 2004, Journal of Biological Chemistry.

[1678]  D. Hospenthal,et al.  Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1679]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[1680]  D. Gubler,et al.  The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? , 2004, Comparative immunology, microbiology and infectious diseases.

[1681]  R. Courtney,et al.  Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects , 2004, Antimicrobial Agents and Chemotherapy.

[1682]  Mark Harris,et al.  Hepatitis C virus NS5A: tales of a promiscuous protein. , 2004, The Journal of general virology.

[1683]  Yanping Wang,et al.  Human intestinal bacteria as reservoirs for antibiotic resistance genes. , 2004, Trends in microbiology.

[1684]  B. Guerra,et al.  Characterization and localization of drug resistance determinants in multidrug-resistant, integron-carrying Salmonella enterica serotype Typhimurium strains. , 2004, Microbial drug resistance.

[1685]  A. Upton,et al.  Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital. , 2004, The New Zealand medical journal.

[1686]  N. M. Dung,et al.  Size and charge characteristics of the protein leak in dengue shock syndrome. , 2004, The Journal of infectious diseases.

[1687]  T. Stachyra,et al.  In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor , 2004 .

[1688]  K. Poole.  Resistance to β-lactam antibiotics , 2004, Cellular and Molecular Life Sciences CMLS.

[1689]  J. Tarrand,et al.  Central Venous Catheter–Related Bacteremia Due to Gram-Negative Bacilli: Significance of Catheter Removal in Preventing Relapse , 2004, Infection Control & Hospital Epidemiology.

[1690]  J. Handelsman,et al.  Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. , 2004, The Lancet. Infectious diseases.

[1691]  P. Keskinen,et al.  Expression of hepatitis C virus core protein inhibits interferon‐induced nuclear import of STATs , 2004, Journal of medical virology.

[1692]  A. Dessen,et al.  The V Antigen of Pseudomonas aeruginosa Is Required for Assembly of the Functional PopB/PopD Translocation Pore in Host Cell Membranes , 2004, Infection and Immunity.

[1693]  S. Kaplan,et al.  Community-Acquired, Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus Musculoskeletal Infections in Children , 2004, The Pediatric infectious disease journal.

[1694]  R. Ramphal.  Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1695]  A. Kanamaru,et al.  Microbiological data for patients with febrile neutropenia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1696]  J. Rello,et al.  Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia , 2004, Intensive Care Medicine.

[1697]  S. Sereika,et al.  Adherence to oral therapies in pelvic inflammatory disease. , 2004, Journal of women's health.

[1698]  T. Pitt,et al.  Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. , 2004, Journal of medical microbiology.

[1699]  M. Wilcox,et al.  Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea. , 2004, The Journal of antimicrobial chemotherapy.

[1700]  Xiao Xue Ma,et al.  Novel Type V Staphylococcal Cassette Chromosome mec Driven by a Novel Cassette Chromosome Recombinase, ccrC , 2004, Antimicrobial Agents and Chemotherapy.

[1701]  L. Berrueta,et al.  Increased Fas‐mediated apoptosis in polymorphonuclear cells from HIV‐infected patients , 2004, Clinical and experimental immunology.

[1702]  R. Arbeit,et al.  The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1703]  J. Buer,et al.  Expression Analysis of a Highly Adherent and Cytotoxic Small Colony Variant of Pseudomonas aeruginosa Isolated from a Lung of a Patient with Cystic Fibrosis , 2004, Journal of bacteriology.

[1704]  D. Pierson,et al.  Microbial Responses to Microgravity and Other Low-Shear Environments , 2004, Microbiology and Molecular Biology Reviews.

[1705]  S. Häussler.  Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. , 2004, Environmental microbiology.

[1706]  J. Rello,et al.  Survey of Ferroxidase Expression and Siderophore Production in Clinical Isolates of Pseudomonas aeruginosa , 2004, Journal of Clinical Microbiology.

[1707]  H. Sun,et al.  Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. , 2004, The Journal of hospital infection.

[1708]  T. Wetter,et al.  Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs. , 2004, Genome research.

[1709]  Wangxue Chen,et al.  Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. , 2004, Microbial pathogenesis.

[1710]  P. Nordmann,et al.  Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa , 2004, Antimicrobial Agents and Chemotherapy.

[1711]  M. Horwitz,et al.  Virulent and Avirulent Strains of Francisella tularensis Prevent Acidification and Maturation of Their Phagosomes and Escape into the Cytoplasm in Human Macrophages , 2004, Infection and Immunity.

[1712]  J. Emerson,et al.  Clinically Feasible Biofilm Susceptibility Assay for Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis , 2004, Journal of Clinical Microbiology.

[1713]  H. Derendorf,et al.  Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue , 2004, Antimicrobial Agents and Chemotherapy.

[1714]  Meghan F. Davis,et al.  Multidrug-resistant Salmonella Typhimurium Infection from Milk Contaminated after Pasteurization , 2004, Emerging infectious diseases.

[1715]  J. Powers,et al.  Trends in antimicrobial drug development: implications for the future. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1716]  D. McNaughton.  Nurse home visits to maternal-child clients: a review of intervention research. , 2004, Public health nursing.

[1717]  P. Donald.  Childhood tuberculosis: the hidden epidemic. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[1718]  M. Allon,et al.  Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[1719]  John R Fulghum,et al.  In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061 , 2004, Journal of Biological Chemistry.

[1720]  B. Alexander,et al.  Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[1721]  T. Barrett,et al.  Antimicrobial use in agriculture: controlling the transfer of antimicrobial resistance to humans. , 2004, Seminars in pediatric infectious diseases.

[1722]  P. Nordmann,et al.  Molecular analysis of metallo-beta-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. , 2004, Antimicrobial agents and chemotherapy.

[1723]  R. Gie,et al.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[1724]  M. Mergeay,et al.  Space flight effects on bacterial physiology. , 2004, Journal of biological regulators and homeostatic agents.

[1725]  J. Krebs.  When Food Kills , 2004, PLoS Biology.

[1726]  F. Saad,et al.  A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. , 2004, The Canadian journal of urology.

[1727]  P. Jurkovich.  HOME- VERSUS HOSPITAL-LAUNDERED SCRUBS: A PILOT STUDY , 2004, MCN. The American journal of maternal child nursing.

[1728]  R. Gie,et al.  The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[1729]  E. Radwanski,et al.  Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men , 2004, Antimicrobial Agents and Chemotherapy.

[1730]  U. Baumann,et al.  Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections. , 2004, Vaccine.

[1731]  P. Ward,et al.  Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1732]  K. Venkateswaran,et al.  Microbial Monitoring of Spacecraft and Associated Environments , 2004, Microbial Ecology.

[1733]  D. Pierson,et al.  Microbial Characterization during the Early Habitation of the International Space Station , 2004, Microbial Ecology.

[1734]  A. Maetzel,et al.  Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. , 2004 .

[1735]  Harry L. T. Mobley,et al.  Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.

[1736]  B. Averhoff.  DNA Transport and Natural Transformation in Mesophilic and Thermophilic Bacteria , 2004, Journal of bioenergetics and biomembranes.

[1737]  P. Ward,et al.  Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1738]  D. Pierson,et al.  Microbial Characterization of Free Floating Condensate aboard the Mir Space Station , 2004, Microbial Ecology.

[1739]  D. Annane,et al.  Corticosteroids for treating severe sepsis and septic shock. , 2004, The Cochrane database of systematic reviews.

[1740]  S. Harbarth,et al.  Are there Patients with Peritonitis Who Require Empiric Therapy for Enterococcus? , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[1741]  L. Townsend,et al.  Role of a Mutation in Human Cytomegalovirus Gene UL104 in Resistance to Benzimidazole Ribonucleosides , 2004, Journal of Virology.

[1742]  S. Garland,et al.  Validation of Roche COBAS Amplicor Assay for Detection of Chlamydia trachomatis in Rectal and Pharyngeal Specimens by an omp1 PCR Assay , 2004, Journal of Clinical Microbiology.

[1743]  D. Raoult,et al.  Surveillance Network for Herpes Simplex Virus Resistance to Antiviral Drugs: 3-Year Follow-Up , 2004, Journal of Clinical Microbiology.

[1744]  A. Tomasz,et al.  Alterations of Cell Wall Structure and MetabolismAccompany Reduced Susceptibility to Vancomycin in an IsogenicSeries of Clinical Isolates of Staphylococcusaureus , 2003, Journal of bacteriology.

[1745]  E. Argyris,et al.  The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity. , 2003, Virology.

[1746]  D. G. White,et al.  Prevalence and Antimicrobial Resistance of Enterococcus Species Isolated from Retail Meats , 2003, Applied and Environmental Microbiology.

[1747]  H. Hahn,et al.  Antimicrobial Resistance in Campylobacter jejuni and Campylobacter coli Strains Isolated in 1991 and 2001-2002 from Poultry and Humans in Berlin, Germany , 2003, Antimicrobial Agents and Chemotherapy.

[1748]  David R. Williams,et al.  The biomedical challenges of space flight. , 2003, Annual review of medicine.

[1749]  A. Wald,et al.  Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. , 2003, The Journal of infectious diseases.

[1750]  R. A. Harris,et al.  Humex : a study on the survivability and adaptation of humans to long-duration exploratory missions , 2003 .

[1751]  M. Wilcox,et al.  Effect of extended perioperative antibiotic prophylaxis on intravascular catheter colonization and infection in cardiothoracic surgery patients. , 2003, The Journal of antimicrobial chemotherapy.

[1752]  C. Bridges,et al.  Transmission of influenza: implications for control in health care settings. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1753]  M. Cormican,et al.  Linezolid Compared with Eperezolid, Vancomycin, and Gentamicin in an In Vitro Model of Antimicrobial Lock Therapy for Staphylococcus epidermidis Central Venous Catheter-Related Biofilm Infections , 2003, Antimicrobial Agents and Chemotherapy.

[1754]  Craig M. Roberts,et al.  Increasing Proportion of Herpes Simplex Virus Type 1 as a Cause of Genital Herpes Infection in College Students , 2003, Sexually transmitted diseases.

[1755]  V. Singh,et al.  Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon. , 2003, Microbiology.

[1756]  M. Nelson,et al.  BHIVA guidelines: coinfection with HIV and chronic hepatitis C virus , 2003, HIV medicine.

[1757]  Kasthuri Venkateswaran,et al.  Microbial characterization of the Mars Odyssey spacecraft and its encapsulation facility. , 2003, Environmental microbiology.

[1758]  G. Pugliese,et al.  Outbreaks of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin Infections , 2003, Infection Control & Hospital Epidemiology.

[1759]  J. Wehland,et al.  Inter- and Intraclonal Diversity of the Pseudomonas aeruginosa Proteome Manifests within the Secretome , 2003, Journal of bacteriology.

[1760]  F. Sörgel,et al.  Antibiotic therapy – rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue , 2003, Andrologia.

[1761]  M. Blaser,et al.  Long-Term Persistence of Resistant Enterococcus Species after Antibiotics To Eradicate Helicobacter pylori , 2003, Annals of Internal Medicine.

[1762]  J. Rello,et al.  A 7-year study of severe hospital-acquired pneumonia requiring ICU admission , 2003, Intensive Care Medicine.

[1763]  S. Jeon,et al.  Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. , 2003, Urology.

[1764]  J. Baumgartner,et al.  Occurrence of Actinomyces in infections of endodontic origin. , 2003, Journal of endodontics.

[1765]  Norma Terrin,et al.  Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years , 2003, Infection Control & Hospital Epidemiology.

[1766]  A. Larocco.  Concurrent antibiotic review programs--a role for infectious diseases specialists at small community hospitals. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1767]  C. Pui,et al.  Viridans Streptococcal Sepsis: Clinical Features and Complications in Childhood Acute Myeloid Leukemia , 2003, Journal of pediatric hematology/oncology.

[1768]  E. J. Young,et al.  Disseminated Actinomyces meyeri infection resembling lung cancer with brain metastases. , 2003, The American journal of the medical sciences.

[1769]  R. Courtney,et al.  Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults , 2003, Antimicrobial Agents and Chemotherapy.

[1770]  K. M. Parris,et al.  A comparison pilot study of public health field nursing home visitation program interventions for pregnant Hispanic adolescents. , 2003, Public health nursing.

[1771]  J. Gordon,et al.  Honor thy symbionts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[1772]  Margaret-Mary G. Wilson,et al.  Sexually transmitted diseases. , 2003, Clinics in geriatric medicine.

[1773]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003 .

[1774]  J. Jensen,et al.  Tetracycline treatment does not eradicate Mycoplasma genitalium , 2003, Sexually transmitted infections.

[1775]  A. Cunningham,et al.  Is HSV serology useful for the management of first episode genital herpes? , 2003, Sexually transmitted infections.

[1776]  H. Mori,et al.  Two‐component system VraSR positively modulates the regulation of cell‐wall biosynthesis pathway in Staphylococcus aureus , 2003, Molecular microbiology.

[1777]  F. Lowy,et al.  Staphylococcus aureus Colonization in a Community Sample of HIV-Infected and HIV-Uninfected Drug Users , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[1778]  Tao Dong,et al.  Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever , 2003, Nature Medicine.

[1779]  M. Goetz,et al.  Early Switch and Early Discharge Opportunities in Intravenous Vancomycin Treatment of Suspected Methicillin-Resistant Staphylococcal Species Infections , 2003, Journal of managed care pharmacy : JMCP.

[1780]  C. Segonds,et al.  Use of Amplified Ribosomal DNA Restriction Analysis for Identification of Ralstonia and Pandoraea Species: Interest in Determination of the Respiratory Bacterial Flora in Patients with Cystic Fibrosis , 2003, Journal of Clinical Microbiology.

[1781]  G. Germann,et al.  Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients. , 2003, FEMS immunology and medical microbiology.

[1782]  L. McDonald,et al.  Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus , 2003, International journal of STD & AIDS.

[1783]  S. O'Brien,et al.  Milkborne general outbreaks of infectious intestinal disease, England and Wales, 1992–2000 , 2003, Epidemiology and Infection.

[1784]  M. Diamond.  Evasion of innate and adaptive immunity by flaviviruses , 2003, Immunology and cell biology.

[1785]  F. Roudot-thoraval,et al.  Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. , 2003, American journal of respiratory and critical care medicine.

[1786]  A. Mirmohammadsadegh,et al.  Spectrum of bacterial isolates in HIV-positive patients with skin and soft tissue infections: emergence of methicillin-resistant Staphylococci , 2003, AIDS.

[1787]  Carlene A. Muto,et al.  SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.

[1788]  R. Bartenschlager,et al.  Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons , 2003, Journal of Virology.

[1789]  D. Dubnau,et al.  DNA transport during transformation. , 2003, Frontiers in bioscience : a journal and virtual library.

[1790]  R. Wenzel,et al.  Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1791]  L. Stodieck,et al.  Genetic models in applied physiology: selected contribution: effects of spaceflight on immunity in the C57BL/6 mouse. II. Activation, cytokines, erythrocytes, and platelets. , 2003, Journal of applied physiology.

[1792]  K. McAdam,et al.  Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. , 2003, Pediatrics.

[1793]  H. Zar,et al.  The impact of HIV infection and trimethoprim-sulphamethoxazole prophylaxis on bacterial isolates from children with community-acquired pneumonia in South Africa. , 2003, Journal of tropical pediatrics.

[1794]  S. Rechter,et al.  Identification of the ATP-binding site in the terminase subunit pUL56 of human cytomegalovirus. , 2003, Nucleic acids research.

[1795]  S. Sperber,et al.  Persistent MRSA bacteremia in a patient with low linezolid levels. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1796]  J. Kaneene,et al.  Campylobacter spp in human, chickens, pigs and their antimicrobial resistance. , 2003, The Journal of veterinary medical science.

[1797]  Z. Memish,et al.  Travel epidemiology: the Saudi perspective. , 2003, International journal of antimicrobial agents.

[1798]  A. Wald,et al.  Natural History of Genital Herpes Simplex Virus Type 1 Infection , 2003, Sexually transmitted diseases.

[1799]  G. Ridgway,et al.  Efficacy and Safety of Azithromycin as Monotherapy or Combined with Metronidazole Compared with Two Standard Multidrug Regimens for the Treatment of Acute Pelvic Inflammatory Disease , 2003, The Journal of international medical research.

[1800]  Jerome J. Schentag,et al.  Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1801]  G. Procop,et al.  Antimicrobial Susceptibility of Vancomycin-Resistant Enterococcus faecium: Potential Utility of Fosfomycin , 2003, Scandinavian journal of infectious diseases.

[1802]  A. Jana,et al.  Serological & virological investigation of an outbreak of dengue fever in Gwalior, India. , 2002, The Indian journal of medical research.

[1803]  E. Vinogradov,et al.  Structural analysis of Francisella tularensis lipopolysaccharide. , 2002, European journal of biochemistry.

[1804]  David A. D'Argenio,et al.  Autolysis and Autoaggregation in Pseudomonas aeruginosa Colony Morphology Mutants , 2002, Journal of bacteriology.

[1805]  A. Petersen,et al.  Impact of Integrated Fish Farming on Antimicrobial Resistance in a Pond Environment , 2002, Applied and Environmental Microbiology.

[1806]  J. Leiva,et al.  Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. , 2002, Diagnostic microbiology and infectious disease.

[1807]  L. Stodieck,et al.  The effect of space flight on the production of actinomycin D by Streptomyces plicatus , 2002, Journal of Industrial Microbiology and Biotechnology.

[1808]  R. Gie,et al.  A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[1809]  R. Purcell,et al.  Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1810]  M. Reddehase.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance , 2002, Nature Reviews Immunology.

[1811]  M. G. Woodbury,et al.  Ultraviolet light C in the treatment of chronic wounds with MRSA: a case study. , 2002, Ostomy/wound management.

[1812]  E. Burd,et al.  Late Prosthetic Hip Joint Infection with Actinomyces israelii in an Intravenous Drug User: Case Report and Literature Review , 2002, Journal of Clinical Microbiology.

[1813]  Y. Carmeli,et al.  Health and economic outcomes of vancomycin-resistant enterococci. , 2002, Archives of internal medicine.

[1814]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.

[1815]  C. Tuazon,et al.  Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1816]  C. Mark Ott,et al.  Microarray analysis identifies Salmonella genes belonging to the low-shear modeled microgravity regulon , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[1817]  Yaseen Arabi,et al.  A prospective study of prolonged stay in the intensive care unit: predictors and impact on resource utilization. , 2002, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[1818]  P. Berche,et al.  Use of 16S rRNA Gene Sequencing for Identification of Nonfermenting Gram-Negative Bacilli Recovered from Patients Attending a Single Cystic Fibrosis Center , 2002, Journal of Clinical Microbiology.

[1819]  C. Stephen,et al.  Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. , 2002, The Canadian veterinary journal = La revue veterinaire canadienne.

[1820]  G. Sonnenfeld,et al.  Immune function during space flight. , 2002, Nutrition.

[1821]  C. Prinz,et al.  Pathogenesis of Helicobacter pylori infection , 2002, Helicobacter.

[1822]  M. C. Padoveze,et al.  Nosocomial infections among HIV-positive and HIV-negative patients in a Brazilian infectious diseases unit. , 2002, American journal of infection control.

[1823]  M. O'Ryan,et al.  Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1824]  P. Nordmann,et al.  Genetic and Biochemical Characterization of CGB-1, an Ambler Class B Carbapenem-Hydrolyzing β-Lactamase from Chryseobacterium gleum , 2002, Antimicrobial Agents and Chemotherapy.

[1825]  M. Krohn,et al.  Lower Genital Tract Infection and Endometritis: Insight Into Subclinical Pelvic Inflammatory Disease , 2002, Obstetrics and gynecology.

[1826]  D. Torre,et al.  Impaired Macrophage Phagocytosis of Apoptotic Neutrophils in Patients with Human Immunodeficiency Virus Type 1 Infection , 2002, Clinical and Vaccine Immunology.

[1827]  J. Clarridge,et al.  Genotypic Diversity of Clinical Actinomyces Species: Phenotype, Source, and Disease Correlation among Genospecies , 2002, Journal of Clinical Microbiology.

[1828]  T. Besser,et al.  Multiresistant clones of Salmonella enterica: The importance of dissemination. , 2002, The Journal of laboratory and clinical medicine.

[1829]  D. Stott,et al.  Nosocomial transmission of influenza. , 2002, Occupational medicine.

[1830]  B. Lange,et al.  Evolving concepts of management of febrile neutropenia in children with cancer. , 2002, Medical and pediatric oncology.

[1831]  C. Altier,et al.  Molecular Characterization of Multidrug-Resistant Salmonella enterica subsp. enterica Serovar Typhimurium Isolates from Swine , 2002, Journal of Clinical Microbiology.

[1832]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[1833]  John W. Beaber,et al.  Genomic and Functional Analyses of SXT, an Integrating Antibiotic Resistance Gene Transfer Element Derived from Vibrio cholerae , 2002, Journal of bacteriology.

[1834]  M. Skov,et al.  Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide , 2002, European Respiratory Journal.

[1835]  Arjun Srinivasan,et al.  Vancomycin Resistance in Staphylococci , 2002, Clinical Microbiology Reviews.

[1836]  P. Wutzler,et al.  Laboratory diagnosis of central nervous system infections caused by herpesviruses. , 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[1837]  Oleg I Orlov,et al.  Telemedicine and spaceflight. , 2002, Aviation, space, and environmental medicine.

[1838]  P. Vandamme,et al.  Infection by Ralstonia Species in Cystic Fibrosis Patients: Identification of R. pickettii and R. mannitolilytica by Polymerase Chain Reaction , 2002, Emerging infectious diseases.

[1839]  B. Walker,et al.  Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities , 2002, Journal of Virology.

[1840]  L. Bianchi,et al.  Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex , 2002, Journal of Virology.

[1841]  Michael S. Gilmore,et al.  Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis , 2002, Nature.

[1842]  R. Wenzel,et al.  Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. , 2002, The New England journal of medicine.

[1843]  P. Cosson,et al.  Pseudomonas aeruginosa Virulence Analyzed in a Dictyostelium discoideum Host System , 2002, Journal of bacteriology.

[1844]  G. Deslée,et al.  Endobronchial actinomycosis associated with foreign body: four cases and a review of the literature. , 2002, Chest.

[1845]  L. John,et al.  Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections , 2002 .

[1846]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[1847]  N. Strachan,et al.  Quantitative risk assessment of human infection from Escherichia coli O157 associated with recreational use of animal pasture. , 2002, International journal of food microbiology.

[1848]  A. Nisalak,et al.  Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. , 2002, The Journal of infectious diseases.

[1849]  D. Maki,et al.  The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1850]  K. Holmes,et al.  Epidemic Lymphogranuloma Venereum During Epidemics of Crack Cocaine Use and HIV Infection in the Bahamas , 2002, Sexually transmitted diseases.

[1851]  J. Lave,et al.  Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. , 2002, American journal of obstetrics and gynecology.

[1852]  R. Gie,et al.  Pulmonary Tuberculosis : A 30-Month Follow-up Evaluation of Young Children in Contact With Adult Multidrug-Resistant , 2002 .

[1853]  P. Donald.  Childhood tuberculosis: out of control? , 2002, Current opinion in pulmonary medicine.

[1854]  J. Graybill,et al.  In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes , 2002, Antimicrobial Agents and Chemotherapy.

[1855]  Thomas Rowe,et al.  Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets , 2002, Journal of Virology.

[1856]  J. Carratalá.  The antibiotic-lock technique for therapy of 'highly needed' infected catheters. , 2002, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1857]  H. Korman,et al.  Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? , 2002, The Journal of urology.

[1858]  I. Feavers,et al.  Development of vaccines against meningococcal disease , 2002, The Lancet.

[1859]  Frederick M. Ausubel,et al.  Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation , 2002, Nature.

[1860]  A. Holzenburg,et al.  The terminase subunits pUL56 and pUL89 of human cytomegalovirus are DNA-metabolizing proteins with toroidal structure. , 2002, Nucleic acids research.

[1861]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[1862]  Z. Brown.  Case study: type-specific HSV serology and the correct diagnosis of first-episode genital herpes during pregnancy. , 2002, Herpes : the journal of the IHMF.

[1863]  Tara L. Kieffer,et al.  In Vivo Clearance of an Intracellular Bacterium, Francisella tularensis LVS, Is Dependent on the p40 Subunit of Interleukin-12 (IL-12) but Not on IL-12 p70 , 2002, Infection and Immunity.

[1864]  G. Eliopoulos,et al.  Molecular Characterization of Vancomycin-Resistant Enterococci Repopulating the Gastrointestinal Tract following Treatment with a Novel Glycolipodepsipeptide, Ramoplanin , 2002, Journal of Clinical Microbiology.

[1865]  A. Quittner,et al.  Effects of tobramycin solution for inhalation on global ratings of quality of life in patients with cystic fibrosis and Pseudomonas aeruginosa infection * † , 2002, Pediatric pulmonology.

[1866]  Robert S. Daum,et al.  Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2002, Antimicrobial Agents and Chemotherapy.

[1867]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.

[1868]  Volker Brass,et al.  An Amino-terminal Amphipathic α-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5A* , 2002, The Journal of Biological Chemistry.

[1869]  E. Bogner,et al.  ATPase Activity of the Terminase Subunit pUL56 of Human Cytomegalovirus* , 2002, The Journal of Biological Chemistry.

[1870]  E. Bogner.  Human cytomegalovirus terminase as a target for antiviral chemotherapy , 2002, Reviews in medical virology.

[1871]  Niall Johnson,et al.  Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza Pandemic , 2002, Bulletin of the history of medicine.

[1872]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1873]  J. Rello,et al.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. , 2002, Critical care medicine.

[1874]  J. Mattick,et al.  Extracellular DNA required for bacterial biofilm formation. , 2002, Science.

[1875]  J. Butts,et al.  In Vitro Assessment of Urinary Isolates of Ampicillin-Resistant Enterococci , 2002, The Annals of pharmacotherapy.

[1876]  W. Witte,et al.  Risk Factors for Nasal Carriage of Staphylococcus aureus in Infectious Disease Patients, Including Patients Infected with HIV, and Molecular Typing of Colonizing Strains , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[1877]  T. Boekhout,et al.  (1557) Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae) , 2002 .

[1878]  Joan L. Robinson,et al.  Sensitivity of a Blood Culture Drawn Through a Single Lumen of a Multilumen, Long-Term, Indwelling, Central Venous Catheter in Pediatric Oncology Patients , 2002, Journal of pediatric hematology/oncology.

[1879]  F. Carr,et al.  The Lactic Acid Bacteria: A Literature Survey , 2002, Critical reviews in microbiology.

[1880]  A. Kritski,et al.  Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. , 2001, American journal of respiratory and critical care medicine.

[1881]  J. Trappe,et al.  Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. , 2001, The Journal of antimicrobial chemotherapy.

[1882]  C. A. Wood,et al.  Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1883]  K. Lewis,et al.  Biofilms and Planktonic Cells of Pseudomonas aeruginosa Have Similar Resistance to Killing by Antimicrobials , 2001, Journal of bacteriology.

[1884]  R. Weinstein,et al.  Vancomycin-resistant enterococci: why are they here, and where do they come from? , 2001, The Lancet. Infectious diseases.

[1885]  G. Serpelloni,et al.  The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1886]  R. Kolter,et al.  DNA as a Nutrient: Novel Role for Bacterial Competence Gene Homologs , 2001, Journal of bacteriology.

[1887]  F. K. Gould,et al.  Use of antibiotic locks to treat colonized central venous catheters. , 2001, The Journal of antimicrobial chemotherapy.

[1888]  J. Sheagren,et al.  Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1889]  D. Snydman,et al.  Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study , 2001, Annals of Internal Medicine.

[1890]  H. Klenk,et al.  A Novel Nonnucleoside Inhibitor Specifically Targets Cytomegalovirus DNA Maturation via the UL89 and UL56 Gene Products , 2001, Journal of Virology.

[1891]  W. I. van der Meijden,et al.  European guideline for the management of tropical genito-ulcerative diseases , 2001, International journal of STD & AIDS.

[1892]  P. Talbot,et al.  Identification of Clinical Isolates ofActinomyces Species by Amplified 16S Ribosomal DNA Restriction Analysis , 2001, Journal of Clinical Microbiology.

[1893]  Daniel L. Feeback,et al.  Immune responses and latent herpesvirus reactivation in spaceflight. , 2001, Aviation, space, and environmental medicine.

[1894]  S. Pita,et al.  The Importance of the Removal of the Intrauterine Device in Genital Colonization by Actinomyces , 2001, Gynecologic and Obstetric Investigation.

[1895]  D. Smee,et al.  Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201. , 2001, Antiviral research.

[1896]  J. Hedegaard,et al.  Phylogeny of the genus Haemophilus as determined by comparison of partial infB sequences. , 2001, Microbiology.

[1897]  J. Trowsdale,et al.  Genetic and functional relationships between MHC and NK receptor genes. , 2001, Immunity.

[1898]  L. C. Silver,et al.  Contamination of Gowns, Gloves, and Stethoscopes With Vancomycin-Resistant Enterococci , 2001, Infection Control & Hospital Epidemiology.

[1899]  R. Titball,et al.  Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. , 2001, Vaccine.

[1900]  W. Scheithauer,et al.  Answering patients' needs: oral alternatives to intravenous therapy. , 2001, The oncologist.

[1901]  D. Weese-Mayer,et al.  Minocycline and Pseudotumor cerebri: The well-known but well-kept secret. , 2001, Pediatrics.

[1902]  M. Yasuda,et al.  Association of Mycoplasma genitalium Persistence in the Urethra With Recurrence of Nongonococcal Urethritis , 2001, Sexually transmitted diseases.

[1903]  I. Okeke,et al.  Dissemination of antibiotic-resistant bacteria across geographic borders. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1904]  A. Siddiqui,et al.  Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[1905]  N. Khardori,et al.  Interaction between biofilms formed by Staphylococcus epidermidis and quinolones. , 2001, Diagnostic microbiology and infectious disease.

[1906]  C. Hart,et al.  Neurodevelopmental outcome in meningococcal disease: a case–control study , 2001, Archives of disease in childhood.

[1907]  E. Jones,et al.  Bacterial contamination of uniforms. , 2001, The Journal of hospital infection.

[1908]  T G Hammond,et al.  Optimized suspension culture: the rotating-wall vessel. , 2001, American journal of physiology. Renal physiology.

[1909]  D. Livermore,et al.  Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. , 2001, The Journal of antimicrobial chemotherapy.

[1910]  C. Leport,et al.  Venous access port--related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1911]  R. Savel,et al.  Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. , 2001, The Journal of infectious diseases.

[1912]  D. Pierson,et al.  Microbial contamination of spacecraft. , 2001, Gravitational and space biology bulletin : publication of the American Society for Gravitational and Space Biology.

[1913]  A. Peschel,et al.  Key Role of Teichoic Acid Net Charge inStaphylococcus aureus Colonization of Artificial Surfaces , 2001, Infection and Immunity.

[1914]  H. Meir,et al.  Fever and granulocytopenia in children with acute lymphoblastic leukemia under induction therapy. , 2001, Saudi medical journal.

[1915]  M. Perkins,et al.  Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[1916]  T. Sorrell,et al.  Cryptococcus neoformans variety gattii. , 2001, Medical mycology.

[1917]  D. Dubnau,et al.  A ComGA‐dependent checkpoint limits growth during the escape from competence , 2001, Molecular microbiology.

[1918]  N. Letvin,et al.  Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys1 2 , 2001, The Journal of Immunology.

[1919]  J. Bartlett,et al.  Principles of Appropriate Antibiotic Use for Acute Pharyngitis in Adults: Background , 2001, Annals of Internal Medicine.

[1920]  M. Işler,et al.  Doxycycline-induced esophageal ulceration. , 2001, Military medicine.

[1921]  C. Venet,et al.  Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients , 2001, Intensive Care Medicine.

[1922]  W. Rabsch,et al.  Non-typhoidal salmonellosis: emerging problems. , 2001, Microbes and infection.

[1923]  R A Weinstein,et al.  Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1924]  M. Rupp,et al.  Arthralgias and myalgias related to quinupristin-dalfopristin administration. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1925]  Yee-Chun Chen,et al.  Necessity of a loading dose when using vancomycin in critically ill patients. , 2001, The Journal of antimicrobial chemotherapy.

[1926]  R. McLean,et al.  Bacterial biofilm formation under microgravity conditions. , 2001, FEMS microbiology letters.

[1927]  B. Walker,et al.  Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV , 2001, Journal of Virology.

[1928]  H. Vlamakis,et al.  Evidence for Extensive Resistance Gene Transfer amongBacteroides spp. and among Bacteroides and Other Genera in the Human Colon , 2001, Applied and Environmental Microbiology.

[1929]  Martin Brunner,et al.  Impaired target site penetration of &bgr; -lactams may account for therapeutic failure in patients with septic shock , 2001, Critical care medicine.

[1930]  J. Farrar,et al.  Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1931]  H Stammer,et al.  Nasal Carriage as a Source of Staphylococcus aureus Bacteremia , 2001 .

[1932]  S. Douthwaite,et al.  Macrolide Resistance Conferred by Base Substitutions in 23S rRNA , 2001, Antimicrobial Agents and Chemotherapy.

[1933]  O. Boillot,et al.  Postoperative infectious complications in paediatric liver transplantation: a study of 48 transplants , 2001, Paediatric anaesthesia.

[1934]  J. Karlowsky,et al.  Nitrofurantoin Is Active against Vancomycin-Resistant Enterococci , 2001, Antimicrobial Agents and Chemotherapy.

[1935]  R. Aebersold,et al.  Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. , 2000, Virology.

[1936]  E. Sondik,et al.  Annual summary of vital statistics: trends in the health of Americans during the 20th century. , 2000, Pediatrics.

[1937]  T. Pennington.  VTEC: lessons learned from British outbreaks , 2000, Symposium series.

[1938]  R. Hancock,et al.  Interactions of Bacterial Cationic Peptide Antibiotics with Outer and Cytoplasmic Membranes ofPseudomonas aeruginosa , 2000, Antimicrobial Agents and Chemotherapy.

[1939]  A. Gasbarrini,et al.  A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates , 2000, Alimentary pharmacology & therapeutics.

[1940]  J. Turnidge,et al.  Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis , 2000, Antimicrobial Agents and Chemotherapy.

[1941]  B. Fantin,et al.  Activity of LY333328 Combined with Gentamicin In Vitro and in Rabbit Experimental Endocarditis Due to Vancomycin-Susceptible or -Resistant Enterococcus faecalis , 2000, Antimicrobial Agents and Chemotherapy.

[1942]  A. Takahashi,et al.  Analysis of deletion mutations of the rpsL gene in the yeast Saccharomyces cerevisiae detected after long-term flight on the Russian space station Mir. , 2000, Mutation research.

[1943]  F. Crokaert.  Febrile neutropenia in children. , 2000, International journal of antimicrobial agents.

[1944]  W. Kern.  Modifications of therapy. , 2000, International journal of antimicrobial agents.

[1945]  K. Radsak,et al.  The potential terminase subunit of human cytomegalovirus, pUL56, is translocated into the nucleus by its own nuclear localization signal and interacts with importin alpha. , 2000, The Journal of general virology.

[1946]  D. Margolis,et al.  Cutaneous Microenvironment of Human Immunodeficiency Virus (HIV)-Seropositive and HIV-Seronegative Individuals, with Special Reference to Staphylococcus aureus Colonization , 2000, Journal of Clinical Microbiology.

[1947]  S. Gillespie,et al.  Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. , 2000, The Journal of infection.

[1948]  C Friis,et al.  Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1949]  P. Hsueh,et al.  Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. , 2000, Diagnostic microbiology and infectious disease.

[1950]  A J Elliott,et al.  BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. , 2000, Journal of medicinal chemistry.

[1951]  C. Walsh.  Molecular mechanisms that confer antibacterial drug resistance , 2000, Nature.

[1952]  G. Overturf.  Technical Report: Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate and Polysaccharide Vaccines and Antibiotic Prophylaxis , 2000, Pediatrics.

[1953]  R. Alm,et al.  Involvement of a Plasmid in Virulence of Campylobacter jejuni 81-176 , 2000, Infection and Immunity.

[1954]  W. J. McBride,et al.  Dengue viral infections; pathogenesis and epidemiology. , 2000, Microbes and infection.

[1955]  M. Terris,et al.  Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. , 2000, The Journal of urology.

[1956]  L. Casimir,et al.  Oral administration of cefixime to lower risk febrile neutropenic children with cancer , 2000, Cancer.

[1957]  C. Brun-Buisson,et al.  New tools in diagnosing catheter-related infections , 2000, Supportive Care in Cancer.

[1958]  N. Gay,et al.  The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes , 2000, Sexually transmitted infections.

[1959]  C. Mark Ott,et al.  Microgravity as a Novel Environmental Signal Affecting Salmonella enterica Serovar Typhimurium Virulence , 2000, Infection and Immunity.

[1960]  P. Wutzler,et al.  Virological diagnosis of herpes simplex encephalitis. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[1961]  H. Doerr,et al.  Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations—relevance for the incidence of genital herpes , 2000, Journal of medical virology.

[1962]  P. Varaldo,et al.  Glycopeptide Resistance in Coagulase-Negative Staphylococci , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[1963]  D. G. Muir,et al.  Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. , 2000, Immunity.

[1964]  S. Chaudhry,et al.  Actinomycosis in HIV infection: a review of a rare complication , 2000, International journal of STD & AIDS.

[1965]  D. Stephens,et al.  Epidemiology and pathogenesis of Neisseria meningitidis. , 2000, Microbes and infection.

[1966]  M. Manns,et al.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C , 2000, Nature Medicine.

[1967]  R. Gilman,et al.  Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru. , 2000, The Journal of infectious diseases.

[1968]  M. Cucchiarini,et al.  Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. , 2000, The Journal of infectious diseases.

[1969]  S. Beck,et al.  Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1970]  H. Einsele,et al.  Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection , 2000, Bone Marrow Transplantation.

[1971]  M. Aron,et al.  Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study , 2000, BJU international.

[1972]  Y. Liu,et al.  hexA of Erwinia carotovora ssp. carotovora strain Ecc71 negatively regulates production of RpoS and rsmB RNA, a global regulator of extracellular proteins, plant virulence and the quorum-sensing signal, N-(3-oxohexanoyl)-L-homoserine lactone. , 2000, Environmental microbiology.

[1973]  M. Cusini,et al.  Mycoplasma genitalium in Males With Nongonococcal Urethritis: Prevalence and Clinical Efficacy of Eradication , 2000, Sexually transmitted diseases.

[1974]  R. Bartenschlager,et al.  Replication of hepatitis C virus. , 2000, The Journal of general virology.

[1975]  A. Wald,et al.  Herpes simplex virus: the importance of asymptomatic shedding. , 2000, The Journal of antimicrobial chemotherapy.

[1976]  M. Kuroda,et al.  Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. , 2000, Biochemical and biophysical research communications.

[1977]  B. Murray,et al.  Vancomycin-resistant enterococcal infections. , 2000, The New England journal of medicine.

[1978]  Laurent Kaiser,et al.  Influenza virus neuraminidase inhibitors , 2000, The Lancet.

[1979]  Jennifer A. Roberts,et al.  Escherichia coli O157:H7; an economic assessment of an outbreak. , 2000, Journal of public health medicine.

[1980]  G. Gottlieb,et al.  Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[1981]  K. Marr.  Staphylococcus aureus Bacteremia in Patients Undergoing Hemodialysis , 2000, Seminars in dialysis.

[1982]  J. Gerberding,et al.  Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. , 1999, The Journal of infectious diseases.

[1983]  J. Burns,et al.  Activities of Tobramycin and Six Other Antibiotics against Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis , 1999, Antimicrobial Agents and Chemotherapy.

[1984]  K. M. Lee,et al.  Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[1985]  C. Rouzioux,et al.  Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. , 1999, The Journal of clinical investigation.

[1986]  B. Williams,et al.  PKR; a sentinel kinase for cellular stress , 1999, Oncogene.

[1987]  G. Arlet,et al.  Diagnosis of venous access port-related infections. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1988]  F. Vandenesch,et al.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1989]  S. Morse,et al.  Chancroid, primary syphilis, genital herpes, and lymphogranuloma venereum in Antananarivo, Madagascar. , 1999, The Journal of infectious diseases.

[1990]  R. Purcell,et al.  Quasispecies in viral persistence and pathogenesis of hepatitis C virus. , 1999, Trends in microbiology.

[1991]  A. Alonso,et al.  Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. , 1999, Microbiology.

[1992]  T. Santantonio,et al.  Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. , 1999, Gastroenterology.

[1993]  C. Brun-Buisson,et al.  Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures , 1999, The Lancet.

[1994]  K. Chik,et al.  Bone marrow transplantation for chronic granulomatous disease: long-term follow-up and review of literature , 1999, Bone Marrow Transplantation.

[1995]  M Schacke,et al.  Laboratory diagnosis of herpes zoster. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[1996]  B. Tümmler,et al.  Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1997]  T. R. Licht,et al.  Plasmid transfer in the animal intestine and other dynamic bacterial populations: the role of community structure and environment. , 1999, Microbiology.

[1998]  S. Zinner.  Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[1999]  N. M. Dung,et al.  Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2000]  L. Simonsen.  The global impact of influenza on morbidity and mortality. , 1999, Vaccine.

[2001]  A. Adimora,et al.  Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. , 1999, JAMA.

[2002]  P. Domingo,et al.  Morbidity associated with long-term use of totally implantable ports in patients with AIDS. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2003]  G. Wormser,et al.  Tropical Infectious Diseases: Principles, Pathogens, and Practice , 1999 .

[2004]  D. R. Taylor,et al.  Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.

[2005]  C. Cunningham-Rundles,et al.  Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.

[2006]  N. Cox,et al.  A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans , 1999, Journal of Virology.

[2007]  S. Shah,et al.  Disorganization of cell division of methicillin-resistant Staphylococcus aureus by a component of tea (Camellia sinensis): a study by electron microscopy. , 1999, FEMS microbiology letters.

[2008]  R. Salmon,et al.  The surveillance of vero cytotoxin-producing Escherichia coli O157 in Wales, 1990 to 1998. , 1999, Emerging infectious diseases.

[2009]  I. Xess,et al.  The first major outbreak of dengue hemorrhagic fever in Delhi, India. , 1999, Emerging infectious diseases.

[2010]  G. Collin.  Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. , 1999, Chest.

[2011]  D. Baltimore,et al.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. , 1999, Immunity.

[2012]  E. De Clercq,et al.  The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling. , 1999, AIDS.

[2013]  G. d’Ettorre,et al.  Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. , 1999, AIDS.

[2014]  D. Steinhauer,et al.  Role of hemagglutinin cleavage for the pathogenicity of influenza virus. , 1999, Virology.

[2015]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[2016]  E Maier,et al.  Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. , 1999, Biochemistry.

[2017]  A. Blum,et al.  Effect of Whey-Based Culture Supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori Infection in Humans , 1999, Digestion.

[2018]  I. Hoffman,et al.  Genital ulcers: etiology, clinical diagnosis, and associated human immunodeficiency virus infection in Kingston, Jamaica. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2019]  Mohamed O. Elasri,et al.  Study of the Response of a Biofilm Bacterial Community to UV Radiation , 1999, Applied and Environmental Microbiology.

[2020]  J. Costerton,et al.  Introduction to biofilm. , 1999, International journal of antimicrobial agents.

[2021]  R. Gie,et al.  Childhood tuberculosis in an urban population in South Africa: burden and risk factor , 1999, Archives of disease in childhood.

[2022]  A. Nisalak,et al.  Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. , 1999, The Journal of infectious diseases.

[2023]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[2024]  R. Gaynes,et al.  Nosocomial Infections in Pediatric Intensive Care Units in the United States , 1999, Pediatrics.

[2025]  H. Domdey,et al.  Safety and Immunogenicity of a Pseudomonas aeruginosa Hybrid Outer Membrane Protein F-I Vaccine in Human Volunteers , 1999, Infection and Immunity.

[2026]  M S Pepe,et al.  Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. , 1999, The New England journal of medicine.

[2027]  O. Wenker,et al.  A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. , 1999, The New England journal of medicine.

[2028]  R. Pinner,et al.  Trends in infectious disease mortality in the United States during the 20th century. , 1999, JAMA.

[2029]  P. Brand,et al.  Systematic review of N‐acetylcysteine in cystic fibrosis , 1999, Acta paediatrica.

[2030]  A. Conde.  Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[2031]  B. Azadian,et al.  An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) infection in HIV-seropositive persons , 1998, International journal of STD & AIDS.

[2032]  Madhur Kumar,et al.  Antisense RNA: Function and Fate of Duplex RNA in Cells of Higher Eukaryotes , 1998, Microbiology and Molecular Biology Reviews.

[2033]  W. Bilker,et al.  The role of chloramphenicol in the treatment of bloodstream infection due to vancomycin-resistant Enterococcus. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2034]  D. Horn,et al.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.

[2035]  J. Gatell,et al.  Influence of human immunodeficiency virus 1 infection and degree of immunosuppression in the clinical characteristics and outcome of infective endocarditis in intravenous drug users. , 1998, Archives of internal medicine.

[2036]  P. K. Sullivan,et al.  The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro. , 1998, Ostomy/wound management.

[2037]  D. Kapoor,et al.  Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. , 1998, Urology.

[2038]  R. Podschun,et al.  Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors , 1998, Clinical Microbiology Reviews.

[2039]  Mi Young Kim,et al.  Thoracic actinomycosis: CT findings. , 1998, Radiology.

[2040]  L. Bopp,et al.  Comparison of Inhibitory and Bactericidal Activities and Postantibiotic Effects of LY333328 and Ampicillin Used Singly and in Combination against Vancomycin-Resistant Enterococcus faecium , 1998, Antimicrobial Agents and Chemotherapy.

[2041]  B. Iglewski,et al.  Cell-to-cell signaling and Pseudomonas aeruginosa infections. , 1998, Emerging infectious diseases.

[2042]  H. Goossens,et al.  Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients , 1998, Leukemia.

[2043]  I. Callaghan,et al.  Bacterial contamination of nurses' uniforms: a study. , 1998, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2044]  D. Nathwani,et al.  SKIN AND SOFT TISSUE INFECTIONS: DEVELOPMENT OF A COLLABORATIVE MANAGEMENT PLAN BETWEEN COMMUNITY AND HOSPITAL CARE , 1998, International journal of clinical practice.

[2045]  L. Casimir,et al.  Fever and neutropenia in children with cancer in one pediatric hospital in Argentina. , 1998, Pediatric hematology and oncology.

[2046]  Michael G. Katze,et al.  Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.

[2047]  G. French.  Enterococci and vancomycin resistance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2048]  A. Capon,et al.  The epidemiology of tuberculosis in New South Wales 1975-1995: the effects of immigration in a low prevalence population. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2049]  A. Aggarwal,et al.  An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. , 1998, Indian pediatrics.

[2050]  G. Meduri,et al.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. , 1998, JAMA.

[2051]  F. Mégraud,et al.  Clinical Relevance of resistant strains of Helicobacter pylori: a review of current data , 1998, Gut.

[2052]  W. Whitman,et al.  Prokaryotes: the unseen majority. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2053]  R. Ptak,et al.  Resistance of Human Cytomegalovirus to Benzimidazole Ribonucleosides Maps to Two Open Reading Frames: UL89 and UL56 , 1998, Journal of Virology.

[2054]  S. Siram,et al.  Appropriateness of a 4 mg/kg gentamicin or tobramycin loading dose in post‐operative septic shock patients , 1998, Journal of clinical pharmacy and therapeutics.

[2055]  A. Stacey,et al.  An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. , 1998, British journal of sports medicine.

[2056]  D. Thompson,et al.  Historical Yearly Usage of Vancomycin , 1998, Antimicrobial Agents and Chemotherapy.

[2057]  D. Klaus,et al.  The effects of space flight on the production of monorden by Humicola fuscoatra WC5157 in solid-state fermentation , 1998, Applied Microbiology and Biotechnology.

[2058]  G. Heller,et al.  Septicemia and Septic Shock in Pediatric Patients: 140 Consecutive Cases on a Pediatric Hematology‐Oncology Service , 1998, Journal of pediatric hematology/oncology.

[2059]  J. Carney,et al.  Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. , 1998, Archives of internal medicine.

[2060]  M. Stinski,et al.  The Gene Product of Human Cytomegalovirus Open Reading Frame UL56 Binds the pac Motif and Has Specific Nuclease Activity , 1998, Journal of Virology.

[2061]  Norbert Bischofberger,et al.  Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 , 1998, Antimicrobial Agents and Chemotherapy.

[2062]  R. Sidwell,et al.  Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection , 1998, Antimicrobial Agents and Chemotherapy.

[2063]  I. Horváth,et al.  Effect of inhaled l-arginine on exhaled nitric oxide in normal and asthmatic subjects , 1998, Thorax.

[2064]  R. Weinstein,et al.  Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. , 1998, The Journal of infectious diseases.

[2065]  R. Hancock,et al.  Cationic peptides: a new source of antibiotics. , 1998, Trends in biotechnology.

[2066]  A. Buzaid,et al.  A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin‐2 , 1998, Cancer.

[2067]  L. Townsend,et al.  Inhibition of Human Cytomegalovirus DNA Maturation by a Benzimidazole Ribonucleoside Is Mediated through the UL89 Gene Product , 1998, Journal of Virology.

[2068]  Y. Fukuchi,et al.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin , 1997, The Lancet.

[2069]  F. Lowy,et al.  Staphylococcus aureus nasal colonization in HIV-seropositive and HIV-seronegative drug users. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[2070]  P. Todd,et al.  Growth characteristics of E. coli and B. subtilis cultured on an agar substrate in microgravity , 1997 .

[2071]  M. Luttges,et al.  Low gravity and inertial effects on the growth of E. coli and B. subtilis in semi-solid media. , 1997, Aviation, space, and environmental medicine.

[2072]  P Parham,et al.  Human diversity in killer cell inhibitory receptor genes. , 1997, Immunity.

[2073]  W. Coulter,et al.  Oral shedding of herpes simplex virus type 1: a review. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[2074]  R. Doms,et al.  A Small-molecule Inhibitor Directed against the Chemokine Receptor CXCR4 Prevents its Use as an HIV-1 Coreceptor , 1997, The Journal of experimental medicine.

[2075]  P. Nordmann,et al.  OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa , 1997, Antimicrobial agents and chemotherapy.

[2076]  W. D’hoore,et al.  Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. , 1997, The Journal of hospital infection.

[2077]  J. Figueroa,et al.  A comparison of prevalence rates of genital ulcers among persons attending a sexually transmitted disease clinic in Jamaica. , 1997, The West Indian medical journal.

[2078]  F. Bazzoli,et al.  Therapy of H. pylori infection. , 1997, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2079]  Kunitomo Watanabe,et al.  Susceptibilities of Actinomyces species and Propionibacterium propionicus to antimicrobial agents. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2080]  C. Henderson,et al.  Effect of prenatal and infancy home visitation by nurses on pregnancy outcomes, childhood injuries, and repeated childbearing. A randomized controlled trial. , 1997, JAMA.

[2081]  K. Marr,et al.  Catheter-Related Bacteremia and Outcome of Attempted Catheter Salvage in Patients Undergoing Hemodialysis , 1997, Annals of Internal Medicine.

[2082]  J. Hawker,et al.  The epidemiology of tuberculosis by ethnic group in Birmingham and its implications for future trends in tuberculosis in the UK. , 1997, Ethnicity & health.

[2083]  A. Harries,et al.  The pattern of tuberculosis in Queen Elizabeth Central Hospital, Blantyre, Malawi: 1986-1995. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2084]  R. Gaynes,et al.  Nosocomial infections in HIV-infected patients: preliminary results from a multicenter surveillance system (1989-1995). , 1997 .

[2085]  I. Golovliov,et al.  Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein , 1997, Infection and immunity.

[2086]  A. Zibert,et al.  Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus , 1997, Journal of virology.

[2087]  M. Ramsay,et al.  Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. , 1997, Communicable disease report. CDR review.

[2088]  A. Yousef,et al.  Adaptation to sublethal environmental stresses protects Listeria monocytogenes against lethal preservation factors , 1997, Applied and environmental microbiology.

[2089]  D. Shapiro,et al.  Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis , 1997, Journal of clinical microbiology.

[2090]  S. Iyobe,et al.  A search for Pseudomonas alginate biosynthesis inhibitors from microbial metabolites. , 1997, The Journal of antibiotics.

[2091]  J. Zeh,et al.  Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. , 1997, The Journal of clinical investigation.

[2092]  T. Marrie,et al.  Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. , 1997, Journal of the American Academy of Dermatology.

[2093]  S. Chanock,et al.  Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects. , 1997, Seminars in oncology.

[2094]  B. Tümmler,et al.  Direct sputum analysis of Pseudomonas aeruginosa macrorestriction fragment genotypes in patients with cystic fibrosis , 1997, Medical Microbiology and Immunology.

[2095]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[2096]  M. Rao,et al.  Field trial of a locally produced, killed, oral cholera vaccine in Vietnam , 1997, The Lancet.

[2097]  M. Shapiro,et al.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2098]  K. Mullane,et al.  Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. , 1996, The Journal of clinical investigation.

[2099]  A. Lamond,et al.  Characterization of the nuclear protein import mechanism using Ran mutants with altered nucleotide binding specificities. , 1996, The EMBO journal.

[2100]  Q. Chen,et al.  [Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine]. , 1996, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[2101]  E. Martin,et al.  Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients , 1996, Intensive Care Medicine.

[2102]  R. Spiller,et al.  Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study , 1996, Helicobacter.

[2103]  G. Sandström,et al.  Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins , 1996, Infection and immunity.

[2104]  C. G. Mayhall,et al.  Prevention and control of vancomycin resistance in gram-positive coccal microorganisms: fire prevention and fire fighting. , 1996 .

[2105]  K. Holmes,et al.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. , 1996, The New England journal of medicine.

[2106]  L. Fisher,et al.  Presumptive specific clinical diagnosis of genital ulcer disease (GUD) in a primary health care setting in Nairobi , 1996, International journal of STD & AIDS.

[2107]  W. Jarvis,et al.  Prevention of Nosocomial Bloodstream Infections: A National and International Priority , 1996, Infection Control & Hospital Epidemiology.

[2108]  R. Leclercq,et al.  Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. , 1996, The Journal of infectious diseases.

[2109]  C. Regamey,et al.  Disseminated infection due to Actinomyces meyeri: case report and review. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2110]  L. Hutwagner,et al.  Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group , 1996, Journal of clinical microbiology.

[2111]  J. Davies,et al.  Origins and Evolution of Antibiotic Resistance , 1996, Microbiology and Molecular Biology Reviews.

[2112]  E. Martin,et al.  Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. , 1996, The Journal of antimicrobial chemotherapy.

[2113]  R. Gie,et al.  A decade of experience with Mycobacterium tuberculosis culture from children: a seasonal influence on incidence of childhood tuberculosis. , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2114]  F. Hayden,et al.  Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. , 1996, JAMA.

[2115]  J. Mattick,et al.  Identification of a novel gene, pilZ, essential for type 4 fimbrial biogenesis in Pseudomonas aeruginosa , 1996, Journal of bacteriology.

[2116]  T. Hadfield,et al.  Demonstration of Chlamydia trachomatis in inguinal lymphadenitis of lymphogranuloma venereum: a light microscopy, electron microscopy and polymerase chain reaction study. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2117]  J. Bauman,et al.  QT Interval Prolongation and Torsades de Pointes Due to Erythromycin Lactobionate , 1995, Pharmacotherapy.

[2118]  E. Helm,et al.  Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. , 1995, European journal of medical research.

[2119]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[2120]  M. Kron,et al.  Randomized, controlled trial of amoxicillin prophylaxis for prevention of catheter-related infections in newborn infants with central venous silicone elastomer catheters. , 1995, The Journal of pediatrics.

[2121]  N. Khardori,et al.  Tolerance ofStaphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents , 1995, Journal of Industrial Microbiology.

[2122]  J. Mainardi,et al.  Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis , 1995, Antimicrobial agents and chemotherapy.

[2123]  J. Smilack.  Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 1995 .

[2124]  R. Fleischmann,et al.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.

[2125]  C S Berkey,et al.  The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.

[2126]  G. J. Taylor,et al.  Wound disinfection with ultraviolet radiation. , 1995, The Journal of hospital infection.

[2127]  G. Jacoby,et al.  A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.

[2128]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[2129]  J. Bagg,et al.  Experience with a novel selective medium for isolation of Actinomyces spp. from medical and dental specimens , 1995, Journal of clinical microbiology.

[2130]  H. Domdey,et al.  Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins , 1995, Infection and immunity.

[2131]  C. Jagannath,et al.  Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies. , 1995, American journal of respiratory and critical care medicine.

[2132]  I. Kilpeläinen,et al.  Lipopolysaccharides of polymyxin B‐resistant mutants of Escherichia coii are extensively substituted by 2‐aminoethyl pyrophosphate and contain aminoarabinose in lipid A , 1995, Molecular microbiology.

[2133]  G. Gurzadyan,et al.  Ultraviolet (193, 216 and 254 nm) photoinactivation of Escherichia coli strains with different repair deficiencies. , 1995, Radiation research.

[2134]  F. Chisari,et al.  Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.

[2135]  M. Levine,et al.  Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O , 1995, Infection and immunity.

[2136]  J. Miller,et al.  Evaluation of API An-IDENT and RapID ANA II systems for identification of Actinomyces species from clinical specimens , 1995, Journal of clinical microbiology.

[2137]  Martin A. Nowak,et al.  Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.

[2138]  A. Bush,et al.  Effects of Pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis , 1995, Pediatric pulmonology.

[2139]  J. Lam,et al.  Monoclonal antibodies that distinguish inner core, outer core, and lipid A regions of Pseudomonas aeruginosa lipopolysaccharide , 1994, Journal of bacteriology.

[2140]  L. Corey,et al.  Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection , 1994, Annals of Internal Medicine.

[2141]  K. Shimotohno,et al.  Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. , 1994, Biochemical and biophysical research communications.

[2142]  L. Grinius,et al.  Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump. , 1994, The Journal of biological chemistry.

[2143]  W. Hiddemann,et al.  Interventional antimicrobial therapy in febrile neutropenic patients , 1994, Annals of Hematology.

[2144]  C. Elbim,et al.  Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming. , 1994, Blood.

[2145]  M. G. Lorenz,et al.  Bacterial gene transfer by natural genetic transformation in the environment. , 1994, Microbiological reviews.

[2146]  B. Roizman,et al.  Herpes simplex genes: the blueprint of a successful human pathogen. , 1994, Trends in genetics : TIG.

[2147]  A. Sjöstedt,et al.  Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection , 1994, Infection and immunity.

[2148]  P. Chyou,et al.  Helicobacter pylori Infection and the Risk for Duodenal and Gastric Ulceration , 1994, Annals of Internal Medicine.

[2149]  L. Putcha,et al.  Factors Affecting Drug Bioavailability in Space , 1994, Journal of clinical pharmacology.

[2150]  C. Woldringh,et al.  Behavior of bacteria and antibiotics under space conditions. , 1994, Aviation, space, and environmental medicine.

[2151]  S. Harthug,et al.  A longitudinal study of phagocyte function in HIV‐infected patients , 1994, AIDS.

[2152]  J. Mouton,et al.  Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model , 1994, Antimicrobial Agents and Chemotherapy.

[2153]  J. Bartlett.  Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2154]  Z Lewandowski,et al.  Biofilms, the customized microniche , 1994, Journal of bacteriology.

[2155]  A. Chaudhuri,et al.  A severe outbreak of E. coli O157 in two psychogeriatric wards. , 1994, Journal of public health medicine.

[2156]  E. Vollaard,et al.  Colonization resistance , 1994, Antimicrobial Agents and Chemotherapy.

[2157]  R. Stephens,et al.  Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan‐dependent mechanism for infection of eukaryotic cells , 1994, Molecular microbiology.

[2158]  D. Armstrong,et al.  Infectious Morbidity Associated with Long-Term Use of Venous Access Devices in Patients with Cancer , 1993, Annals of Internal Medicine.

[2159]  F. Melchior,et al.  Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor [published erratum appears in J Cell Biol 1994 Jan;124(1-2):217] , 1993, The Journal of cell biology.

[2160]  B. Walker,et al.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV , 1993, Journal of virology.

[2161]  L. Poulsen,et al.  Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice , 1993, Infection and immunity.

[2162]  E. Mini,et al.  Adverse Effects of Macrolide Antibacterials , 1993, Drug safety.

[2163]  Suharyono,et al.  Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children. , 1993, The Journal of infectious diseases.

[2164]  G. Pier,et al.  Inhibition of adherence of mucoid Pseudomonas aeruginosa by alginase, specific monoclonal antibodies, and antibiotics , 1993, Infection and immunity.

[2165]  D. Podzamczer,et al.  A prospective study of the risk of tuberculosis among HIV‐infected patients , 1993, AIDS.

[2166]  B. Cookson,et al.  Vancomycin-resistant enterococci , 1993, The Lancet.

[2167]  G. King,et al.  Application of a Tetrazolium Salt with a Water-Soluble Formazan as an Indicator of Viability in Respiring Bacteria , 1993, Applied and environmental microbiology.

[2168]  K. Radsak,et al.  Identification of the gene product encoded by ORF UL56 of the human cytomegalovirus genome. , 1993, Virology.

[2169]  G. Taylor.  Immune changes during short‐duration missions , 1993, Journal of leukocyte biology.

[2170]  M. Struelens,et al.  Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients , 1993, Journal of clinical microbiology.

[2171]  S. Rojanasuphot,et al.  Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. , 1993, Pediatrics.

[2172]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[2173]  P. Pizzo,et al.  Management of fever in patients with cancer and treatment-induced neutropenia. , 1993, The New England journal of medicine.

[2174]  A. Fortier,et al.  T-cell-independent resistance to infection and generation of immunity to Francisella tularensis , 1993, Infection and immunity.

[2175]  J. W. Conlan,et al.  Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes , 1992, Infection and immunity.

[2176]  Suharyono,et al.  Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children , 1992, The Lancet.

[2177]  G. Bodey,et al.  Infectious complications of indwelling vascular catheters. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2178]  S. Thompson,et al.  Pelvic Inflammatory Disease and Fertility: A Cohort Study of 1,844 Women with Laparoscopically Verified Disease and 657 Control Women with Normal Laparoscopic Results , 1992, Sexually transmitted diseases.

[2179]  A. Tärnvik,et al.  Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium , 1992, Infection and immunity.

[2180]  K. Schaal,et al.  Actinomycete infections in humans--a review. , 1992, Gene.

[2181]  A. Weiner,et al.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution , 1992, Journal of virology.

[2182]  D. Frappaz,et al.  [Study of serum kinetics of vancomycin during the "antibiotic-lock" technique]. , 1992, Archives francaises de pediatrie.

[2183]  R. Furth,et al.  Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients , 1992, Clinical and experimental immunology.

[2184]  M S Chandler,et al.  The gene encoding cAMP receptor protein is required for competence development in Haemophilus influenzae Rd. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2185]  R. Lanciotti,et al.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction , 1992, Journal of clinical microbiology.

[2186]  D. Graham,et al.  Factors influencing the eradication of Helicobacter pylori with triple therapy. , 1992, Gastroenterology.

[2187]  M. Aymard,et al.  Occurrence and characterization of acyclovir‐resistant herpes simplex virus isolates: Report on a two—year sensitivity screening survey , 1992, Journal of medical virology.

[2188]  D. Wong,et al.  Microbial flora on doctors' white coats. , 1991, BMJ.

[2189]  I. Bakker-Woudenberg,et al.  Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin inKlebsiella pneumoniae pneumonia and septicemia in leukopenic rats , 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[2190]  D. Prapotnich,et al.  Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. , 1991, The Journal of urology.

[2191]  M. Blaser,et al.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.

[2192]  S. Adam,et al.  Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import , 1991, Cell.

[2193]  M. Meltzer,et al.  Live vaccine strain of Francisella tularensis: infection and immunity in mice , 1991, Infection and immunity.

[2194]  R. Burke,et al.  Growth of Francisella spp. in rodent macrophages , 1991, Infection and immunity.

[2195]  C. Crumpacker,et al.  A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. , 1991, The New England journal of medicine.

[2196]  J. Emond,et al.  Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. , 1991, Reviews of infectious diseases.

[2197]  D. Ellis,et al.  Environmental isolation of Cryptococcus neoformans gattii from California. , 1991, The Journal of infectious diseases.

[2198]  H. Endtz,et al.  Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. , 1991, The Journal of antimicrobial chemotherapy.

[2199]  P. Trieu-Cuot,et al.  Inducible transfer of conjugative transposon Tn1545 from Enterococcus faecalis to Listeria monocytogenes in the digestive tracts of gnotobiotic mice , 1991, Antimicrobial Agents and Chemotherapy.

[2200]  T. Littlejohn,et al.  Efflux‐mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline‐ and sugar‐transport proteins , 1990, Molecular microbiology.

[2201]  D. Sack,et al.  Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. , 1990, Vaccine.

[2202]  A. Nesburn,et al.  Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript , 1990, Journal of virology.

[2203]  M P Weinstein,et al.  Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. , 1990, The Journal of infectious diseases.

[2204]  K. Rand,et al.  Daily stress and recurrence of genital herpes simplex. , 1990, Archives of internal medicine.

[2205]  Gl Ridgway,et al.  Principles and Practice of Infectious Diseases , 1990 .

[2206]  C. Murray,et al.  Tuberculosis in developing countries: burden, intervention and cost. , 1990, Bulletin of the International Union against Tuberculosis and Lung Disease.

[2207]  Yunus,et al.  Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up , 1990, The Lancet.

[2208]  B. Murray.  The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.

[2209]  Anusha,et al.  Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory , 1990, Journal of clinical microbiology.

[2210]  N. G. Nair,et al.  Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro , 1989, Journal of clinical microbiology.

[2211]  L. Gutmann,et al.  In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria , 1989, European Journal of Clinical Microbiology and Infectious Diseases.

[2212]  P. Murray,et al.  In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis , 1989, Antimicrobial Agents and Chemotherapy.

[2213]  R. Sweet,et al.  Pelvic inflammatory disease in adolescent females. Epidemiology, pathogenesis, diagnosis, treatment, and sequelae. , 1989, Pediatric clinics of North America.

[2214]  J. Fuhrer,et al.  Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates , 1989, Journal of clinical microbiology.

[2215]  H. Krumholz,et al.  Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. , 1989, The American journal of medicine.

[2216]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[2217]  M. Soules,et al.  A Comparison of the Fallopian Tube's Response to Overt and Silent Salpingitis , 1989, Obstetrics and gynecology.

[2218]  T. Olson,et al.  Actinomycosis of the middle ear. , 1989, International journal of pediatric otorhinolaryngology.

[2219]  M. Cairo,et al.  Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. , 1988, The Journal of infectious diseases.

[2220]  R. Ramphal,et al.  The binding of anti-pseudomonal antibiotics to macromolecules from cystic fibrosis sputum. , 1988, The Journal of antimicrobial chemotherapy.

[2221]  A. Fauci,et al.  Impairment of neutrophil bactericidal capacity in patients with AIDS. , 1988, The Journal of infectious diseases.

[2222]  D. Sack,et al.  IMPACT OF B SUBUNIT KILLED WHOLE-CELL AND KILLED WHOLE-CELL-ONLY ORAL VACCINES AGAINST CHOLERA UPON TREATED DIARRHOEAL ILLNESS AND MORTALITY IN AN AREA ENDEMIC FOR CHOLERA , 1988, The Lancet.

[2223]  B. Messing,et al.  Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[2224]  S. Halstead,et al.  Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.

[2225]  P. Futrakul,et al.  Hemodynamic response to high-dose methyl prednisolone and mannitol in severe dengue-shock patients unresponsive to fluid replacement. , 1987, The Southeast Asian journal of tropical medicine and public health.

[2226]  S. Straus,et al.  Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model. , 1987, Journal of the American Academy of Dermatology.

[2227]  K. Rolston,et al.  Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. , 1987, The American journal of medicine.

[2228]  M. S. St. Louis,et al.  Chloramphenicol-resistant Salmonella newport traced through hamburger to dairy farms. A major persisting source of human salmonellosis in California. , 1987, The New England journal of medicine.

[2229]  H. V. van Saene,et al.  Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation. , 1987, Reviews of infectious diseases.

[2230]  B. Rowe,et al.  Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. , 1986, British medical journal.

[2231]  J. Levy.  Antibiotic activity in sputum. , 1986, The Journal of pediatrics.

[2232]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[2233]  A. Minson,et al.  Detection of herpes simplex virus-specific DNA sequences in latently infected mice and in humans , 1986, Journal of virology.

[2234]  W. Boll,et al.  Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus , 1986, Cell.

[2235]  E. Bottone,et al.  Isolation of highly encapsulated Cryptococcus neoformans serotype B from a patient in New York City , 1986, Journal of clinical microbiology.

[2236]  O. Garden,et al.  Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? , 1985, The Journal of hospital infection.

[2237]  W. Cates,et al.  Self-reported pelvic inflammatory disease in the US: a common occurrence. , 1985, American journal of public health.

[2238]  T. Yokota,et al.  Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus , 1985, Antimicrobial Agents and Chemotherapy.

[2239]  R. Qualls,et al.  UV inactivation of pathogenic and indicator microorganisms , 1985, Applied and environmental microbiology.

[2240]  B. Ramsey,et al.  Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. , 1985, The American review of respiratory disease.

[2241]  A. Sitges-Serra,et al.  Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments , 1985, Journal of clinical microbiology.

[2242]  H. Jordan,et al.  Enhancement of experimental actinomycosis in mice by Eikenella corrodens , 1984, Infection and immunity.

[2243]  R. Reichman.  Herpes simplex virus infections , 1984, European Journal of Clinical Microbiology.

[2244]  D. Bennhoff.  Actinomycosis: Diagnostic and therapeutic considerations and a review of 32 cases , 1984, The Laryngoscope.

[2245]  A Cogoli,et al.  Cell sensitivity to gravity. , 1984, Science.

[2246]  K. Kwon-Chung,et al.  Epidemiologic differences between the two varieties of Cryptococcus neoformans. , 1984, American journal of epidemiology.

[2247]  A. Fauci,et al.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. , 1983, The New England journal of medicine.

[2248]  M. Leinonen,et al.  ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS Implications for Vaccine Development and Pathogenesis , 1983, The Lancet.

[2249]  K. Holmes,et al.  Genital herpes simplex virus infections: clinical manifestations, course, and complications. , 1983, Annals of internal medicine.

[2250]  G. Ayliffe,et al.  Contamination of protective clothing and nurses' uniforms in an isolation ward. , 1983, The Journal of hospital infection.

[2251]  J. N. Varghese,et al.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase , 1983, Nature.

[2252]  B. Murray,et al.  High-level resistance to gentamicin in clinical isolates of enterococci. , 1983, The Journal of infectious diseases.

[2253]  J. Niederhuber,et al.  Totally implanted venous and arterial access system to replace external catheters in cancer treatment. , 1982, Surgery.

[2254]  R. Fromtling,et al.  Serotype B/C Cryptococcus neoformans isolated from patients in nonendemic areas , 1982, Journal of clinical microbiology.

[2255]  D. Fry,et al.  Enterococcal Bacteremia Clinical Implications and Determinants of Death , 1982, Annals of surgery.

[2256]  G. Simon,et al.  Efficacy of ceftriaxone in serious bacterial infections , 1982, Antimicrobial Agents and Chemotherapy.

[2257]  E. Crawford,et al.  Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. , 1982, The Journal of urology.

[2258]  Sumarmo,et al.  Failure of hydrocortisone to affect outcome in dengue shock syndrome. , 1982, Pediatrics.

[2259]  C. Mitrakul,et al.  Pulse therapy in severe form of dengue shock syndrome. , 1981, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[2260]  J. Warner,et al.  Bacteremia and bacteriuria after transrectal prostatic biopsy. , 1981, Urology.

[2261]  F. Waldvogel,et al.  Gentamicin inactivation in purulent exudates: role of cell lysis. , 1980, The Journal of infectious diseases.

[2262]  D. Krogstad,et al.  Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall , 1980, Antimicrobial Agents and Chemotherapy.

[2263]  P. Raibaud,et al.  R-plasmic transfer from Serratia liquefaciens to Escherichia coli in vitro and in vivo in the digestive tract of gnotobiotic mice associated with human fecal flora , 1980, Infection and immunity.

[2264]  R. Stern,et al.  Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis. , 1979, The Journal of infectious diseases.

[2265]  S. Cho,et al.  Opportunistic fungal infection among cancer patients. A ten-year autopsy study. , 1979, American journal of clinical pathology.

[2266]  R. Webster,et al.  Analysis of antigenic drift in recently isolated influenza A (H1N1) viruses using monoclonal antibody preparations. , 1979, Virology.

[2267]  K. Kwon-Chung,et al.  Cryptococcus bacillisporus sp. nov.: Serotype B-C of Cryptococcus neoformans , 1978 .

[2268]  S. N. Zaloguev,et al.  Methods for microbiological and immunological studies of space flight crews , 1978 .

[2269]  C. Potter,et al.  The effects of peroral or local aerosol administration of 1-aminoadamantane hydrochloride (amantadine hydrochloride) on influenza infections of the ferret. , 1977, The Journal of antimicrobial chemotherapy.

[2270]  B. O'leary,et al.  Mining the Apollo and Amor Asteroids , 1977, Science.

[2271]  D. Maki,et al.  A semiquantitative culture method for identifying intravenous-catheter-related infection. , 1977, The New England journal of medicine.

[2272]  K. Kwon-Chung,et al.  Epidemiologic differences among serotypes of Cryptococcus neoformans. , 1977, American journal of epidemiology.

[2273]  S. Halstead,et al.  Antibody-enhanced dengue virus infection in primate leukocytes , 1977, Nature.

[2274]  A. Rouillon,et al.  Transmission of tubercle bacilli: The effects of chemotherapy. , 1976, Tubercle.

[2275]  T. Stamey,et al.  Resistance to nalidixic acid. A misconception due to underdosage. , 1976, JAMA.

[2276]  R. Compans,et al.  Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. , 1976, The Journal of general virology.

[2277]  T. Shwe,et al.  Hydrocortisone in the management of dengue shock syndrome. , 1975, The Southeast Asian journal of tropical medicine and public health.

[2278]  S. Rabinowitz,et al.  Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection , 1975, Infection and immunity.

[2279]  U. Chaturvedi,et al.  Experimentally produced cardiac injury following dengue virus infection. , 1974, Indian journal of pathology & bacteriology.

[2280]  R. Rucker,et al.  Outpatient intravenous medications in the management of cystic fibrosis. , 1974, Pediatrics.

[2281]  M. G. Wheatcroft,et al.  Effects of a Simulated Skylab Mission on the Oral Health of Astronauts , 1974, Journal of dental research.

[2282]  G R Taylor,et al.  Recovery of medically important microorganisms from Apollo astronauts. , 1974, Aerospace medicine.

[2283]  G W Comstock,et al.  The prognosis of a positive tuberculin reaction in childhood and adolescence. , 1974, American journal of epidemiology.

[2284]  J. R. Brown.  Human actinomycosis: A study of 181 subjects* , 1973 .

[2285]  S. Rabinovich.  Rimantadine Therapy of Influenza A Infection in Mice , 1972, Antimicrobial Agents and Chemotherapy.

[2286]  R. Moellering,et al.  Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. , 1971, The Journal of clinical investigation.

[2287]  F. W. Adair,et al.  Resistance of Pseudomonas to quaternary ammonium compounds. I. Growth in benzalkonium chloride solution. , 1969, Applied microbiology.

[2288]  M. Artenstein,et al.  Human immunity to the meningococcus. II. Development of natural immunity. , 1969 .

[2289]  S. Balaya,et al.  Investigations on an outbreak of dengue in Delhi in 1967. , 1969, The Indian journal of medical research.

[2290]  J. Homma,et al.  Dissociation in Pseudomonas aeruginosa. , 1968, The Japanese journal of experimental medicine.

[2291]  D. E. Carey,et al.  Concurrent Isolation from Patient of Two Arboviruses, Chikungunya and Dengue Type 2 , 1967, Science.

[2292]  P. Sparling.  Genetic Transformation of Neisseria gonorrhoeae to Streptomycin Resistance , 1966, Journal of bacteriology.

[2293]  H. Gelfand,et al.  THE EPIDEMIC OF ACUTE HAEMORRHAGIC FEVER, CALCUTTA, 1963: EPIDEMIOLOGICAL INQUIRY. , 1964, The Indian journal of medical research.

[2294]  M. Paulshock,et al.  Antiviral Activity of 1-Adamantanamine (Amantadine) , 1964, Science.

[2295]  L. Pine.  RECENT DEVELOPMENTS ON THE NATURE OF THE ANAEROBIC ACTINOMYCETES. , 1963, Annales de la Societe belge de medecine tropicale.

[2296]  T. Watanabe.  Infective heredity of multiple drug resistance in bacteria. , 1963, Bacteriological reviews.

[2297]  E. D. Kilbourne,et al.  Airborne Transmission of Influenza Virus Infection in Mice , 1962, Nature.

[2298]  W. D. Tigertt.  Soviet viable Pasteurella tularensis vaccines. A review of selected articles. , 1962, Bacteriological reviews.

[2299]  C. Evans,et al.  Hypothermia in Mice Due to Influenza Virus Infection.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2300]  K. Eriksen,et al.  “Celbenin”-resistant Staphylococci , 1961, Ugeskrift for laeger.

[2301]  C. Shepard.  NONACID-FAST BACTERIA AND HeLa CELLS: THEIR UPTAKE AND SUBSEQUENT INTRACELLULAR GROWTH , 1959, Journal of bacteriology.

[2302]  M. Glahn.  Cervico-facial actinomycosis; etiology and diagnosis. , 1954, Acta chirurgica Scandinavica.

[2303]  J. Shaw,et al.  Infectivity of pulmonary tuberculosis in relation to sputum status. , 1954, American review of tuberculosis.

[2304]  D. Sher.  Waterhouse-Friderichsen syndrome. , 1949, Minnesota medicine.

[2305]  D. Mitchison,et al.  Streptomycin Resistance in Pulmonary Tuberculosis , 1948, British medical journal.

[2306]  M. Barber,et al.  Infection by penicillin-resistant staphylococci. , 1948, Lancet.

[2307]  J. Bigger.  TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION , 1944 .

[2308]  L. Foshay,et al.  Vaccine Prophylaxis against Tularemia in Man. , 1942, American journal of public health and the nation's health.

[2309]  F. Womack,et al.  OBSERVATIONS ON THE INFECTION OF CHICK EMBRYOS WITH BACTERIUM TULARENSE, BRUCELLA, AND PASTEURELLA PESTIS , 1941, The Journal of experimental medicine.

[2310]  M. D. Eaton.  Transmission of Epidemic Influenza Virus in Mice by Contact , 1940, Journal of bacteriology.

[2311]  A. A. Smorodintseff,et al.  INVESTIGATION ON VOLUNTEERS INFECTED WITH THE INFLUENZA VIRUS , 1937 .

[2312]  T. Francis,et al.  IMMUNOLOGICAL STUDIES WITH THE VIRUS OF INFLUENZA , 1935, The Journal of experimental medicine.

[2313]  I. C. Hall,et al.  INTESTINAL FLORA IN NEW-BORN INFANTS: WITH A DESCRIPTION OF A NEW PATHOGENIC ANAEROBE, BACILLUS DIFFICILIS , 1935 .

[2314]  R. Shope.  THE INFECTION OF FERRETS WITH SWINE INFLUENZA VIRUS , 1934, The Journal of experimental medicine.

[2315]  W. B. Wherry,et al.  Infection of Man with Bacterium Tularense , 1914 .

[2316]  Susan,et al.  Aspergillus species and other moulds in respiratory samples from cystic fibrosis patients: A laboratory-based study with focus on azole-resistance in Aspergillus fumigatus , 2019 .

[2317]  P. Chandrasekar,et al.  Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations , 2016, Infection and drug resistance.

[2318]  R. Zell,et al.  Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2. , 2016, The Journal of antimicrobial chemotherapy.

[2319]  P. Burgel,et al.  Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy , 2016 .

[2320]  Tim Schmitz,et al.  Principles And Practice Of Clinical Virology , 2016 .

[2321]  L. Dinis,et al.  Susceptibility to ultraviolet light C of Pseudomonas aeruginosa biofilms from hydropathic respiratory treatment equipments: impact in water quality control and public health , 2015 .

[2322]  L. Rice,et al.  Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2323]  K. Radigan,et al.  Modeling human influenza infection in the laboratory , 2015, Infection and drug resistance.

[2324]  N. Magné,et al.  Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia , 2015, Biomedical journal.

[2325]  Y. Hakozaki,et al.  Lemierre's Syndrome Associated with Periodontal Injury-derived Odontogenic Infection that Did Not Respond to Meropenem. , 2015, Internal medicine.

[2326]  Haiyin Wang,et al.  Use of genome sequencing to assess nucleotide structure variation of Staphylococcus aureus strains cultured in spaceflight on Shenzhou-X, under simulated microgravity and on the ground. , 2015, Microbiological research.

[2327]  J. Ha,et al.  Lemierre's syndrome - an unusual complication of otitis externa in a young, healthy female. , 2015, The Journal of laryngology and otology.

[2328]  C. Arias,et al.  Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species , 2015 .

[2329]  F. Bruyère,et al.  Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. , 2015, The Journal of urology.

[2330]  V. Seija,et al.  Sepsis caused by New Delhi metallo-β-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: case report and literature review. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2331]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2332]  G. Sharma,et al.  Pseudomonas aeruginosa biofilm: potential therapeutic targets. , 2014, Biologicals : journal of the International Association of Biological Standardization.

[2333]  H. Elphick,et al.  Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. , 2014, The Cochrane database of systematic reviews.

[2334]  M. Thursz,et al.  HCV transmission in industrialized countries and resource-constrained areas , 2014, Nature Reviews Gastroenterology &Hepatology.

[2335]  S. Piscitelli,et al.  Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics. , 2014, Pharmacogenomics.

[2336]  J. Shimada,et al.  Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2337]  Matthias Cavassini,et al.  [Infectious diseases]. , 2014, Revue medicale suisse.

[2338]  A. Finn,et al.  Advances towards the prevention of meningococcal B disease: a multidimensional story. , 2014, The Journal of infection.

[2339]  [Integrase inhibitor in HIV therapy. Does dolutegravir set new standards?]. , 2014, MMW Fortschritte der Medizin.

[2340]  A. Aggarwal,et al.  Multidrug resistant NDM-1 metallo-beta-lactamase producing Klebsiella pneumoniae sepsis outbreak in a neonatal intensive care unit in a tertiary care center at central India. , 2014, Indian journal of pathology & microbiology.

[2341]  K. Budde,et al.  Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study , 2013 .

[2342]  S. Pournaras,et al.  Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. , 2013, International journal of antimicrobial agents.

[2343]  C. Rice,et al.  Innate immune responses to hepatitis C virus. , 2013, Current topics in microbiology and immunology.

[2344]  K. Laupland,et al.  Outpatient parenteral antimicrobial therapy. , 2013, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[2345]  Y. Niu,et al.  Synthesis of AApeptides. , 2013, Methods in molecular biology.

[2346]  J. Garnacho-Montero,et al.  De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock , 2013, Intensive Care Medicine.

[2347]  K. Kagawa,et al.  Early diagnosis of Lemierre's syndrome based on a medical history and physical findings. , 2013, Internal medicine.

[2348]  M. Mccown,et al.  Vector-borne disease surveillance in puerto rico: pathogen prevalence rates in canines ? Implications for public health and the u.s. Military ? Applying the one health concept. , 2013, Journal of special operations medicine : a peer reviewed journal for SOF medical professionals.

[2349]  Ying-qun Ji,et al.  Lemierre syndrome caused by Arcanobacterium haemolyticum. , 2013, Chinese medical journal.

[2350]  Kenichi Kuroda,et al.  Antimicrobial polymers as synthetic mimics of host-defense peptides. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[2351]  M. Yasuda,et al.  Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2352]  A. Papa,et al.  Lemierre's syndrome presenting to the ED: rapidly fatal sepsis caused by methicillin-susceptible Staphylococcus aureus Staphylococcus protein A type t044. , 2013, The American journal of emergency medicine.

[2353]  B. Cunha,et al.  Mycoplasma pneumoniae preceding Lemierre's syndrome due to Fusobacterium nucleatum complicated by acute Epstein-Barr virus (EBV) infectious mononucleosis in an immunocompetent host. , 2013, Heart & lung : the journal of critical care.

[2354]  J. Blache,et al.  De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study , 2013, Intensive Care Medicine.

[2355]  T. Abramo,et al.  A 10-month-old with Lemierre syndrome complicated by purulent pericarditis. , 2013, The American journal of emergency medicine.

[2356]  R. Hamasuna.  Identification of treatment strategies for Mycoplasma genitalium-related urethritis in male patients by culturing and antimicrobial susceptibility testing , 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2357]  M. Bounthavong,et al.  Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination , 2013, Infection and drug resistance.

[2358]  F. Penin,et al.  Hepatitis C virus proteins: from structure to function. , 2013, Current topics in microbiology and immunology.

[2359]  Huldrych F. Günthard,et al.  Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. , 2012, JAMA.

[2360]  S. Pendle,et al.  Reactive arthritis associated with proctitis due to Chlamydia trachomatis serovar L2b. , 2012, Sexually transmitted diseases.

[2361]  M. Yasuda,et al.  Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2362]  R. Cantón,et al.  MALDI-TOF MS improves routine identification of non-fermenting Gram negative isolates from cystic fibrosis patients. , 2012, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2363]  F. Cockerill.  Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement;[... provides updated tables for... M02-A11 and M07-A9]. , 2012 .

[2364]  N. Rouphael,et al.  Neisseria meningitidis: biology, microbiology, and epidemiology. , 2012, Methods in molecular biology.

[2365]  A. Kritski,et al.  Epidemiological aspects of tuberculosis in children and adolescents in Rio de Janeiro. , 2012, Jornal de pediatria.

[2366]  Kousuke Saito,et al.  Clinical effectiveness of neuraminidase inhibitors—oseltamivir, zanamivir, laninamivir, and peramivir—for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010–2011 influenza season in Japan , 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2367]  P. Nordmann,et al.  NDM-4 Metallo- (cid:1) -Lactamase with Increased Carbapenemase Activity from Escherichia coli , 2012 .

[2368]  Pei Wang,et al.  Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells , 2013, PloS one.

[2369]  A. Tunkel,et al.  Meningococcal Vaccines , 2012, BioDrugs.

[2370]  A. V. van Toorenenbergen.  Between-laboratory quality control of automated analysis of IgG antibodies against Aspergillus fumigatus. , 2012, Diagnostic microbiology and infectious disease.

[2371]  J. Roberts,et al.  The Clinical Relevance of Plasma Protein Binding Changes , 2012, Clinical Pharmacokinetics.

[2372]  N. Fishman,et al.  Healthcare Infection Control Practices Advisory Committee , 2012 .

[2373]  T. Harris,et al.  Seasonality of tuberculosis in New York City, 1990-2007. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[2374]  G. Papadopoulos,et al.  Economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in Canada. , 2012, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[2375]  Experiences from the Shiga toxin-producing Escherichia coli O 104 : H 4 outbreak in Germany and research needs in the field , 2012 .

[2376]  R. Pradl,et al.  Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial , 2012, Critical Care.

[2377]  James Davis,et al.  The Breadth of Hospital-Acquired Pneumonia : Nonventilated versus Ventilated Patients in Pennsylvania , 2012 .

[2378]  J. Carlet,et al.  Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin? , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2379]  D. Paterson,et al.  Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill , 2012 .

[2380]  D. Nathwani,et al.  Junior doctors' knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2381]  J. Rello,et al.  Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis , 2011 .

[2382]  Guy Boivin,et al.  Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. , 2011, The Journal of infectious diseases.

[2383]  Matthew Biggerstaff,et al.  Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2384]  J. Dungan.  Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects , 2011 .

[2385]  Pw Taylor,et al.  Stability of medications in space: therapeutic implications for extended duration space missions. , 2011 .

[2386]  J. Vestbo.  Community Transmission of Oseltamivir-Resistant A(H1N1)pdm09 Influenza , 2011 .

[2387]  T. Tsukamoto,et al.  Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis , 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[2388]  J. Vallés,et al.  Health-care-associated bloodstream infections at admission to the ICU. , 2011, Chest.

[2389]  H. Stephens,et al.  HLA and other gene associations with dengue disease severity. , 2010, Current topics in microbiology and immunology.

[2390]  Sascha Sauer,et al.  Mass spectrometry tools for the classification and identification of bacteria , 2010, Nature Reviews Microbiology.

[2391]  P. Glue,et al.  Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir. , 2010, British journal of clinical pharmacology.

[2392]  W. Stamm,et al.  Chlamydia trachomatis (Trachoma, Perinatal Infections, Lymphogranuloma Venereum, and Other Genital Infections) , 2010 .

[2393]  F. Penin,et al.  The domain 2 of the HCV NS5A protein is intrinsically unstructured. , 2010, Protein and peptide letters.

[2394]  W. Bowie,et al.  Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital. , 2010, The Journal of emergency medicine.

[2395]  Á. Atallah,et al.  De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. , 2010, The Cochrane database of systematic reviews.

[2396]  M. Momol,et al.  Phage therapy for plant disease control. , 2010, Current pharmaceutical biotechnology.

[2397]  S. Aaron,et al.  The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. , 2010, Chest.

[2398]  A. Oliver,et al.  Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. , 2010, Clinical Microbiology and Infection.

[2399]  G. Schecter,et al.  Linezolid in the treatment of multidrug-resistant tuberculosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2400]  Satyajit Das,et al.  PRO 140--a novel CCR5 co-receptor inhibitor. , 2010, Recent patents on anti-infective drug discovery.

[2401]  J. Campos,et al.  Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. , 2010, Current opinion in infectious diseases.

[2402]  M. Gazagnes,et al.  [Lemierre's syndrome]. , 2010, Annales francaises d'anesthesie et de reanimation.

[2403]  A. Del Arco,et al.  Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2404]  S. Grau,et al.  [Stability: a factor to consider in antibiotic-lock solutions]. , 2010, Enfermedades infecciosas y microbiologia clinica.

[2405]  J. Bartlett,et al.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2406]  T. D. de Kievit.  Quorum sensing in Pseudomonas aeruginosa biofilms. , 2009, Environmental microbiology.

[2407]  J. Poolman,et al.  Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years. , 2009, Vaccine.

[2408]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[2409]  S. Fukuhara,et al.  Antibiotic prescriptions for upper respiratory tract infection in Japan. , 2009, Internal medicine.

[2410]  B. Eley,et al.  High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2411]  L. Worona-Dibner.  [Randomized, double-blind, placebo-controlled trial: Effect of Lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children]. , 2009, Revista de gastroenterologia de Mexico.

[2412]  A. Vicens Vicens,et al.  [Antibiotic prophylaxis in transrectal prostate biopsy]. , 2009, Actas urologicas espanolas.

[2413]  Frederick Hayden,et al.  Developing new antiviral agents for influenza treatment: what does the future hold? , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2414]  S. DeMarco,et al.  Recent progress in the discovery of macrocyclic compounds as potential anti-infective therapeutics. , 2009, Current medicinal chemistry.

[2415]  William M. Lee,et al.  Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. , 2009, Gastroenterology.

[2416]  D. Levine,et al.  Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[2417]  M. Dupon,et al.  [Management of 315neutropenic febrile episodes in a cancer center]. , 2009, Medecine et maladies infectieuses.

[2418]  Susan Olender,et al.  Advances in antiretroviral therapy. , 2009, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[2419]  James M Williams.  2009 update in prevention, evaluation, and outpatient treatment of influenza. , 2009, Current medical research and opinion.

[2420]  A. Krieg,et al.  NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS. , 2009, Microbes and infection.

[2421]  L. Gubareva,et al.  Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt. , 2009, Journal of infection and public health.

[2422]  L. Gubareva,et al.  Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. , 2009, Antiviral research.

[2423]  D. Livermore.  Defining an extended-spectrum beta-lactamase. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2424]  Michael J. Smith.  Meningococcal tetravalent conjugate vaccine. , 2008, Expert opinion on biological therapy.

[2425]  J. Wei.  Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? , 2008 .

[2426]  G. Rossolini,et al.  The spread of CTX-M-type extended-spectrum beta-lactamases. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2427]  J. Guinea,et al.  Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections. , 2008, Future microbiology.

[2428]  S. Wann,et al.  Community-associated methicillin-resistant Staphylococcus aureus infective endocarditis with Panton-Valentine leukocidin gene in an injection drug user with HIV infection. , 2008, Internal medicine.

[2429]  E. Jirillo.  Hepatitis C virus disease : immunobiology and clinical applications , 2008 .

[2430]  G. Peters,et al.  Basic aspects of the pathogenesis of staphylococcal polymer-associated infections , 2007, Infection.

[2431]  H. Ward,et al.  Lymphogranuloma venereum in the United kingdom. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2432]  R. Daum,et al.  Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. , 2007, The New England journal of medicine.

[2433]  M. Baucus.  National Association of Children's Hospitals , 2007 .

[2434]  D. Caugant,et al.  Lessons from meningococcal carriage studies. , 2007, FEMS microbiology reviews.

[2435]  D. Klaus,et al.  Microgravity, bacteria, and the influence of motility , 2007 .

[2436]  M. Rohde,et al.  Pseudomonas aeruginosa cupA-encoded fimbriae expression is regulated by a GGDEF and EAL domain-dependent modulation of the intracellular level of cyclic diguanylate. , 2007, Environmental microbiology.

[2437]  O. Haller,et al.  Pathogenic Viruses: Smart Manipulators of the Interferon System , 2007, Current topics in microbiology and immunology.

[2438]  R. Daum,et al.  Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton–Valentine leukocidin , 2007, Laboratory Investigation.

[2439]  D. Stephens.  Conquering the meningococcus. , 2007, FEMS microbiology reviews.

[2440]  S. Gellman,et al.  Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. , 2007, Journal of the American Chemical Society.

[2441]  K. Tateda,et al.  Stability of FR264205 against AmpC beta-lactamase of Pseudomonas aeruginosa. , 2007, International journal of antimicrobial agents.

[2442]  Adela M. Luján,et al.  Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. , 2007, Microbiology.

[2443]  H. Tamamura,et al.  Development of low molecular weight CXCR4 antagonists by exploratory structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. , 2007, Current medicinal chemistry.

[2444]  Fred C Tenover,et al.  Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2445]  H. Tamamura,et al.  Therapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agents. , 2007, Biopolymers.

[2446]  D. Trunkey,et al.  Emergency medicine in space. , 2007, The Journal of emergency medicine.

[2447]  G. Torpier,et al.  Preliminary results , 2007 .

[2448]  P. Gardner.  Clinical practice. Prevention of meningococcal disease. , 2006, The New England journal of medicine.

[2449]  J. Rello,et al.  Risk Factors for Ventilator-associated Pneumonia by Pseudomonas aeruginosa in Presence of Recent Antibiotic Exposure , 2006, Anesthesiology.

[2450]  Patrice Courvalin,et al.  Vancomycin resistance in gram-positive cocci. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2451]  D. Nickle,et al.  Human Immunodeficiency Virus Type 1 env Evolves toward Ancestral States upon Transmission to a New Host , 2006, Journal of Virology.

[2452]  Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006. , 2006, MMWR. Morbidity and mortality weekly report.

[2453]  Gerda Horneck,et al.  General human health issues for Moon and Mars missions: Results from the HUMEX study , 2006 .

[2454]  Laurent Poughon,et al.  HUMEX, a study on the survivability and adaptation of humans to long-duration exploratory missions, part II: Missions to Mars , 2006 .

[2455]  M. Chung,et al.  Thoracic actinomycosis: CT features with histopathologic correlation. , 2006, AJR. American journal of roentgenology.

[2456]  S. Bantia,et al.  Anti-influenza virus activity of peramivir in mice with single intramuscular injection. , 2006, Antiviral research.

[2457]  F. Aarestrup.  Antimicrobial resistance in bacteria of animal origin , 2006 .

[2458]  K. Lyseng-Williamson,et al.  Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes. , 2006 .

[2459]  Nikolai Polikarpov,et al.  Survey of environmental biocontamination on board the International Space Station. , 2006, Research in microbiology.

[2460]  Chong-Jen Yu,et al.  Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: clinical features, risk-factors and outcomes. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2461]  D. Stevens.  The role of vancomycin in the treatment paradigm. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2462]  A. Fluit.  Towards more virulent and antibiotic-resistant Salmonella? , 2005, FEMS immunology and medical microbiology.

[2463]  Shobha Broor,et al.  Serodiagnosis of dengue during an outbreak at a tertiary care hospital in Delhi. , 2005, The Indian journal of medical research.

[2464]  R. Smego,et al.  Cervicofacial actinomycosis: Diagnosis and management , 2005, Current infectious disease reports.

[2465]  G. Rossolini,et al.  Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2466]  Donald R Graham,et al.  Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2467]  J. Malfuson,et al.  [A 7-year survey of strains identified in blood cultures in a clinical hematology unit]. , 2004, Medecine et maladies infectieuses.

[2468]  R. Wenzel,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Emerging Resistance among Bacterial Pathogens in the Intensive Care Unit – a European and North American Surveillance Study (2000–2002) Intensive-care Unitantibiotic Susceptibility , 2022 .

[2469]  John W. Beaber,et al.  SOS response promotes horizontal dissemination of antibiotic resistance genes , 2004, Nature.

[2470]  C. Hart,et al.  Meningococcal Disease , 1974, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2471]  K. Itani,et al.  Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2472]  D. Vaughn,et al.  Dengue epidemiology: virus epidemiology, ecology, and emergence. , 2003, Advances in virus research.

[2473]  M. Björkholm,et al.  Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. , 2003, The hematology journal : the official journal of the European Haematology Association.

[2474]  A. Espinel-Ingroff.  Medical Mycology in the United States , 2003, Springer Netherlands.

[2475]  Jeffrey F Peipert,et al.  Clinical practice. Genital chlamydial infections. , 2003, The New England journal of medicine.

[2476]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2477]  N. Hanson.  AmpC beta-lactamases: what do we need to know for the future? , 2003, The Journal of antimicrobial chemotherapy.

[2478]  E. Erbelding.  Glycoprotein D-adjuvant vaccine to prevent genital herpes. , 2003, Current infectious disease reports.

[2479]  R. Webster,et al.  Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. , 2002, Antiviral research.

[2480]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[2481]  G. O’Toole,et al.  Mechanisms of biofilm resistance to antimicrobial agents. , 2001, Trends in microbiology.

[2482]  J. Andrews.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[2483]  M. Kino,et al.  [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections]. , 2001, The Japanese journal of antibiotics.

[2484]  A. Antoniadou,et al.  Antipseudomonal antibiotics. , 2001, The Medical clinics of North America.

[2485]  A. Nisalak,et al.  Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. , 2000, The Journal of infectious diseases.

[2486]  P. K. Sullivan,et al.  A comparative study of the effects of UVC irradiation on select procaryotic and eucaryotic wound pathogens. , 2000, Ostomy/wound management.

[2487]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[2488]  S. Calderwood,et al.  Cholera vaccines. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2489]  G. Löwhagen,et al.  Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden. , 2000, International journal of STD & AIDS.

[2490]  J. Perfect,et al.  Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. , 2000, The Journal of antimicrobial chemotherapy.

[2491]  Oleg O. Bilukha,et al.  Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[2492]  G. Duckworth,et al.  Escherichia coli O157 incident associated with a farm open to members of the public. , 1999, Communicable disease and public health.

[2493]  N. Anderson,et al.  An early intervention program for adolescent mothers: a nursing demonstration project. , 1999, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[2494]  Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. , 1999, MMWR. Morbidity and mortality weekly report.

[2495]  S. Jagannath,et al.  Problem of Tuberculosis Among Children in the Community : Situation Analysis in the Perspective Of Tuberculosis in India , 1999 .

[2496]  C. Dewey,et al.  Use of antimicrobials in swine feeds in the United States , 1999 .

[2497]  M. O'riordan,et al.  Infections in children with cancer: a continued need for the comprehensive physical examination. , 1999, Journal of pediatric hematology/oncology.

[2498]  A. Sjöstedt,et al.  Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. , 1999, Infection and immunity.

[2499]  B. Sheff,et al.  Neisseria meningitidis , 1999, Nursing.

[2500]  M. Kacena,et al.  Gentamicin: effect on E. coli in space. , 1999, Microgravity science and technology.

[2501]  H. Kock,et al.  Implantable Vascular Access Systems: Experience in 1500 Patients with Totally Implanted Central Venous Port Systems , 1998, World Journal of Surgery.

[2502]  B. Murray,et al.  Diversity among multidrug-resistant enterococci. , 1998, Emerging infectious diseases.

[2503]  J. Turnidge.  The pharmacodynamics of beta-lactams. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2504]  G. Ayliffe.  The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2505]  D M Fleming,et al.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. , 1997, The New England journal of medicine.

[2506]  A. Gabrielli,et al.  Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. , 1997, Annals of internal medicine.

[2507]  P. Gilbert,et al.  Antibiotic resistance of biofilms. , 1996, Biofouling.

[2508]  L. Liaudet,et al.  Cutaneous and muscular abscesses secondary to Actinomyces meyeri pneumonia. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2509]  A. Sjöstedt,et al.  The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. , 1996, Microbiology.

[2510]  D. Patel,et al.  Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases. , 1996, Microbial drug resistance.

[2511]  T. Bergström,et al.  Antigenic differences between HSV-1 and HSV-2 glycoproteins and their importance for type-specific serology. , 1996, Intervirology.

[2512]  K. Reddy,et al.  Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group. , 1996, Annals of internal medicine.

[2513]  E. Gotuzzo,et al.  Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru. , 1995, Vaccine.

[2514]  I. Golovliov,et al.  Adjuvanticity of ISCOMs incorporating a T cell-reactive lipoprotein of the facultative intracellular pathogen Francisella tularensis. , 1995, Vaccine.

[2515]  C. Dekker,et al.  A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]. , 1995, Annals of internal medicine.

[2516]  J. Maniloff,et al.  Virus taxonomy : eighth report of the International Committee on Taxonomy of Viruses , 2005 .

[2517]  G. Koumakis,et al.  Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis. , 1995, Bone marrow transplantation.

[2518]  C. Woldringh,et al.  Growth and division of Escherichia coli under microgravity conditions. , 1994, Research in microbiology.

[2519]  J. Rello,et al.  Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. , 1994, Intensive care medicine.

[2520]  R. Esteban,et al.  Epidemiology of hepatitis C virus infection. , 1993, Journal of hepatology.

[2521]  W. J. Bean,et al.  Influenza--a model of an emerging virus disease. , 1993, Intervirology.

[2522]  D. Wolf,et al.  Cell culture for three-dimensional modeling in rotating-wall vessels: an application of simulated microgravity. , 1992, Journal of tissue culture methods : Tissue Culture Association manual of cell, tissue, and organ culture procedures.

[2523]  A. Goldstone,et al.  Teicoplanin and prophylaxis of Hickman catheter insertions. , 1992, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[2524]  C. Janeway,et al.  The immune system evolved to discriminate infectious nonself from noninfectious self. , 1992, Immunology today.

[2525]  C. Richardson,et al.  Longitudinal Studies Of Virulence Factors of Pseudomonas Aeruginosa in Cystic Fibrosis , 1991, Pathology.

[2526]  W. Cates,et al.  Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. , 1990, Epidemiologic reviews.

[2527]  C. Janeway.  Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[2528]  J. Heffner.  Pleuropulmonary manifestations of actinomycosis and nocardiosis. , 1988, Seminars in respiratory infections.

[2529]  P. Pecco,et al.  Short-term treatment of streptococcal tonsillitis with ceftriaxone. , 1988, Chemotherapy.

[2530]  R. Michod,et al.  DNA repair and the evolution of transformation in the bacterium Bacillus subtilis. , 1988, Genetics.

[2531]  P. Lerner.  The lumpy jaw. Cervicofacial actinomycosis. , 1988, Infectious disease clinics of North America.

[2532]  A R Hinman,et al.  Field evaluation of vaccine efficacy. , 1985, Bulletin of the World Health Organization.

[2533]  D. Weir,et al.  The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization. , 1985, Clinical and experimental immunology.

[2534]  N N Liz'ko,et al.  [The quantitative composition of the intestinal lactoflora before and after space flights of different lengths]. , 1984, Die Nahrung.

[2535]  V. V. Portugalov,et al.  [Effect of a 22-day space flight on the lymphoid organs of rats]. , 1977, Kosmicheskaia biologiia i aviakosmicheskaia meditsina.

[2536]  M. Widya,et al.  Clinical observations on dengue shock syndrome (an evaluation of steroid treatment). , 1975, Paediatrica Indonesiana.

[2537]  J. Dhar,et al.  Oral lymphogranuloma venereum and cervical lymphadenopathy. , 1974 .

[2538]  B. Pongpanich,et al.  Studies on dengue hemorrhagic fever. Clinical study: an evaluation of steroids as a treatment. , 1973, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[2539]  V. Shilov,et al.  Microbiological and immunological aspects of extended manned space flights. , 1971, Life sciences and space research.

[2540]  M. Varkey,et al.  Dengue outbreak in Vellore, southern India, in 1968, with isolation of four dengue types from man and mosquitoes. , 1970, The Indian journal of medical research.

[2541]  S. Ferebee.  Controlled chemoprophylaxis trials in tuberculosis. A general review. , 1970, Bibliotheca tuberculosea.

[2542]  B. Ghosh.  A study on the epidemic of dengue-like fever in Pondicherry. (1964-65 and 1965-66). , 1968, Journal of the Indian Medical Association.

[2543]  R Narain,et al.  Distribution of tuberculous infection and disease among households in a rural community. , 1966, Bulletin of the World Health Organization.

[2544]  S. Chatterjee,et al.  Virological investigation of cases with neurological complications during the outbreak of haemorrhagic fever in Calcutta. , 1965, Journal of the Indian Medical Association.

[2545]  S. Chatterjee,et al.  HAEMORRHAGIC FEVER IN CALCUTTA: SOME EPIDEMIOLOGICAL OBSERVATIONS. , 1964, The Indian journal of medical research.

[2546]  T. Woodward,et al.  Studies on human infection with Pasteurella tularensis; comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease. , 1957, Transactions of the Association of American Physicians.

[2547]  J. Parks,et al.  Lymphogranuloma venereum. , 1947, American practitioner and digest of treatment.

[2548]  P. Chandrasekar,et al.  Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients , 2012, Infection and drug resistance.

[2549]  S. Choi,et al.  Risk Factors for Mortality in Patients with Invasive Mucormycosis , 2013, Infection & chemotherapy.

[2550]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .

[2551]  R. Tuckuviene,et al.  submit your manuscript | www.dovepress.com , 2022 .